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Inter-individual variations exist in response to dietary factors and to the 
pathophysiologic development of endpoints related to vascular diseases and cognitive 
impairment. Therefore, the evaluation and characterisation of responses to a dietary 
intervention targeting vascular and cognitive health is of importance. A series of 
investigations were set out. Firstly, previous evidence of randomised controlled trials 
(RCTs) supplementing fruit and targeting vascular and/or cognitive improvement was 
sought and evaluated by systematic reviews incorporating meta-analyses. Collectively, 
the reviews have shown that the consumption of berries with dosage ranging from 22 
to 45 g powder, 150 to 300 g frozen berry and 100 to 500 ml juice resulted in a 3.68 
mmHg reduction on systolic blood pressure and 1.68 mmHg reduction on DBP. A 
human dietary intervention with 37 participants was performed comparing two forms 
of blueberry; either whole fresh blueberry (160 g), freeze-dried blueberry powder (20 
g) or placebo control (microcrystalline cellulose) in a 1-week single-blinded cross-over 
RCT in a relatively young outwardly healthy population. There was no significant effect 
of either blueberry intervention to improve either vascular function or cognition. No 
significant putative discriminating urinary metabolites between interventions were 
found using supervised multivariate analysis. The response to the intervention was 
calculated for each endpoint using percentage change (+ / -%) compared to the 
baseline. Extensive inter-individual variation was found in vascular health parameters 
(- 141 % - + 525 %) and cognitive domains (- 114 % - + 96 %) post-interventions, but 
there was no consistent response following the two interventions between and within 
participants. Although several discriminatory metabolites were found between 
responder (RS) and non-responder (NRS) groups it was not possible to identify 
predictors of response using receiver-operator-curve analysis. To conclude, we did 
not find a predictive urinary metabolite as a potential biomarker for differentiating 
between RS and NRS and no consistent individual responses following both blueberry 
and blueberry powder interventions were found. This is the first blueberry intervention 
applying quartile division to characterise response in vascular and cognitive endpoints 
following a specific dietary intervention. The overall approach for defining a metabolic 
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Cognitive decline and impaired vascular function are common and important 
characteristics that differ in extent between individuals [1, 2]. Cognitive decline with 
ageing has been shown to increase the risk of neurodegenerative diseases and 
impaired vascular function is also involved in the pathogenesis of cardiovascular 
diseases (CVD) [1, 2]. The modulation of cognition and vascular function by normal 
genetic variation is well established while individual variation is mainly influenced by 
lifestyle behaviours, with an unbalanced diet being one of them [1, 3, 4].  Therefore, 
to identify individuals that show improved responses following a specific dietary 
intervention can help to improve an individual’s dietary regime to maximise health 
benefits. 
 
Recent developed technologies allow the use of high-throughput ‘-omic’ analysis in 
nutritional research [5], and metabolomic analysis can help to identify variations in 
metabotypes across individuals that show different responses to the biological 
endpoints. Overall, this PhD programme investigated dietary whole blueberry and 
freeze-dried blueberry powder interventions aimed at improving a range of endpoints 
related to vascular function and cognition and characterised the inter-individual 
variation in each endpoint to categorise participants as responders (RS) or non-
responders (NRS) to the intervention. Finally, we aimed to identify metabolic 
predictors of response to the intervention using metabolomics. 
 
1.1.1 Vascular function and vascular assessments 
 
Cardiovascular disease (CVD) is currently one of the major causes of death worldwide. 
World Health Organisation (WHO) has reported that 31 % of global death (17.9 million) 
in 2016 were attributable to CVD [6]. Therefore, vascular homeostasis and function 
are important for health and well-being. Improvement of blood pressure, the plasma 
lipid profile including cholesterol and triglycerides have been shown to associate with 
risk reduction for CVD [7]. Therefore, maintaining normal blood pressure level and 
blood lipid profile were important for maintaining normal vascular function. Endothelial 
function is also an important indicator of vascular health. Endothelial dysfunction is a 
pathological state of the vascular endothelium (the inner layer of blood vessels) and 
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is a major manifestation underlying atherosclerosis, CVD or other vascular diseases 
[8]. The key to healthy ageing in terms of vascular change is also to maintain 
homeostasis of endothelial function [9]. The circulating endothelial-dependent relaxing 
factor, nitric oxide (NO), possesses a wide range of biological properties that regulate 
vascular homeostasis, modulate vascular dilator tone, balance local cell growth and 
protect the vessels from platelets aggregation, indicating an essential role in 
maintaining normal vascular function [10].  
 
There are different non-invasive methods assessing vascular health in human 
interventions that contribute to inter-individual variation in response to the assessment 
tools [11]. The most prevalent measurements utilised in previous studies assessing 
vascular health include pulse wave velocity (PWV) for assessing arterial stiffness and 
flow-mediated dilation (FMD) for assessing endothelial function [12-15]. Other 
methods assessing vascular health including the reactive hyperaemia index (RHI), 
augmentation index (Aix), the lase doppler flowmetry and iontophoresis have been 
applied in a wide range of studies [16-19]. PWV reflects the speed of the blood 
pressure wave to move down the blood vessel, it is a good indicator of arterial 
dispensability and stiffness [20]. Vascular (dys)function has also been assessed by 
PWV in previous interventions [12-15]. Flow mediated-dilation (FMD) has been largely 
used in studies assessing endothelial (dys)function as the gold standard tool [13, 21-
23]. However, there were also inconclusive reports using FMD, and on other methods 
(e.g. the reactive hyperaemia index/RHI, augmentation index/Aix, the lase Doppler 
flowmetry and iontophoresis etc.) to assess vascular (dys)function [16-19]. The 
methods measuring vascular health have been compared previously and PWV 
presented with better repeatability and reproducibility than FMD, so FMD was not used 
in the current study [11]. It should be noted that the choice of vascular assessment 
tools could explain a level of variation in different interventions, as reviewed in Chapter 
2. 
 
1.1.2 Cognition and cognitive assessments 
 
Cognitive function is comprised of cerebral activities that involve various cognitive 
domains, such as attention and memory, to help our brain process and react to every-
day tasks [24]. Cognitive function is commonly assessed through the domains of 
attention, executive functions, memory functions, language, visual perception and 
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processing, social and emotional processing [25]. The cognitive domains categorised 
in studies often vary depending on the cognitive ability that researchers intend to 
assess, for example, researchers have argued that the information processing speed 
and attention underlie the domain of executive functions [26]. 
 
Neurodegenerative diseases like dementia and Alzheimer’s disease are shown to be 
associated with cognitive impairment [27]. The measurement of cognitive impairment 
is important since the rising prevalence of dementia [27] and the benefits of earlier 
detection and prevention [28]. Cognitive tasks used for the cognitive assessment 
normally depended on the task requirements [25]. For example, for the assessment of 
executive function, tasks such as Stroop Colour and Word Test [29, 30], Serial 3s 
and/or Serial 7s Subtractions [29, 31], Corsi Block-Tapping Task [29], Digit Span 
(backward) [32, 33] are usually used. For memory assessment, tasks such as List 
Learning Tasks and Word Recall (e.g. California Verbal Learning)  [34, 35], Paired 
Associate Verbal Learning Test [31, 32], and Picture Memory are often used [29]. Self-
rated Scales have also been used to assess mood in a range of studies [29-31]. 
However, the impact of blueberry interventions on specific cognitive domains could 
not be quantitatively compared with a number of other trials because of the large 
variability in the assessment tools and scoring interpretations. This concern also 
presented in other dietary trials assessing cognition [36]. For example, the number of 
correct answers or the time taken to complete the task have been interpreted per study 
to assess processing speed, as per the meta-analysis in this area [37]. For example, 
here in the meta-analysis in Chapter 3, we only categorised the time taken to complete 
the task as assessing processing/psychomotor speed and the accuracy (or the 
number of the correct answers) assessing attention or working memory, depending on 
the specific tasks, in order to achieve quantitative comparison across studies. 
Consistently reported cognitive performance tools are recommended for future studies 
to better interpret study results. 
 
1.1.3 Blueberries  
 
Blueberries have become very popular in the United Kingdom. In 2018 the United 
Kingdom imported 48,000 tonnes of blueberry (the genus Vaccinium), together with 
the national production the average annual consumption reached an estimated 0.7 kg 
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per capita [38]. Blueberries contain significant amounts of nutrients, such as vitamin 
K, vitamin C, folate, K, Mn, Cu and an array of polyphenols which have been shown 
to exert neuro- and vascular-protective in vivo and in vitro [39, 40] and for this reason 
are supplemented in the current interventions. Anthocyanins are the major class of 
polyphenols in blueberries (approximately 92 mg/100 g) and include 
monoarabinosides, monoglucosides and monogalactosides of cyanidin (Cy), 
petunidin (Pt), peoni- din (Pn), delphinidin (Dp) and malvidin (Mv) and their glucosides 
[41] (Figure. 1.1). 
 




The anthocyanin profile in berries is a factor explaining variability in the biological 
responses observed in dietary interventions with berries. For instance, blueberries 
contain primarily delphinidin, malvidin, and petunidin whereas raspberries and 
blackberries contain primarily cyanidin, pelargonidin and malvidin [43]. Although 
consumption of anthocyanins can be in the range of 200 mg/d [44], the bioavailability 
appears low as they are believed to be poorly absorbed and rapidly excreted [45]. The 
rate of polyphenol absorption from blueberries could be influenced by dose 
administered [46], and the matrix of the food source [47], and several studies have 
suggested that the rate of anthocyanin absorption is influenced by their chemical 
structure. Targeted analysis of bioactives reveals plasma concentrations of 0 to 4 
micromolar from an approximately 50 mg dose with excretion ranging from 0.3 % to 
43 % [45]. Studies have pointed to an approximately 1 - 2 h peak max in plasma [48-
50], with a peak max in urine from 2 h [50, 51], but metabolites can persist in urine for 
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5 d after consumption [51]. The bioavailability of blueberry metabolites will vary 
between individuals and is dependent on complex absorption, distribution, metabolism 
and excretion (ADME) mechanisms [52]. Variations can be due to phase I and II 
metabolism of blueberry anthocyanins and the enzymes could play a role at the 
microbial, age, smoking, sex, and genetic levels to induce variability in anthocyanin 
metabolism [53, 54]. Indeed, the anthocyanin metabolites such as glucuronides, 
sulphates and glycoside derivates [48-50] formed during phase 2 metabolism, are 
present in large diversity and intensity [51]. Bioavailability has also been compared 
between whole blueberries and blueberry juice. An acute metabolite profiling study 
examined the difference in the plasma and urinary metabolome 2 h following ingestion 
of either blueberry juice or whole blueberries, and found higher intensity of phenolic 
metabolites (including those conjugated to sulphate, glycoside or glucuronide), and 
fatty acyl derivatives in urine following whole blueberry intake compared to blueberry 
juice intake, however further time points are required for a full biokinetic profile [55]. 
Nevertheless, the differences were relatively minor. Furthermore, Kuntz et al. 
compared the bioavailability of selected anthocyanins from grape and blueberry juice 
with a smoothie and found no difference in plasma pharmacokinetics and recovery of 
the major anthocyanin species, but found significantly higher concentrations of the 
phenolic acid 3,4-dihydrobenzoic acid after ingestion of the juice [56]. These data may 
help to explain bioavailability variations in the blueberry products. Also, a systematic 
review has shown that the intake of fruit juice offered similar protection against cancer 
and cardiovascular disease to the intake of whole fruit [57], and thus a similar 
proportion of bioactive phytochemicals must remain in the processed products. 
 
1.1.4 The effect of blueberry intake on vascular function and cognition 
 
The normal functioning of our brain demands energy for various neuronal activities 
(e.g. synthesis and actions of neurotransmitters, nerve impulse propagation, 
metabolism of homocysteine etc.), all these functions require sufficient and constant 
supply of micronutrients to the brain [58, 59], which indicates that dietary factors have 
an important influence on cognitive function. There is also commonly accepted 
evidence from recent years that normal vascular function is also associated with heart-
healthy eating behaviours [60]. One in vivo study observed that only cyanidin and 
delphinidin could induce the inhibitory effect on the redox-sensitive p38 MAPK and c-
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jun-N-terminal kinase pathways that have been  shown to improve platelet function, 
an indicator for reduced blood pressure [61]. This provides a potential mechanism of 
action for benefits to vascular function by blueberry ingestion.  
 
Single nutrients, such as vitamins, minerals, phytochemicals and polyphenols (e.g. 
cocoa flavonoids) from plant - based foods have shown beneficial effects in improving 
cognition, and vascular health [62-66]. However, from nutritional perspective, 
employing single whole foods instead of single components as a supplementation in 
interventions is more reasonable. Unlike natural bioactive compounds, synthetic single 
nutrient supplements are likely to be metabolised through different pathways. For 
example, concern has been raised over the use of supplemental folic acid instead of 
the consumption of leafy green vegetables in that synthetic folic acid is metabolised in 
the liver instead of the gut similar to natural folates [67]. Therefore, the protective 
effects on vascular function and cognition of whole fruit intervention or fruit intervention 
in different forms (e.g. powder, juice) instead of single nutrients are worth exploring.  
 
As reviewed in Chapters 2 & 3, only one study has supplemented whole frozen 
blueberry [68]. There have been interventions supplementing freeze-dried blueberry 
powder (22 - 45 g, 4 - 8 weeks), blueberry juice (480 ml, 8 weeks) that have reported 
either no effects or improved effects on blood pressure (BP) [69-74], PWV [69, 73], 
blood lipids [71, 73, 75] and nitric oxide (NO) [69, 73, 76]. For cognition and mood 
assessment measuring memory, executive function, attention, psychomotor speed or 
mood scales, long term interventions (100 mg extract powder - 200 g whole blueberry 
equivalent, 6 - 24 weeks) have found inconclusive results on cognitive performance 
[29, 68, 77]. 
 
Chapters 2 & 3 & 7 have systematically reviewed and discussed dietary blueberry 
interventions targeting high-risk populations that have demonstrated positive findings 
on the improvement to vascular health and/or cognitive health. In conclusion, low-risk 
populations (< 60 years old and healthy) receiving either blueberry powder or whole 
blueberry (100 mg extract - 560 g whole blueberry equivalent) or concentrate (30 ml) 
supplementations both acutely (1 - 24 h) and chronically (6 - 24 weeks) have shown 
less beneficial effects compared to high-risk populations towards vascular- and 
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cognitive-protective benefit following blueberry consumptions independent of the 
various dosage and duration implemented.  
 
1.1.5 The effect of processing on blueberries  
 
Food processing, food temperature and pH might also modify blueberry anthocyanin 
content bio-accessibility and bioavailability, depending on the technology and 
processing conditions [78]. Processing, such as smashing or thermal conditions, can 
damage the cell structure of blueberry releasing cytoplasmic content that can make 
bioactive compounds like anthocyanins more accessible for absorption [79]. Moreover, 
the presence of other constituents formed from the technological process or added 
from food matrix could modify the bioavailability of the anthocyanins due to their 
liability to bind, solubilize, or stabilize anthocyanins [78]. In previous interventions, the 
blueberry powder was usually consumed with a meal [69, 72] and the interaction with 
the food matrix could be one of the main factors determining bioactive stability and 
accessibility.  
 
In terms of the nutritional value, blueberry powder normally contains a lower sugar 
content compared to the whole blueberry and the glucose load in the fruit matrix has 
been shown to delay anthocyanin absorption, which could result from the competitive 
action of glucose and anthocyanin on the sodium-dependent glucose cotransporter 
SGLT-1 [80]. The blueberry skin is rich in anthocyanins and usually kept during the 
freeze-drying processing of the blueberry to powder [81]. It has also been shown that 
fibre content is contained during the processing from blueberry to powder [82]. The 
technological processing to blueberry powder could also cause increased bio-
accessibility and absorption of bioactives in relation to the whole blueberry [78]. The 
metabolic difference and treatment effects shown following whole blueberry and 
processed blueberry interventions are reviewed and discussed throughout Chapters 




1.1.6 Inter-individual variations in vascular and cognitive response to dietary 
intervention 
 
It is agreed that effective dietary strategies can help to reduce the global burden of 
nutrition-related non-communicable diseases (NCDs) [83]. Most dietary interventions 
and the corresponding guidelines focus on population averages [84, 85]. However, a 
range of recent studies have addressed the high inter-individual variations in response 
to dietary interventions that demand the development of characterising response to 
the clinical endpoints to achieve optimal nutrition [86, 87]. 
 
The characterisation of responses and variation to dietary interventions is important to 
maximise health and optimise personalised nutrition. When exploring the inter-
individual variations in response to the clinical endpoints, standard deviation (SD) is a 
measure of variation at the endpoint and most studies assess the group effect 
andreport SD as a reflection of group response variation [16]. There is also a number 
of studies that have calculated the coefficient of variation (CV) as it is also a 
measurement of group response variation [88, 89]. In the current study the response 
level was calculated taking relative changes to baseline into account for each 
individual, to further illustrate intra-individual changes in response to the intervention.  
 
For the endpoints assessing blood pressure and arterial stiffness as shown in Chapter 
2, blueberry powder studies presented SD of 8.00 - 11.00 mmHg in the response of 
SBP [69-72], SD of 1.20 - 9.77 mmHg in the response of DBP [69-72] and SD of 0.90 
- 2.14 m/s in the response of PWV [69, 70]. It has been shown that lowering SBP by 
5 mmHg or more could decrease CVD risk by 3% to 38% [90, 91] and the minimal 
clinically important difference (MCID) for PWV is a reduction of 1 m/s [92]. Therefore, 
it’s important to explore the range of response following the same intervention at the 
individual level even though the group effect may not be statistically significant. The 
inter-individual variation to intervention endpoints are not limited to fruit 
supplementations. For example, a ketogenic dietary intervention reported a 103 % and 
68 % variation (CV) among participants in response to blood triglyceride and glucose 




For the endpoints assessing cognition and mood, the inter-individual differences in 
cerebral blood flow dynamics, neural correlates, heritability, physical, social 
environment, and personality all constitute complex associations between individual 
response and specific cognitive domain phenotype. The review in Chapter 3 
demonstrated a larger variation across studies assessing memory (SD of 2.2) relative 
to executive function (SD of 0.08 - 0.16) following either blueberry powder or blueberry 
concentrate intervention [77, 93, 94]. Apart from fruit interventions, a large variation in 
the correct response to working memory (SD of 181.35) and mood (SD of 12.71) 
assessments have also been shown among healthy individuals following a 
Mediterranean dietary intervention [95]. There are also multiple factors affecting 
variations in the cognitive response among individuals. It has also been shown that 
age-related changes in cognition and the susceptibility of different cognitive domains 
to ageing are not unitary across all individuals and the susceptibility of cognitive 
domains to ageing are not uniform neither [96]. Certain aspects of memory and 
attention have shown attenuated performance with age while others suggested a 
significant decline [96]. Although from a big picture perspective, cognitive decline 
seems to be one of the deficits seen in ageing [97], many older adults can out-perform 
young adults or at least maintain the same level as the young on some cognitive tasks, 
for instance, to keep good comprehension by effectively using context to interpret 
message in speech and language [98]. In addition to ageing, which has been shown 
to lead to cognitive decline [96], brain structure differences estimated for individuals 
have also been shown to associate with inter-individual variations in cognitive 
functioning [99]. For instance, the variation in response for the choice reaction time 
(the time taken to indicate a choice in cognitive tasks) assessing psychomotor speed 
across individuals has been shown to correlate with brain fractional anisotropy of the 
optic radiation [100]. 
 
Nevertheless, currently the in-depth characterisation of inter-individual variation in 
response to vascular and/or cognitive endpoint following dietary interventions is 
scarce. Potential influencers of inter-individual variation in vascular and cognitive 
response to dietary blueberry interventions include bioavailability and metabolism of 
blueberry polyphenols, SNPs (single nucleotide polymorphisms), and gut microbiota 
between individuals [101]. The health status of participants has also been shown to 
affect the response to dietary interventions in biomarkers of vascular and cognitive 
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functions. For example, individuals with Metabolic syndrome (MetS) have a higher 
degree of endothelial dysfunction (assessed by RHI) compared to individuals with 
multiple CVD risk factors such as elevated blood pressure, waist circumference, lipid 
profile and fasting blood glucose level without MetS [102]. Ageing has also shown to 
be associated with less elastic blood vessels which contributed to the augmented 
vasoconstrictor and reduced vasodilator responsiveness [103]. More studies similar to 
ours that aim to explore the inter-individual variation in response to vascular and/or 
cognitive endpoints following dietary interventions and the factors found to influence 
the response have been compared and contrasted in Chapter 6.  
 
1.1.7 Metabolite profiling for investigating inter-individual variation  
 
Metabolomics is a technique that investigates small-molecule metabolite profiles of 
biological fluids that reflect biochemical processes [5]. Metabolomics explores a whole 
range of endogenous or exogenous metabolite profiles found in a biological system, 
combined with high-throughput analytical chemistry and multivariate data analysis 
[104]. Identification of metabolomic biomarkers has been commonly used in research 
investigating metabolic pathways, thus the approach could pave the way for 
characterising individuals in intervention studies combined with physiological and 
biochemical assessments [105]. Metabolomic profiling has also been extensively used 
in nutritional research including randomised clinical trials and observational studies 
[104].  
 
For example, metabolomic profiles have been characterised and differentiated 
between multiple dietary patterns including a low-fat diet, a low glycaemic index diet, 
a very-low-carbohydrate diet, and a healthy diet concordant with WHO eating 
guidelines [106]. Metabolomic profiling has also been applied to investigate 
metabolomic changes associated with single food intake, such as polyphenol-rich 
foods [107]. Urinary metabolomic profiling following dietary intakes of polyphenol-rich 
foods including coffee, tea, red wine, citrus fruit, apple and pear, and chocolate has 
reported five polyphenol metabolites with a high predicting ability of polyphenol-rich 
food intake [107]. Using untargeted metabolomic profiling, higher intakes of fruit and 
whole grains haven also been shown to link with higher levels of the plasma metabolite 
hippurate that acted as biomarker for reduced odds of having MetS (OR: 0.795[0.082]; 
 
 25 
P = 0.026) [108]. Metabolomic profiling has also been applied to investigate the 
nutrient-metabolism interactions, for example the phospholipid metabolism and pro-
inflammatory response following vitamin E supplementation [109]. Bioavailability of 
bioactive has also been investigated using metabolomic profiling following dietary 
interventions. An investigation of anthocyanin bioavailability following bilberry 
consumption has suggested that about 20 % of anthocyanins could be absorbed in 
the small intestine during 8 h after the ingestion and were detected in both urine and 
plasma circulations (Cmax 777 ± 192 nmol/l) [110]. Metabolomic analysis utilising 
Liquid Chromatography-Mass Spectrometer (LC-MS), as adopted in the current study, 
would also provide analysis of a wide range of small molecules including the 
hydrophilic polyphenols, the main phytochemicals in blueberry [111]. 
 
Inter-individual (between-individual) and intra-individual variations need to be taken 
into account for categorising response following a dietary intervention and usually 
inter-individual variation rather than intra-individual variation could account for most of 
the variability in metabolite profile that showed association with response [112]. For 
example, a prospective longitudinal study used Cox regression and assessed the 
association of metabolite profiles in patients with different cognitive status for 
identifying discriminating metabolites that represent the between - individual variations 
in the cognitive response [113]. After adjustment for lifestyle and physiological factors, 
increased intensity of metabolite N-acetyl-1-methylhistidine was significantly 
associated with greater 6 - year change in Delayed Word Recall scores (β = -0.66 
words; P = 3.65 × 10-4); 2 metabolites (one unnamed and a long-chain omega-6 
polyunsaturated fatty acid found in vegetable oils were significantly associated with 
less decline on the Digit Symbol Substitution Test (β = 1.25 digit-symbol pairs, P = 
9.47 × 10-5); another 2 unnamed compounds and three sex steroid hormones were 
associated with an increased risk of dementia (P < 3.9 × 10-4) [113]. Based on existing 
evidence, metabolic profiling of individuals following blueberry interventions were used 
to explore the biological pathways between blueberry metabolism and the responses 
to vascular and cognitive endpoints in the current thesis.   
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1.2 Novelty of the work  
 
The impact of fruit interventions (different types and processed forms) and their effect 
on improving cognitive/vascular function with a focus on individual responses is 
underexplored in comparison to studies assessing only group effect following an 
intervention. Therefore, the current thesis aims to characterise individual response as 
responder (RS) and non-responder (NRS) group at the both vascular and cognitive 
endpoints following the blueberry interventions. Apart from inter-individual variation 
during metabolism, substantial heterogeneity in the categories and forms of fruit 
chosen and durations in the interventions might also contribute to inconsistent results 
of dietary fruit’s health benefit [16, 114]. So far, the benefits of blueberry consumption 
in cognitive and endothelial decline are inconclusive, and there are insufficient clear 
mechanisms linking blueberry consumption to human cognition or vascular health [41, 
115]. Therefore, the current thesis also aims to investigate the protective benefit of 
chronic dietary blueberry interventions in different forms for both vascular and 
cognitive function using systematic reviews and meta-analysis.  
 
There are emerging needs to investigate metabolomic responses to an intervention 
and to further develop personalised approaches such as the validation of biochemical 
markers and therefore apply them as indicators of diagnosis and treatment of 
cognitive/vascular function decline. Therefore, another aim of the current thesis is to 
explore the metabolic pathways underlying different vascular and cognitive responses 
following the blueberry interventions. In future, similar approaches can be used to fully 
understand the variability in response within and between individuals and this can 
further lead to the development of more personalised nutritional plans. 
 
1.3 Chapter synopsis 
 
In the present thesis, Chapters 2 & 3 conducted systematic review and meta-analysis 
of RCTs assessing vascular and cognitive functions that spanned over 1 week to help 
inform the choice of fruit intervention to a specific category and/or processed form. 
Chapter 4 describes the notion of using a blueberry intervention, the population, and 
the design of a crossover RCT, including the participants recruitment, sample size 
calculation, experimental procedure on each study visit, clinical and biochemical 
 
 27 
measures used for collecting experimental data and human samples. Chapter 4 also 
described the mathematical method basing on previous research evidence to quantify 
the RS and NRS groups. Statistical methods used for analysing study results from the 
clinical endpoints and the metabolomic assay are also described.  
 
Chapter 5 reports the study results including participant demographics at baseline, 
sample size, and the treatment effects shown on vascular and cognitive functions 
following the two interventions compared to the control. The metabolomic differences 
originating from whole blueberry and blueberry powder interventions were investigated 
and discussed. Chapter 6 reports inter-individual response to each biological endpoint 
and consistency across participants. The chapter then goes on to characterise 
metabolomic between RS and NRS groups. Predictor metabolites that can act as 
biomarkers for predicting RS are also explored. Effects of blueberry interventions 
assessing the vascular and cognitive endpoints are discussed and compared to 
previous interventions in Chapter 7. Chapter 7 also summarises the main findings from 
each chapter and discusses the gap in knowledge that the current study has filled, as 
well as implications for exploring individual responses to a dietary intervention to 
benefit health.  
 
1.4 Objectives  
 
i. To systematically review the effects of chronic dietary fruit interventions (≥ 1 
week) in different categories (e.g. berry, cherry, citrus) and processed forms 
(e.g. whole, juice, powder) on vascular and cognitive functions, and apply a 
meta-analysis where available to help inform the fruit intervention. 
ii. To analyse and compare the effects of chronic dietary interventions 
supplementing whole blueberry and freeze-dried blueberry powder on cognitive 
and vascular functions in healthy adults. 
iii. To characterise inter-individual responses to vascular and cognitive endpoints 
to the interventions and assess consistency of response within and between 
participants 
iv. To identify any predictive metabolic biomarkers that may predict response in 
vascular and/or cognitive endpoints to blueberry interventions and to further 
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understand the mechanisms underlying different individual responses to the 





i. A specific category and processed form of fruit interventions with largest 
number of studies reporting positive findings on vascular and/or cognitive 
functions can be identified and supported by the meta-analyses evidence 
where available.  
ii. There will be statistical significance of the improvement to at least one of the 
primary vascular and/or cognitive endpoints following the whole blueberry and 
blueberry powder interventions compared to the control in healthy adults and 
no difference in endpoints between whole blueberry and freeze-dried blueberry 
powder intervention arms. 
iii. Individual response at the vascular and cognitive endpoints following the whole 
blueberry and freeze-dried blueberry interventions can be characterised and 
the consistency of the individual response can be characterised across the 
primary endpoints following the two blueberry interventions.  
iv. A predictive metabolic biomarker can be identified following the whole 
blueberry and/or freeze-dried blueberry powder interventions for predicting 













Chapter 2. Systematic review and 
meta-analysis of fruit interventions 













The section 2.1 is arising from publication: Wang, Y. Gallegos, J.L. Haskell-Ramsay, 
C. et al. Effects of chronic consumption of specific fruit (berry, citrus and cherries) on 
CVD risk factors: a systematic review and meta-analysis of randomised controlled 
trials. Eur J Nutr (2020). https://doi.org/10.1007/s00394-020-02299-w 
 
2.1  Effects of fruit consumption on vascular function: a systematic review 
and meta-analysis of randomised controlled trials. 
 
2.1.1  Introduction 
Current WHO recommendations for fruit and vegetable consumption are for a 
minimum 400 g/d [116]. A recent meta-analysis indicated that an intake of 800 g/day 
of fruit was associated with a 27 % reduction in relative risk of vascular diseases [117].  
It is well recognised that vascular health can be affected by several dietary factors 
[118]. Interventional studies also provided evidence supporting the consumption of a 
range of fruit and fruit juice to reduce vascular disease risk factors. For example, 
consumption of fruit containing relatively high levels of anthocyanins and procyanidins, 
such as berry, has been shown to improve vascular disease risk factors, namely 
endothelial dysfunction, dyslipidaemia, platelet aggregation, and hypertension [119, 
120], whereas flavanone-rich fruit, such as orange, were effective in improving 
hypercholesterolaemia [119].  
 
Fruit juice and powder may be effective methods to increase overall fruit consumption, 
which may explain the emerging intervention studies investigating health benefits with 
fruit powder and juice supplementations. In regards to nutritional value, freeze-dried 
fruit powder that is devoid of water retains concentrated bio-accessible antioxidants, 
fibre and other components [121]. Research has suggested that the juicing process 
can lead to a lower content of fibre and certain bioactives such as polyphenols, 
vitamins, and minerals [122, 123], while other research suggests that processing can 
increase the bioavailability of bioactives [124]. A recent single-dose bioavailability 
study showed only minor differences between whole fruit and the juice [55]. 
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An initial search for fruit interventions assessing vascular function was conducted and 
most studies supplemented berry, citrus, and cherry fruit, therefore, this systematic 
review focused on only berry, citrus and cherry fruit interventions. The initial search 
covered both acute (< 24 h post-prandial study) and chronic interventions and the 
reviews in Chapters 2 & 3 focused on only chronic interventions. Acute studies are 
discussed in Chapters 4 - 7. For chronic studies, most were of at least 1 week duration 
so 1 week was used as a cut off, as described in the eligibility criteria below. The 
systematic review and meta-analysis were reduced to comply with the word limit but 
the full details can be found in the publication. 
 
2.1.2 Objectives 
Given the potential for differing nutritional value of varying types and forms of fruit, it 
is likely that their health benefits will also differ. However, little is known about the 
comparative effect of processed fruit on cognitive and vascular function. A review of 
this type is important to clarify the evidence base for the type and form of fruit that is 
most vascular-protective and to further inform our interventional design. The objective 
of this study was to systematically review and meta-analyse available human 
interventions to evaluate the potential effect of consumption of whole, freeze-dried, 
powdered fruit and fruit juice on CV risk factors and vascular function in randomised 
controlled trials (RCTs) to inform the type and processed form of a fruit-based 
interventional design.  
 
2.1.3 Methods 
We searched for studies investigating the effect of berry, citrus and cherry 
supplementations on vascular function. Berry, citrus and cherry are different types of 
fruit. Berry so defined is a fleshy fruit that usually contains no stone or pit and includes 
grapes, blueberries, strawberries, pomegranates etc; citrus is ‘sour’ fruit and includes 
most commonly oranges, grapefruits, tangerines, lemons, and limes; cherry is a fleshy 
drupe and categorised as stone fruit [125]. The following specific inclusion criteria were 
applied: 1) study design: RCTs; 2) subjects: adult subjects ≥ 18 years of age; 3) 
interventions: interventional RCTs providing or promoting berry, or cherry or citrus fruit 
 
 32 
or their juice or freeze-dried, or powdered fruit consumption; 4) intervention length: at 
least 1 week; 5) control: control groups without components of citrus fruit, cherry, or 
berry, likely placebo group; 6) outcomes: The primary outcomes were the whole body 
measurements: systolic and diastolic blood pressure (SBP and DBP) and the 
endothelial (dys)function assessed by flow-mediated dilation (FMD) and arterial 
stiffness assessed by pulse wave velocity (PWV); the secondary outcomes were the 
blood biomarkers including circulating fatty acids Triglycerides (TAGs) and total 
cholesterol (TC), low-density lipoprotein cholesterol (LDL - C) and high-density 
lipoprotein (HDL - C); vascular inflammatory biomarkers such as high-sensitivity C-
reactive protein (hsCRP), Nitric Oxide (NO), Intercellular Adhesion Molecules (ICAMs) 
and Vascular Adhesion Molecules (VCAMs) were also explored (details described 
below); 6) only English-language and peer-reviewed articles were included. No 
restriction of publication year was applied. 
 
2.1.4 Data sources 
The present systematic review and meta-analysis was conducted in accordance with 
Cochrane [126] and Centre for Reviews and Dissemination guidelines [127] and was 
reported according to PRISMA guidelines [128]. The protocol has been registered with 
PROSPERO, the International Prospective Register of Systematic Reviews 
(Registration number CRD42018091896). Two researchers (YW, JLG) assessed 
articles independently for inclusion eligibility. The searches using PubMed, Web of 
Science, Scopus and psycARTICLES were conducted from inception until January 
2020. No restriction of publication year was applied, and the search result covered 
studies published between 1960 and 2020.  
 
The search of the investigated themes in this review was as following: (Fruit OR citrus 
OR orange OR berry OR berries OR grape OR blueberry OR blueberries OR 
blackberry OR blackberries OR raspberry OR raspberries OR cranberry OR 
cranberries OR cherry OR cherries) AND ("endothelial function" OR "vascular 
function" OR "vascular risk factors" OR hypertension OR "blood pressure" OR BP OR 
"pulse wave velocity" OR PWV OR "flow-mediated dilation" OR FMD OR lipid OR 
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cholesterol OR LDL OR HDL OR triglyceride OR biomarkers OR inflammatory OR 
Nitric Oxide OR NO OR ICAM OR VCAM OR CRP AND (trial OR intervention).  
 
2.1.5 Study selections 
YW and JLG selected articles independently for eligibility. Articles were moved to the 
next screening phase or discarded when full disagreement was reached. Any 
disagreements that were not resolved were handled by JKL serving as an arbitrator. 
All records were exported to EndNote X8 reference management software. The 
selection of eligible studies was based on two steps. Firstly, the title and abstract of 
each study were screened for relevance; full texts were then reviewed for those 
without certainty for inclusion. Reference lists of included papers and relevant 
systematic reviews were also screened by hand-searching for additional articles. 
 
2.1.6 Data abstraction 
Data were extracted by YW and JLG independent of each other, their selections for 
accuracy were reviewed in a meeting. Corresponding authors were contacted via e-
mail to request information if there were missing data or for clarification. Data from 
endpoints and the baseline were obtained. A pre-defined data extraction form in 
Microsoft Excel 2016 was used to input studies data, which included information on 1) 
author and published year; 2) study design; 3) population characteristics (ethnicity, 
mean age, sex, mean body mass index (BMI), health status and sample size at 
baseline); 4) treatment details (intervention type, length, dosage and frequency); 5) 
control group settings; 6) retention rate; 7) measured outcomes for both experimental 
group and placebo group at baseline and the longest post-intervention time point to 
avoid the bias of selectively choosing data.  
 
2.1.7  Risk of bias assessments 
Study quality for RCTs was assessed by Jadad Score (0 to 5), which took into account 
whether a trial was randomised and blinded with appropriate procedure, and whether 
dropouts were well recorded; a score ≥ 3  indicates a high-quality trial [129]. 
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Publication bias was assessed by Funnel plot and Egger’s test, ‘trim and fill’ method 
was implemented to identify and correct for funnel plot asymmetry arising from 
publication bias [130]. 
 
2.1.8  Data synthesis  
R studio version 3.5.2 and the package “meta” [131] were used to pool and meta-
analyse data from collected studies. Subgroup analysis with at least 10 studies 
supplementing berry was implemented to estimate the specific effects and the 
heterogeneity for each interventional subgroup. Sensitivity analysis was performed to 
investigate the impact of studies adjusting for participants’ physical level [132, 133] 
and also the impact of juice quality on the meta-analysis results. 
 
All pooled results were presented as weighted mean difference with 2-sided P values. 
95% confidence intervals (CIs) and prediction intervals were both presented in the 
results. The FMD value was expressed in percentage unit and the PWV value was 
expressed in m/s; the conversion of cm/s to m/s for PWV value was applied when 
necessary for pooled mean differences in meta-analysis. For blood lipids, the 
conversion factor 1 mmol/L = 38.67 mg/dL was used for total, HDL, and LDL 
cholesterol level and 1 mmol/L = 88.57 mg/dL for triglycerides level [134] where 
applicable.  
 
The Hartung-Knapp-Sidik-Jonkman method for random-effects meta-analysis [135] 
was applied. Heterogeneity was estimated by Cochrane Q statistics and the 
consistency of study results was assessed by I2 statistics as an extension of Cochrane 
Q statistics and an  I2 > 50 % is considered for a high heterogeneity level [136]. The 
effect sizes based on the weighted mean difference (WMD) between treatment groups 
were used when measurement units of assessed outcomes were comparable across 
studies. The standardized mean difference (SMD) was used when studies have used 
different measurement units and the conversion had failed. 
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2.1.9 Literature search 
 
In accordance with PRISMA guidelines [128], Figure. 2.1 describes the selection 
process of included studies. The search for literatures assessing vascular function and 
cognition was carried out together but only the final record for vascular function was 
reported here. The initial search produced 13861 articles from the four databases, this 
record was reduced to 8613 articles after duplicates were removed. After screening of 
the titles and abstracts for eligibility, the final selection identified 45 trials assessing 
vascular function. From trials included, 38 trials assessing vascular function were 
entered into the meta-analysis. 
  
2.1.10  Study characteristics 
For studies assessing vascular disease risk factors (Table. 2.1), forty-five studies were 
included in this systematic review, of which 18 were cross-over randomized controlled 
trials (RCT) and 27 were parallel RCTs [16]. The sample size of both experimental 
and control group in the interventions ranged from 5 to 63. The total sample size for 
the intervention group was 1130; the total sample size for the control group was 1109. 
Participants’ characteristics at baseline also vary across studies; most trials recruited 
healthy subjects (n = 13), while there were 7 studies with participants manifesting 
increased vascular disease risks (elevated lipid profiles and hypertension) and 3 with 
diagnosed CVD or coronary heart disease (CHD); 18 with metabolic syndrome 
(inclusive of overweight); 1 with mild‑to‑moderate dementia, 1 with chronic obstructive 
pulmonary disease, 1 with type 2 diabetes and 1 with end-stage renal disease [16]. 
However, there were not enough studies with different participants’ characteristics to 
do sub-group analysis to explore the effect of participants’ characteristics at baseline. 
 
For studies assessing vascular function, there were 32 studies (71 % of the 
interventions) that supplemented fruit juice and 13 studies supplemented whole fruit 
and fruit in other freeze-dried forms [16]. Treatments were all delivered in arms of 
experimental and control groups. The mean chronic treatment duration was 57 days 
with a standard deviation (SD) of 43 days (ranged from 7 days to 180 days). 
 
 36 















Sample (sample at baseline/N, 
age/years, % male, mean BMI (kg/ 
m2), health status, ethnicity (%)) 



















N =23(20), age 48.6 ± 15.4, 20 %, BMI 
37.0 ± 9.9, obese but otherwise healthy 
adults, N/A 
60 g grape powder was 
equivalent to 330 g or 2.2 
cups of fresh grapes and 
contained 297 mg total 
polyphenols (as gallic acid 
equivalents) for 4 weeks 
PBO was matched 







SBP, DBP, TC, HDL, LDL, TG, 
CRP, ET-1, IL-6: oxLDL, 










N=25, age 51.3 ± 9.6, male and BMI 
N/A, metabolic syndrome, N/A 
46 g/d grape powder 
equals to 2 serving of fresh 
grapes  for 30 days 
Placebo 96 % 
SBP, DBP, FMD, TG, HDL, 









N=40(38), age 47.8 ±13.3, 61 %, BMI 
23.9 ± 4.8, End-Stage Renal Disease 
patients on dialysis 3 times a week for at 
least 3 months, N/A 
100ml pomegranate juice, 3 
times a week after subjects' 
dialysis session for 8 weeks 
No intervention as 
control 
97.60 % 











N=19, age 48±13, 53 %, BMI 32.1±4.9, 
subjects with increased CVD risk, N/A  
500 ml/d red orange juice 
for 1 week 
placebo drink (12 
healthy non-diabetic 
subjects acting as 
control group) 
91 % 
FMD, GTN (glyceryl-trinitrate), 











N=25, age 53.8±2, 100 %, BMI 26±1, 
mild hypercholesterolemic men (LDL-C 
between 130 and 190 mg/L), N/A 
200 ml (3 times/d) blond 
orange juice for 4 weeks 
control beverage 96 % 
glucose, TC, LDL, 
HDL,TC/HDL, TG, ApoA-1, 
ApoB, Lpa, hsCRP, Brachial 
FMD, sICAM-1, sVCAM-1, sE-
selectin 
3 






N=11, age 30 ± 10, N/A, BMI 24.43 ± 
3.23, healthy, N/A 
30 ml Montmorency tart 
cherry juice for 20 days 
placebo 100 % SBP, DBP, TC, LDL, TG, IL-7 3 











N=63, age 43±12, 69 %, BMI 28±3.8, 
stage 1 hypertension,   42 % black 
490 ml/d concord grape 
juice containing 965 mg 
anthocyanins for 8 weeks 
Placebo drink 77 % SBP,DBP, TG TC, LDL, HDL 3 
Dohadwala






 N=44, age 62±10, 68 %, BMI 29.5±4.5, 
coronary heart disease, Black 45.5 % 
480 ml/d double-strength 
cranberry juice for 4 weeks 







diameter, Dilation to 
nitroglycerin, Baseline flow, 
FMD, Hyperaemic flow, InPAT 











N=52, age 58±4, 0 %, BMI 25.7±2.3, 
Postmenopausal woman, 100 %  
Caucasian 
340 ml/d (2 times of 170 
ml) concentrate blond 





SBP, DBP, Pulse pressure, 
FMD dilation, Baseline brachial 
diameter ,PAT ratio, Pulse 










N=45(41), age 52.2 ± 13.6, 49 %, BMI 
29.0 ±5.1, healthy, N/A 
 
500 ml/d (2 times of 250 
ml) blood orange juice 
providing 50 mg 
anthocyanins for 4 weeks 
500 ml blonde OJ 
without anthocyanins 
91 % 
SBP, DBP, ba PWV, cf PWV, 
NO, CRP, TG, HDL-C, LDL-C 
2 
Lamport, 







N=25(19), age 43.2 ± 0.6, 0 %, BMI 24.6 
± 0.5, healthy, N/A 
 
355 ml/d concord grape 
juice for 12 weeks and 
assessed at 6, 12 weeks 
energy-, taste-, and 
appearance-
matched placebo  






N=13(10), age 38.1 ± 12.5, N/A, BMI 
32,2 ± 4.6, overweight and obese, N/A 
240 ml/d tart chery juice for 
4 weeks 
placebo juice 77 % 











N=20, age 53.5 ± 10.1, N/A, BMI 33.0 ± 
4.77, metabolic syndrome, N/A 
 
60 g/d grape powder 
(contributing 195 mg total 
polyphenols) for 4 weeks 
placebo powder 100 % 
Total cholesterol, HDL-C and 
HDL particles, TG 
3 









N=24, age 56±1, 100 %, BMI 27.4 ± 0.3, 
overweight healthy, N/A 
500 ml/d orange juice for 4 
weeks 




SBP, DBP, Pulse pressure, 











N=18, age 47.8 ± 9.7, 100 %, BMI 24.8 
± 2.6, subjects with CVD risk factors, 
N/A 
Freeze-dried wild blueberry 
powder 25 g/d in water, 
equals to 250 ml/d for 6 
weeks 
placebo drink 
consisted of 250 mL 
water, 7.5 g fructose, 
7 g glucose, 0.5 g 
citric acid and 0.03 g 
blueberry flavour  
89 % 
RHI,FRHI,AI,AI@75,Diastolic 
pressure, SBP, Total 
NO,sVCAM-1 
2 








N=35, age 45 ± 10, 100 %, BMI 28.3 ± 
2.4, overweight, N/A 
500 ml/d of 27 % cranberry 
juice for 4 weeks 
placebo juice 100 % 
Heart rate, Systolic BP, 
Diastolic BP , MAP, Resting 
AIx ,Δ AIx salbutamol, Δ AIx 
GTN,Global endothelial 
function, NOx ,Uric acid, 
Oxidized LDL , sICAM-1 , 










N=26, age 26.34 ± 4.93, 38 %, BMI 
23.21± 4.10, healthy, N/A 
 
Weight equivalent 7 ml/kg/d 
of 100 % concord grape 
juice for 2 weeks and 




matched the flavour, 
colour, calorie, and 
sugar profile of the 





Total cholesterol, LDL-C, TG, 










N=13, age 38 ± 8, 62 %, BMI 23±2, 
healthy, N/A 
6g/day (138.6 mg 
anthocyanins) blackcurrant 
powder in water for 1 week 
blackcurrant juice 3-
4 mg anthocyanins 
per dose 
77 % 
SBP, DBP, mean arterial BP, 
heart rate, Stroke volume, 
cardiac output, peripheral 
resistance 
2 





N=60, high dose intervention: high dose 
control: low dose intervention: low dose 
control: 15: 15 : 15 : 15, age 49 ± 10, 
9 %, BMI 36 ± 6.5, obese adults with 
elevated serum lipids, N/A 
High-dose 50 g/d freeze 
dried strawberry  (10 % 
weight of fresh 




dose calorie- and 
100 % 
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25 g/d  freeze-dried 
strawberry for 12 weeks 
fibre-matched 
control 24g/d 
Basu, et al. 
2010  (US) 
Parallel 
RCT 
N=30, intervention: control 15:12, age 
47.0 ± 3.0, 7 %, BMI 37.5 ± 2.15, 
metabolic syndrome, N/A 
 
Freeze-dried strawberry 
beverage (50 g freeze-dried 
strawberries ∼ 3 cups fresh 
strawberries) for 8 weeks 
4 cups of water/d  90 % 





Basu, et al. 
2011  (US) 
Parallel 
RCT 
N=31, intervention: control 15:16, age 
52.0 ± 8.0, 0 %, BMI 40.0 ± 7.7, 
metabolic syndrome,  N/A 
240 ml/d containing 458 mg 
total polyphenols of 
cranberry juice for 8 weeks 
Placebo drink 97 % 
SBP, DBP, Total cholesterol, 
HDL-C,LDL-C,TGs 
3 






N=66, intervention: control 25:33, age 
50.3 ± 3.0 SE, 8 %, BMI 37.8 ± 2.3, 
metabolic syndrome, N/A 
480 ml freeze-dried 
blueberry beverage (50 g 
freeze-dried blueberry) for 
8 weeks 




SBP, DBP, TG, Total , LDL-, 







N=30, intervention: control 15:15, age 
60 ± 10.9, N/A, BMI 31.4±4.8, chronic 
obstructive pulmonary disease, N/A 
400 ml/d pomegranate juice 
(2660 mg/d anthocyanins) 
for 5 weeks 











N=144 (115), 1 cup : 1/2 cup: control 
37:39:39, age 63± 7, N/A, BMI 31.2 ± 
3.0, metabolic syndrome, N/A 
26 g blueberry powder 
equivalent to 1 cup (150 g) 
and 1/2 cup (75 g) 
blueberry for 6 months 
dextrose, 
maltodextrin, and 
fructose, which were 
produced as a 





artificial colour and 
flavourings 








N=79 (78), intervention: control 40 : 38, 
age 43.1 ± 1.1, N/A, BMI 30.8 ± 0.4, 
non-smoking overweight, N/A 
450 ml/d cranberry extract 




designed to look, 
smell, and taste 
such as the CEB, 




CRP, IL-6, IL-10, IL-23, TNF-α; 
IFN-γ  
3 
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N=37, intervention: control 20:17, age 
intervention: control 28.5 ± 3.7: 27.3 ± 
4.2, 40 %:53 %, BMI 70.0± 3.7: 69.5 + 
3.9, older adults, N/A 
68 ml/d of Montmorency 
tart cherry concentrate was 
diluted with 412 mL of 
water for 12 weeks 
Control drink was 




Foods, Chicago, IL, 
USA) with water. 
100 % 








N=20, intervention: control 11:9; age 18-
40 years old 0 %, BMI N/A, healthy, N/A 
750 ml/d cranberry juice for 
2 weeks 










N=74, intervention: control 37:32, age 
41.8 ± 10.7, 30 %, BMI 32.1 ± 4.1, 
obese or with additional metabolic 
syndrome (42 %), non-Hispanic white 
race (62.3) 
Low bioactive diet plus one 
and half of fresh  grapefruit 
daily for 6 weeks 
A low bioactive diet 
devoid of citrus  
93 % sVCAM-1, hsCRP 1 
Flammer, 




N=84, intervention: control 32:37, age 
49.5 ± 16.2, 45%, BMI 27.7±5.9: 27.2 ± 
5.5, peripheral endothelial dysfunction 
and CVD risk factors, N/A 
460 ml/d ( 2 times of 230 
ml/d) of  (54%) cranberry 
juice (double-strength 
Ocean Spray® light 











RHI, SBP, DBP, pulse 












N=20, intervention: control 10:10, age 
25-55 years old, N/A, BMI 30.0-39.9, 
obesity, N/A 
120 ml/d pomegranate juice 
for 1 month 








N=51, intervention: control 25:26, age 
18-55, N/A, BMI 25.0-29.9, overweight, 
N/A 
480 ml/d of concord grape 
juice for 12 weeks 













N=73, intervention: control 39:38, age 
58.0 ± 9.2: 60.1 ±9.5, 47 %, BMI 
26.3±4.3: 25.1±4.0, metabolic 
syndrome, N/A 
750mg/d (4 capsules) 
powdered black raspberry 
for 12 weeks 
Placebo group-
cellulose, 
isomaltose, and corn 
powder. 
92 % 
Resting brachial artery 
diameter, Reactive 
















N=51 intervention: control 26:25, age 
56.4±9.2: 60.7±10.4, N/A, BMI 25.9±4.6, 
24.7±3.9, metabolic syndrome, N/A 
750mg/d (4 capsules) 
powdered black raspberry 
for 12 weeks 
Placebo 100 % 











N=49 intervention: control 20:20, age 
59.7±4.58: 57.3±4.77, 1 %, BMI 
30.1±5.94: 32.7±6.80. pre- and stage 1 
hypertension, N/A 
22 g/d of freeze-dried 
blueberry powder for 8 
weeks and assessed at 4 
and 8 weeks 
22 g macronutrient-
matched control 





artificial purple and 
red colour, citric 
acid, and silica 
dioxide 
83 % 
SBP, DBP, Mean arterial 
pressure, Carotid-femoral 
pulse wave velocity, Brachial-
ankle pulse wave velocity, 
Heart rate 
4 





N=49, intervention: control 24:25, age 
78.9±5.2 : 80.6± 6.6, 51 %, BMI 
25.7±3.4: 26.6 ±3.5, mild- to moderate 
dementia, N/A 





Letter verbal fluency 
(executive function),SBP, 







N=66, high dose intervention: low dose 
intervention: control 21:22:21, age 
51+11, 67 %, BMI 29.2±6.9, healthy, 
N/A 
250 ml/d of high 
blackcurrant juice drink 
(81.5 mg/100 ml total 
polyphenols); low 
blackcurrant juice drink 
(27.3 mg/100 ml total 
polyphenols), for 6 weeks 










N=43(37), intervention: control 19:18, 
age 46.6±11.5: 42.0±14.4, 31.6 %: 
27.8 %, BMI 33.5±6.7, metabolic 
syndrome, N/A 
325 ml/d pf acai berry 
beverage (containing 1139 
mg L−1 gallic acid 
equivalents of total 
polyphenols) for 12 weeks 
325 ml placebo 
beverage 
86 % 
Total cholesterol, TGs, hs-
CRP, IL-6, TNF-a 
2 
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N=51(48), intervention: control 24:24, 
age 39±1.24 : 36.1± 0.92, 33 %, BMI 
24.99± 1.26  24.99± 1.06, healthy, N/A 
330 ml/d of pomegranate 
juice for 4 weeks 
Lemonade drink-




contained only a 





PWV, SBP, DBP, MAP, Heart 
rate 
3 






N=47, intervention: control 25:21, age 
38.3±6.16: 37.2±5.78, 38 %, BMI 
24.6±3.63: 23.5±3, healthy, N/A 
250 ml/d of cherry juice 
concentrate (30 ml diluted 
with 220 ml of water; 
Cherry Active®) for 6 
weeks 
Lemonade drink 98 % 
PWV, hsCRP, SBP, DBP, 







N=46, intervention: control 23:23, age 
56.86± 8.47, 33.3 %: 38 %, BMI 
29.22±3.98: 27.78 ± 3.45, patients with 
type 2 diabetes, N/A 
200 ml/d pomegranate juice 
for 8 weeks 
No intervention 100 % 
SBP, DBP, TC, HDL, LDL, TG, 
ApoB, ApoA 
5 





N=20, intervention: control 10:10, age 
64.9±4.0: 72.9± 5.6, 38.5 %, BMI 
24.7±1.0: 26.6± 1.1, hypertensive 
elderly, N/A  
200 ml/d  of grape juice for 
12 weeks 
No intervention 91 % SBP, DBP 1 
McAnulty, 




N=25, intervention: control 13:12, age 
46.15:±11.92:39.92±13.38, N/A, BMI 
27.8± 5.46: 24.23± 3.44, sedentary 
males and females, N/A 
38 g/d blueberry powder, 
equivalent to 250 g 
rehydrated berries for 6 
weeks 
placebo powder 




citric acid, and a flow 
agent (silica) 
100 % 
SBP, DBP, Aix (Augmentation 








N=60, intervention: control 30:30, age 
49.8±11.1: 50.0±11.6, 48 %, BMI 27.8± 
3.8: 28.9± 4.5, healthy, N/A 
480 ml/d of cranberry juice 





Total cholesterol, LDL 
cholesterol, HDL cholesterol, 
TGs, apo A-I,apo A-II, apoB, 
sICAM, sVCAM, Diastolic BP, 
Systolic BP,CRP 
4 








N=45, intervention: control 26:19, age 
69±11, 89 %, BMI 28±6, CHD and 
myocardial ischemia patients, 86.67 % 
white 
240 ml/d of pomegranate 
juice for 3 months 
Placebo drink 93 % 
SBP, DBP, Total cholesterol, 
HDL-C,LDL-C,TGs 
4 







N=46, intervention: control 23:23,  age 
55±2: 59±2, 36 %, BMI 35.2 ± 0.8: 36.0 
± 1.1, metabolic syndrome, N/A 
45 g/d of freeze-dried 
blueberry powder, equals to 
2 cups of fresh whole 
blueberry/ consumed with 
24-oz yogurt and skim milk-
based smoothie, for 6 
weeks 
identical smoothie 
without the blueberry 
powder 
87 % 






Among the fruit juice category, most studies evaluated the effect of cranberry juice, 
grape juice, pomegranate juice, cherry juice, orange juice (n = 7, 5, 5, 5, 4 respectively). 
The mean dosage applied for these types of juice was 480 ml, 353 ml, 238 ml, 173.6 
ml and 425 ml respectively. The remaining interventions included blueberry juice (n = 
1), grapefruit juice (n = 1), barberry juice (n = 1), blackcurrant juice (n = 1), strawberry 
juice (n = 1) and acai berry juice (n = 1) . Among whole fruit and fruit in other freeze-
dried forms of interventions, 4 studies supplemented freeze-dried blueberry powder. 
Portion conversion of powder to whole fruit was provided in each study; typically the 
mean dosage of blueberry powder supplementations was 32.75 g (equivalent to 
approximately 1.5 cups of fresh blueberry). Three trials supplemented freeze-dried 
grape powder. The mean dosage of grape powder supplemented was 55.33 g, which 
is equivalent to approximately 2.5 cups of fresh grape. The remaining 5 studies 
supplemented other berry (powdered raspberry, powdered blackcurrant, freeze-dried 
strawberry) and citrus fruit (1.5 portion of grapefruit following a low bioactive diet). 
 
2.1.11 Study quality  
For studies assessing vascular disease risk factors, the average retention rate for all 
included trials was 92.64 %, of which 30 out of 45 RCTs obtained no less than 3 points 
of total Jadad score. Trials generally provided adequate description of methods and 
procedures, although only 40 % and 33.33 % of RCTs implemented true 
randomization and true blinding respectively with an adequate description of methods 
(e.g. computerised statistical randomisation). Jadad scores were provided in 
Appendix. 1.1. 
 
2.1.12 Meta-analysis  
Thirty-eight trials were included in the meta-analysis. The meta-analysis of 38 studies 
assessing FMD, PWV, SBP, DBP, levels of TAG, TC, HDL-C and LDL-C and levels of 
vascular inflammatory biomarkers ICAMs, VCAMs, hsCRP and NO were displayed in 
forest plots [16]. The interventions used in these studies supplemented blueberry 
powder, grape juice, grape powder, cranberry juice, orange juice, whole grapefruit, 
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pomegranate juice, raspberry powder, freeze-dried strawberry, acai berry juice, and 
barberry juice.  
 
Our principal findings from a meta-analysis of interventions supplementing with berry 
(including 531 treatment and 502 placebo participants) including barberry juice, 
blueberry powder, cranberry juice, freeze-dried strawberry, grape juice, grape powder, 
pomegranate juice and raspberry powder suggested significantly reduced SBP by 
3.68 mmHg [95 % CI - 6.79 to - 0.58; P = 0.02] (Figure. 2.2) and DBP by 1.78 mmHg 
[95 % CI - 3.43 to - 0.12; P = 0.04] (Figure. 2.3) respectively. There was no significant 
improvement of DBP by the citrus juice interventions compared to the control. 
 
Subgroup analysis showed that specific interventions using cranberry juice, with mean 
dosage of 432 ml and length of 8 weeks including 149 treatment participants has 
significantly decreased SBP and DBP by 1.52 mmHg (95 % CI - 2.97 to - 0.07; P = 
0.05) (Figure. 2.3) and 1.52 mmHg (95 % CI -2.87 to -0.18, P = 0.04) respectively. 
Two cherry juice interventions including 36 treatment participants with dosage of 30 
ml for 20 days and 330 ml for 6 weeks separately also led to a significant reduction in 
SBP by 3.11 mmHg (95 % CI - 4.06 to - 2.15; P = 0.02). The berry group including 
blueberry juice, cranberry juice, grape powder, pomegranate juice and raspberry 
powder was also shown to significantly increase sVCAM-1 levels by 14.57 ng/mL (95 % 
CI 4.22 to 24.93, P = 0.02) in the treatment group relative to the control. The I2 test 
suggested significant substantial heterogeneities for berry group investigating the 
effects on SBP (I2 = 78 %, P < 0.01) (Figure. 2.3) and DBP (I2 = 78 %, P < 0.01) 
(Figure. 2.4). Significant substantial heterogeneities for the citrus juice group 





Figure. 2.2 The effect of berry interventions including (a) barberry juice, (b) 
blueberry powder, (c) cranberry juice, (d) freeze-dried strawberry, (e) grape juice, 





















Figure. 2.3 The effect of berry interventions including (a) barberry juice, (b) 
blueberry powder, (c) cranberry juice, (d) grape juice, (e) grape powder, (f) 






















Figure. 2.4 The effect of (a) cherry juice, (b) grapefruit juice, and (c) orange juice 
interventions assessing SBP and (d) cherry juice, (e) grapefruit juice, and (f) 
orange juice interventions assessing DBP 
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There were no significant effects of other included intervention groups on other 
vascular and inflammatory markers: FMD, PWV, TAG, TC, LDL-C, HDL-C, ICAMs, 
VCAMs, NO or hsCRP. The forest plots of these markers were provided in 
Appendices. 1.2 - 1.3. The I2 test suggested no heterogeneity for berry interventions 
assessing the effect on FMD (I2 = 0 %, P = 0.39) and non-significant moderate 
heterogeneities for berry interventions assessing the effect on PWV (I2 = 58 %, P = 
0.07). The I2 test suggested significant substantial and moderate heterogeneities for 
the berry group (I2 = 71 %, P < 0.01) and cherry juice (I2 = 55 %, P = 0.14) investigating 
the effects on TC respectively. There are significant moderate heterogeneity for the 
berry group investigating the effects on HDL-C (I2 = 56 %, P < 0.01); non-significant 
moderate heterogeneities were shown for the berry group investigating the effects on 
TAG (I2 = 36 %, P = 0.08), LDL (I2 = 37 %, P = 0.08). Funnel plots and the egger’s test 
for the berry group showed an overall symmetric distribution of the interventions 
around the standard error for the investigated outcomes of TAG, TC, LDL-C (egger’s 
tests P > 0.05). Funnel plots and the egger’s test for the berry group showed an overall 
symmetric distribution of the berry interventions around the standard error for the 
investigated outcomes of SBP; asymmetric distributions were shown for the berry 
group investigating the effect on DBP and TAG, trim and fill method was further 





2.1.13  Principal findings 
The berry group overall has shown improvements to both SBP and DBP by over 3 
mmHg and 1 mmHg respectively, which revealed the potential of the berry group to 
play a beneficial role in the diet to maintain vascular health. The dosage of juice and 
freeze-dried powder in the included berry group ranged from 100 ml - 500 ml and 750 
mg - 46 g respectively. One freeze-dried strawberry study supplemented 3 cups. The 
duration of the berry group interventions ranged from 14 days to 120 days. Specifically, 
high doses of 432 ml cranberry juice showed improvements to blood pressure in our 
meta-analysis. Small studies of cherry juice, categorised as stone fruit, using up to 
330 ml showed improvement to systolic blood pressure but not diastolic blood 
pressure.  
 
However, there are evidence from acute interventions (≤ 24 hours) showing that frozen 
blueberries [137, 138] have improved SBP in meta-analysis and blueberry 
interventions combing both acute and chronic interventions also improved SBP 
significantly, which showed vascular protective potential of blueberry supplements 
(Shown in Figure. 2.5). The largest number of interventions supplementing powder 
were also using blueberry powder in this review with high heterogeneity existed, which 
could be accounted by the variations of the study design. It would be of nutritional 
interest to test powered berry against whole fruit if more RCTs with consistent dosage 
and intervention length were conducted. 
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Figure. 2.5 Forest plot of (a) small sized acute studies supplementing frozen 


















These findings suggested that berry interventions, especially using juiced cranberry 
may effectively reduce SBP and DBP. However, the limitations within each cranberry 
juice intervention included small sample size [139], not refraining from other 
polyphenol-rich foods/beverage throughout [12, 140, 141], and different blood 
pressure between groups at baseline [142] that have made the meta-analyses results 
inconsequential. 
 
2.1.14  Previous evidence of RCTs assessing vascular function 
For interventions assessing vascular function, our review showed that blueberry and 
grape in both juiced and freeze-dried forms have been supplemented frequently, 
however, this quantitative analysis only displayed an improvement on the outcomes 




A previous systematic review investigated the impact of fruit polyphenols on blood 
lipids (n = 17), platelet function (n = 9), BP (n = 9) and endothelium-dependent 
vasodilation (vascular function) (n = 7) and suggested that polyphenols from fruit such 
as pomegranate, purple grape and blueberry are particularly effective at preventing 
hypertension compared to other vascular disease risk factors [119]. The berry group 
in particular was shown to possess vascular-protective properties; the underlying 
mechanisms highlighted include inhibitory effects on inflammatory gene expression, 
oxidative stress, carbohydrate digestive enzymes and foam cell formation as well as 
increased effect on nitric oxide synthase following anthocyanins, the major polyphenol 
in berry [120]. 
 
In another meta-analysis of 95 prospective studies of fruit and vegetable intake, Aune 
et al. found that fruit juice intake had little association with CVD and total cancer, while 
slight inverse associations were observed for CHD with Risk Ratio (RR) [95 % CI, 0.79 
(0.63 - 0.98)], stroke with RR [95 % CI, 0.67 (0.60 - 0.76)] and all-cause mortality with 
RR [95 % CI, 0.87 (0.83 - 0.91)] every 100 g/d increment, however, the very low 
number of fruit juice studies (n = 2) made these findings preliminary and more studies 
are needed before any firm conclusions can be drawn [117]. Aune et al. also reported 
an inverse association between high vs. low berry consumption and all-cause mortality 
in the meta-analysis, whereas no similar associations were observed for CHD and 
CVD [117]. Knowledge about powdered fruit forms for the association with disease 
risk is currently very limited [143]. 
 
However, there is evidence showing that increasing the consumption of fruit juice by 
one serving per day was associated with a 7 % greater incidence of type 2 diabetes 
(95 % CI, 0.8 % to 14 %) [144] and there was also greater risk of weight gain with 
higher consumption of fruit juice, probably because of the high sugar content and 
excess calories provided [145]. Fruit juice contains quantities of sugar classified as 
‘free’ sugars like sucrose, compared with whole fruit in which the sugars are classified 
as intrinsic. Increased dietary fructose following sucrose intake is reported to increase 
de novo lipogenesis (DNL) levels and VLDL, which has been shown to increase the 
risk of developing non-alcoholic fatty liver disease (NAFLD) [146]. Therefore, cautious 
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interpretations should be made for choosing fruit juice interventions or for promoting 
fruit juice consumption as healthy options to increase fruit and vegetable intake. 
 
Our review has also shown elevated sVCAM-1 levels after berry interventions, 
however, some authors have suggested that the magnitude of the increase in sVCAM-
1 may not be clinically relevant, as the other vascular inflammatory markers did not 
change between the treatment and the control group after the interventions [147], 
which is also in line with the results of other inflammatory markers in our review. Aside 
from this, Bardagjy et al. and Ruel et al. reported significantly higher sVCAM-1 levels 
in the treatment group at the baseline compared to the control, which may contributed 
to the elevated sVCAM level after the interventions in the berry-treated group [141, 
148]. There is also limited study data under some types of fruit interventions (i.e. grape 
powder and pomegranate juice) investigating all risk factors to be meta-analysed. 
Although the consumption of a range of berry have been linked with alleviated disease 
risks, considering the results from our review and previous evidence, current evidence 
is insufficient and inconsistent to substantiate the consumption of specific berry or 
other fruit as a vascular-protective dietary strategy.   
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2.1.15  Implications for the intervention design 
Several points were raised from these reviews to help inform our study design: 
i. Cranberry and cherry juice studies have shown improvements to SBP, however 
we have to emphasize that the analyses were limited to either small samples 
size, unbalanced baseline blood pressures, or neglected diet refrainment. 
Furthermore, improvements to other outcomes were not observed, which 
overall does not support the notion that the consumption of these specific fruit 
powder or other fruit juice will confer a vascular-protective benefit.  
ii. Future interventions on supplementing berry (i.e. blueberry, cranberry, grape) 
with a sufficient sample size are warranted, as these appeared to have the 
biggest potential to improve vascular function.  
iii. No fresh fruit was identified in the previous interventions, which could be due 
to the difficulty of storage and allocation during the intervention. Fresh whole 
fruit is generally how the fruit is consumed in the general population, which 
highlights a novel and necessary intervention for future studies.  
iv. Apart from fruit juice, most RCTs supplemented freeze-dried powder and this 
form could also be an effective method to increase overall fruit consumption. 
Increased intake of “free sugar” in fruit juice has been shown to increase the 
risk of weight gain, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) 
[144, 145, 149], which is a controversial option considering fruit juice for health 
promoting and also for our study design.  
v. Supplementing whole frozen blueberry in acute duration (300 g, < 24h) [18, 137] 
along with supplementing blueberry powder in chronic duration (equivalent to 
150 - 300 g whole blueberry, 6 - 8 weeks) [69-72] to both young and older 
participants may significantly reduce SBP to benefit vascular function. A long 
term investigation for whole blueberry assessing vascular function is lacking 









Chapter 3. Systematic review and 
meta-analysis of fruit interventions 












3.1  Effects of fruit consumption on cognition : a systematic review and meta-




It is well recognised that cognitive impairment can be affected by several dietary 
factors [118]. One dose–response meta-analysis with a total of 31,104 participants 
and 4,583 incident cases of cognitive impairment and dementia showed that an 
increment of 100 g per day of fruit and vegetable consumption was related to an 
approximately 13 % (Odds Ratio/OR = 0.87, 95 % CI 0.77 - 0.99) reduction in cognitive 
impairment and dementia risk [150]. A number of interventional studies showed 
positive results indicating that intake of a range of flavonoid-rich fruit (e.g. blueberry, 
orange juice) could improve both immediate and chronic cognitive performance or 
mood in older adults [151]. Currently there is correlation across cognitive domains (i.e. 
working memory and executive function) [152], and no correlations of the 
improvements for different cognitive domains following fruit interventions were found.   
A number of potential underlying mechanisms have been identified including the 
interaction of fruit polyphenols, and antioxidants with intracellular neuronal and glial 
signalling pathways, energy metabolism, regulation of cerebral blood flow, and 
protection against neurotoxins and neuroinflammation [153-155]. However, findings 
are contradictory, for example a previous study using cherry juice has shown no 
cognitive benefit in middle-aged [156] or older adults [157] with and without dementia 
following acute (≤ 24 hours) supplementation. Whilst sample size was indicated as a 
factor in these null findings, the length of intervention as well as types and forms of 




Given the potential for differing nutritional value of varying types and forms of fruit, it 
is likely that their health benefits will also differ. However, little is known about the 
comparative effect of processed fruit on cognitive. A review of this type is important to 
clarify the evidence base for the type and form of fruit that is most cognitive-protective 
and to further inform our interventional design. The aim of this study was to 
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systematically review and meta-analyse available human interventions to evaluate the 
potential effect of consumption of whole, freeze-dried, powdered fruit and fruit juice on 
cognition and mood in RCTs to support findings from the previous chapter and inform 




We searched for studies investigating the effect of berry, citrus and cherry 
supplementations on cognitive health. The inclusion criteria for interventions and 
participants was the same with the section 2.1.3. The primary outcomes were memory, 
executive function, psychomotor speed and mood (details described below). 
 
3.1.4 Data sources 
 
The protocol and databases used were the same with section 2.1.4. The search of the 
investigated themes in this review was as following: (Fruit OR citrus OR orange OR 
berry OR berries OR grape OR blueberry OR blueberry OR blackberry OR 
blackberries OR raspberry OR raspberries OR cranberry OR cranberries OR cherry 
OR cherries) AND cogniti* OR memory OR “executive function” OR “reaction time” 
OR “psychomotor speed” OR attention OR mood) AND (trial OR intervention). 
 
3.1.5  Study selections 
 
Procedure of study selections was the same with section 2.1.5.  
 
3.1.6 Data abstraction 
 




3.1.7 Risk of bias assessments 
 
Jadad Score (0 to 5) [129], funnel plot and Egger’s test [130] were used to assess 
study quality and publication bias, as described in section 2.1.7. 
 
3.1.8  Data synthesis  
 
R studio version 3.5.2 and the package “meta” [131] were used to pool and meta-
analyse data from collected studies. Sensitivity analysis was performed to investigate 
the impact of studies adjusting for participants’ physical level [132, 133] and also the 
impact of juice quality on the meta-analysis results. 
 
All pooled results were presented as weighted mean difference with 2-sided P values. 
95 % confidence intervals (CIs) and prediction intervals were both presented in the 
results. Basing on the categorised cognitive tasks, meta-analyses investigating the 
effects of berry interventions on memory, executive function and psychomotor speed 
[68, 77, 158-160] and 2 cherry juice studies assessing executive function and 
psychomotor speed were carried out [132, 161]. Two grape powder studies assessing 
MMSE (Mini Mental State Examination), which measures cognitive impairment, were 
also included [30, 162]. Memory and executive function both encompass the essential 
cognitive processes in a person’s life [163]. Psychomotor speed assesses the 
individual’s ability to detect and respond to a stimulus and therefore reflects the 
relationship between cognition and physical movements [164]. The random-effects 
model, heterogeneity and effect size estimations for meta-analysis were described in 
section 2.1.8.  
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3.1.9 Literature search 
 
In accordance with PRISMA guidelines [128], Figure. 3.1 describes the selection 
process of included studies. The search for literatures assessing vascular function and 
cognition was carried out together but only the final record for cognitive function was 
reported here. The initial search produced 13861 articles from the four databases, this 
record was reduced to 8613 articles after duplicates were removed. After screening of 
the titles and abstracts for eligibility, the final selection identified 14 trials assessing 
cognition. From trials included, 10 trials assessing cognition were entered into the 
meta-analysis. 
 
3.1.10 Study characteristics 
For studies assessing cognition and mood (Table. 3.1), there were 2 cross-over RCTs 
[158, 165] and 12 parallel RCTs [30, 68, 77, 132, 159-162, 166-169], 13 of these 
studies recruited older participants (aged 60 years or older) [30, 68, 77, 132, 159-162, 
165-169]. Baseline characteristics of participants varied across interventions, 8 
studies included healthy participants at baseline [68, 77, 132, 158, 159, 162, 165, 169], 
5 studies included older people manifesting cognitive decline [30, 160, 166-168] and 
the remaining 1 study recruited diagnosed mild to moderate dementia [161]. 
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Table. 3.1 Summary of interventions assessing the effect of fruit supplementation on cognition and mood 
 
Reference Study design 
Sample (sample at 
baseline/N, 
age/years,  %male, 
mean BMI (kg/ m2), 
health status )  
Intervention type, dose and 
duration 










group 67.5 ± 3.0: 69.0 ± 
3.3 years, intervention: 
control group 58.33 % : 
42.86 % males, mean 
BMI intervention: control 
group 25.9 ± 3.3: 27.1 ± 
4.0 healthy 
30 ml blueberry (BB) concentrate 
(blueberry active) providing 387 
mg anthocyanidins, 12 weeks,  
isoenergetic synthetic 
blackcurrant and apple cordial as 
control 
Detection Task, 
Groton maze timed 
chase test and 
learning test, 
sequential letter 1-
back and 2-back 
tasks, fMRI, serum 
sample   
Improved executive function (Groton maze 
learning task accuracy). Also improved task-
related brain activation (Brodman areas, 
presumes, anterior cingulate, insula and 








N=21 (8:8), 80.4 





Blueberry powder: 12.5*2g 
equivalent to 148 g whole 
blueberry, 16 weeks, placebo 
powder: 12*2g 
Sequential letter n-
back tasks, fMRI 
Trend for improving working memory at 
larger sample size (effect size d = 1.02).  
Also increased BOLD activation in the left 
pre-central gyrus, left middle frontal gyrus, 
and left inferior parietal lobe during tasks 





N = 110 (57:52), 56-75 
years, 48.2 % males, 
mean BMI 23.2±1.0, 
healthy 
250 mg/d Cognigrape-V. vinifera 
fruit extracted powder and 
maltodextrin (30–40 %), 12 
weeks, placebo was composed of 
maltodextrin 
MMSE score, BDI, 
HARS, RBANS 
Improved attention, language, immediate 
and delayed memory. Supplementation also 
produced a significant reduction in BDI 
(−15.8 %) and HARS (−24.9 %) scores with 
respect to baseline levels (p < 0.0001) and 
placebo (p < 0.0001 for BDI and p < 0.05 for 
HARS. 
3 
(Chai et al. 
2019) 
Parallel RCT N = 20 (17: 17); 28.5 ± 
3.7: (27.3 ± 4.2); 70.0 ± 
3.7: 69.5 ± 3.9 years; 
40 %:52.9 % males; BMI 
28.5 ± 3.7: (27.3 ± 4.2); 
older adults with normal 
cognitive function  
480 ml tart cherry juice (68 ml 
Montmorency tart cherry juice 
concentrate was diluted with 412 
ml water) per day for 12 weeks; 
placebo consisted of mixing 
unsweetened black cherry 
flavoured Kool-Aid (Kraft Foods, 
United States) with water. 
Dextrose and fructose were 
added to match the carbohydrate 
content found in tart cherry 
Memory ability, 
Memory contentment, 
Memory strategy, digit 
span, PAL first trial 
memory, PAL total 
errors adjusted, RTI 
movement time, RTI 
reaction time, RVIP A, 
RVIP mean latency, 
SWM strategy, SWM 
total error 
Increased subjective memory in the domain 
of contentment with memory by 5 % and 
reduced movement time by 4 % in 
comparison with the control drink. Also 
reduced errors in episodic visual memory by 
23 % compared to control drink as assessed 
by PAL task. 
2 








N = 50 (24:23); 
69.28±6.45 years old, 
Healthy. Cognitive intact 
subjects 
909 ml/d 27 % cranberry juice for 
5 weeks, placebo drink 
Immediate free recall, 





term retrieval, cued 
recall, delayed free 
recall, delayed 
recognition, Faces I, 
Faces II, Digit symbol, 
Part A, Part B, Word 
page, colour page, 
colour-word page 
A nonsignificant trend (P = 0.123) observed 
for twice as many subjects of subjective, self-
report improved memory in cranberry group 







N=37, 66.7 ±5.3 years, 
35.13 % males, mean 
BMI 26.1±1.1, healthy 
older adults 
High-flavanone (305 mg) 100 % 
orange juice, 500ml/d for 8 
weeks, equicaloric low-flavanone 
(37 mg) orange-flavoured cordial 
(500 mL) as control 
SBP, DBP, DSST, 
DSST dual, Go-No-Go 





Delayed VPA, PANAS 
Positive and Negative 
Affect Scale 
Improved cognition (significant drink x visit 
interaction for global cognitive function and 
executive function). No effect on mood and 
BP. 
5 




N = 49 (24:25), 78.9 ± 
5.2 : 80.6 ± 6.6 years, 
51 % males, mean BMI 




200 ml/d cherry juice, 12 weeks, 
flavonoid-devoid apple juice as 
control 
 
RAVLT, SPOT, Boston 
naming test, TMT, 
Digit Span Backwards 
Task, Category and 
Letter Verbal Fluency, 
SB, DBP, serum 
sample 
 
Improved cognition in memory and executive 
function and reduced SBP of 7.7 mmHg after 









N= 12 (5:7), 78.2±5.0 
years, 66.67 % males, 
older adults with early 
memory decline but not 
dementia 
100 % Concord grape juice, 6 
and 9 ml/kg/d, 3 portions daily, 12 
weeks, placebo beverage 
CVLT, SPALT, GDS, 
glucose and insulin 
Improved memory and insulin level after 








N= 21 (11:10), 76.9±6.1 
years, 52.38 % males. 
mild cognitive 
impairment 
100 % Concord grape juice 
6.3−7.8 mL/ kg/d, 3 portions daily, 
16 weeks, placebo beverage 
CVLT, GDS, fMRI, 
SBP, DBP 
Attenuated cognitive error (5.03 vs 7.16 
interference errors on recognition memory 
task) and great activation in right superior 
parietal cortex and right middle frontal cortex 
regions after juice treatment. No effect on 
mood and BP. 
2 










N=25, 43.2±0.6 years 
old healthy females, 
mean BMI 24.6 ± 0.5 
355 ml/d concord grape juice, 
6wks and 12 weeks, energy-, 
taste-, and appearance-matched 
placebo 
VVLT and VSLT IR & 
DR, RVIP, Grooved 
Pegboard, Tower of 
Hanoi, SBP, DBP, 
Subjective Mood, 
Driving performance 
Better immediate spatial memory and 
aspects of driving performance after GJ 
intake. No difference in mood between 
groups 
4 






N=13 (5:5), 72.2± 4.7 
years, 50 % males, mild 
cognitive decline 
Grape formulation ---freeze-dried 
grape powder in 8 oz. water, 72 
g/d---3 standard servings daily, 6 
months, placebo formulation 
matched in appearance, flavour, 
smell, volume and content of 
fructose and glucose but free of 





Visual Retention Test, 
Rey-Osterreith CFT, 
Boston Naming Test, 
LF, Category Fluency, 
Stroop, TMT Parts A 
and B, Wisconsin Card 
Sorting Test-64, 
WAIS-III Tasks, 







Attenuated decline in brain metabolites at 
regions of right posterior cingulate cortex and 
left superior posterolateral temporal cortex 
and improved correlated attention after grape 







N = 42 (18:19). 67.8 
±4.6:  67.3 ±4.8 years, 
28 %:37 % males, mean 
BMI 24.1±3.7:  24.0±2.5, 
age-related motor and 
cognitive decline 
24 g/d freeze-dried blueberry 
powder. 90 days, placebo powder  
CVLT, ANT, DS, TMT, 
TST, wMWM, GDS, 
POMS 
Attenuated cognitive error and improved 
executive function after blueberry treatment. 






N = 20 (13:7), 69.5±9.3: 
68.4±7.7 years, 45 % 
males, mean BMI 
26.4±3.9: 26.2±3.2, 
healthy 
6-cup (48 ounce (1.4 kg))/week 
frozen blueberry, 6 weeks, 
placebo/carrot juice with low 
anthocyanins contents 
Grip strength, SRT, 
adaptive gait tests, 
TMT-B 
Reduced errors (76.9 % vs 57.1 % of 
participants in BB vs Control had reduced 
errors) and improved mobility after BB 
treatment.   
3 








N = 122-->112 
(29:28:28:27); 70.8±3.88 
years; 38.50 % males, 
healthy older adults 
500mg, 1000mg blueberry 
powder or 111mg purified 
blueberry extract for 24 weeks, 
colour matched placebo 




Corsi Block Task, 
Stroop Task, and 
Modified Attention 
Network Task (MANT), 
the Serial 3, Serial 7, 
and Sternberg task, 
the PANAS-NOW  
No effect on cognition and mood after the 
blueberry powder intervention. Improved 
episodic memory performance in delayed 
word recognition and marginally significant 
improved visuo-spatial Corsi Block 
performance at 3, but not 6, months following 
blueberry extract intervention. 
5 
ADAS= the Alzheimer's Disease Assessment Scale, ADCS-ADL=the Alzheimer’s Disease Cooperative Study-Activities of Daily Living, AG=Affect Grid, ANT=Attention Network 
Task, BDI=Beck Depression Inventory, CBFV=Cerebral Blood Flow Velocity, CERAD=Consortium to Establish a Registry for Alzheimer’s Disease, CFT=Complex Finger Tapping, 
CPT=Continuous Performance Task, CRT=Choice Reaction Time, CS=Contrast Sensitivity, CVLT=California Verbal Learning Test, DBP=Diastolic Blood Pressure, 
DPR=Delayed Picture Recognition, DRS=the Dementia Rating Scale, DSST=Digit Symbol Substitution Test, DV=Digit Vigilance, DVR=Delayed Verbal Recall, DWR=Delayed 
Word Recognition, EEG= Electroencephalogram, fMRI=Functional Magnetic Resonance Imaging, FVT=Freiburg Vision Test, GDS=Geriatric Depression Scale, HARS=Hamilton 
Anxiety Rating Scale, IWR=Immediate Word Recall, IVR=Immediate Verbal Recall, LF=Letter Fluency, LM=Letter Memory, MMSE=Mini Mental State Examination, 
NWM=Numeric Working Memory, NIRS=Near-IR spectroscopy, NPI=Neuropsychiatric Inventory, PANAS=Positive and Negative Affect Scale, PP=Picture Presentation, 
POMS=Profile of Mood States questionnaire, RAVLT= Rey Auditory Verbal Learning Test, RBANS= Repeatable Battery for the Assessment of Neuropsychological Status, 
RT=Reaction Time, RVIP=Rapid Visual Information Processing, SBP=Systolic Blood Pressure, SFT=Simple Finger Tapping, SPOT=Self-ordered Pointing Task, SPALT=Spatial 
Paired Associate Learning Test, SRT=Simple Reaction Time, sVOI=Standardised Volume of Interest, SWM=Spatial Working Memory, TMT=Trail Making Task, TST=Task 
Switching Task, VAS=Visual Analogue Scales, vMWM=Virtual Morris Water Maze, VPA=Verbal Paired Association, VSLT=Visual Spatial Learning Test, VVLT=Visual Verbal 
Learning Test, WAIS=Wechsler Adult Intelligence Scale, WFC=Word Fragment Completion, WMS=Wechsler Memory Scale, WP=Word Presentation 
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For studies assessing cognitive health, there were 8 studies supplementing fruit juice, 
5 studies supplemented fruit powder and only 1 study used whole frozen fruit. Among 
14 studies, the mean intervention duration was 13 weeks, ranging from 6 weeks to 6 
months. Among the juice supplementations, 3 studies were accumulated under the 
groupings of grape juice with mean dosage of 408 ml/d, 2 were cherry juice with mean 
dosage of 340 ml/d, 1 was cranberry juice with 32 ounces/d (around 942 ml), 1 was 
blueberry juice concentrate and 1 was orange juice study with 500 ml/d. Three studies 
supplemented blueberry powder with mean dosage of 16.3 g/d and 2 supplemented 
grape powder with mean dosage of 48.5 g/d; portion conversion of powder to whole 
fruit were provided in 3 studies [30, 160, 168]. For example, Lee et al. supplemented 
grape powder that was comparable to 3 servings of fresh grape daily (approx. 504 g/d 
fresh grape) [30]. Two studies supplementing blueberry powder were equivalent to 
providing 1 cup and 1.5 cups of fresh blueberry as measured in FDA recommended 
fruit portions respectively [160, 168]. Schrager et al. supplemented 200 g/d whole 
frozen blueberry [68]. 
 
3.1.11  Study quality  
 
For studies assessing cognitive health, the average retention rate was 92 %; 11 out of 
14 studies obtained no less than 3 points of the total Jadad score (Appendix. 2.1). 
Five studies implementing blinding, randomisation and control all provided adequate 
description of methods and procedures; 4 implemented true randomisation; 2 studies 
implemented true blinding, where the placebo were colour and taste matched to mask 
treatments, and the received treatment was not revealed until the statistical analysis 
was completed for double blinding. 
3.1.12  Meta-analysis  
 
As shown in Table. 3.2, for studies included in the meta-analysis, memory was 
assessed as either the number of correct responses or accuracy (%) in Immediate 
Word Recall, Delayed Word Recall or CVLT List Free Recall (California Verbal 
Learning Test); executive function was assessed as the total score, or the number of 
correct responses or arcsine transformation of the square root of the proportion of 
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correct answers in Digit Symbol Substitution Test, Digit Span, 2-Back Task or Rapid 
Visual Information Processing (RVIP); psychomotor speed was assessed as reaction 
time (RT, ms or s) of Trail Making Task, Reaction Time Test (RTI), Simple Reaction 
Time, 2-Back Task or RVIP. Studies incorporating grape juice, grape powder, 
blueberry juice, blueberry powder, cranberry juice and frozen blueberry constituting a 
berry group along with studies supplementing cherry juice, categorised as stone fruit, 
were able to provide sufficient data to run meta-analysis. There was insufficient data 
for mood to be entered into meta-analysis, but the mood assessment results for 
individual studies were reported in Table. 3.2. 
 
All 14 included studies assessed cognition with 13 studies reporting improvement or 
trend for improvement in cognition; 4 studies assessed mood with 1 study 
supplementing grape juice finding a trend for mood improvement. The largest portion 
of studies assessing cognition supplemented frozen, juiced or powdered berry (11 out 










Cognitive task entered 
into meta-analysis* 
Unit of test 
scores* 
Results of the chosen task 
Memory 
grape juice 
Lamport, et al. 2016 (UK) 




cranberry juice Crews et al. 2005 (US) Delayed free recall correct numbers No changes 
blueberry 
powder 










cranberry juice Crews et al. 2005 (US) Digit symbol raw score No changes 
blueberry 
powder 
Boespflug et al. 2018 (US) 2-Back task 
arc 
No changes 
blueberry juice Bowtell et al. 2017 (UK) 2-Back task arc No changes 
cherry juice 
Chai, S. C. et al. 2019 (US) Digit span score No changes 
Kent, et al. 2017 (Australia) 
Digit span backwards 
task (short-term memory) 
score Final score between groups (P = 0.02) 
Psychomotor 
speed 
grape juice Lamport, et al. 2016 (UK) RVIP reaction time ms No changes 
cranberry juice 
Crews et al. 2005 (US) 
Trial making task 
reaction time 
total time No changes 
frozen blueberry Schrager, et al. 205 (US) Simple reaction time ms No changes 
blueberry 
powder 
Boespflug et al. 2018 (US) 
2-Back task reaction time 
ms 
ms No changes 
cherry juice 
Kent, et al. 2017 (Australia) 
Trail making task 
reaction time 
ms No changes 
Chai, S. C. et al. (2019).US RTI reaction time ms No changes 
MMSE grape powder 
Calapai, et al. 2017 (Italy) MMSE score Change score between groups (P < 0.01) 
Lee, et al. 2017 (US) MMSE score No changes 
*arc: arcsine transformation of the square root of the proportion of correct answers; CVLT: California Verbal Learning Test; RVIP: Rapid Visual Information 




Notably, cherry juice induced a borderline significance in improvement of psychomotor 
speed after the intervention compared to control (SMD = -0.37, 95 % CI -0.74 to 0.01, 
P = 0.05, t1 = -12.52) in Figure. 3.2 The berry group induced no significant difference 
for psychomotor speed between intervention and control group (SMD = 0.53, 95 % CI 
- 0.62 to 1.37, P = 0.24, t3 = 1.47). For the assessment of executive function, the berry 
group induced no significant difference between intervention and control group (SMD 
= 0.05, 95 % CI - 0.29 to 0.39, P = 0.79, t5 = 0.45) and cherry juice induced no 
significant difference between the two groups (SMD = - 0.65, 95 % CI - 15.63 to 14.34, 
P = 0.68, t1 = - 0.55). For memory assessment, the berry group induced no significant 
difference between intervention and control groups (SMD = 0.04, 95 % CI - 0.89 to 
0.97, P = 0.87, t2 = 0.19). Apart from the analysis assessing cognitive domains, two 
grape powder studies were able to provide MMSE (Mini Mental State Examination) 
data, but no significant difference was shown between intervention and control groups 
(MD = 0.87, 95 % CI -6.40 to 8.15, P = 0.37, t1 = 1.53). The remaining forest plots are 
found in Appendix. 2.2. Funnel plots and the egger’s test for the berry group showed 
an overall symmetric distribution of the berry interventions around the standard error 
for the investigated outcomes of executive function, memory and psychomotor speed; 
symmetric distributions were shown for the cherry interventions investigating the effect 
on executive function and psychomotor speed and grape powder interventions 
investigating the effect on MMSE test (egger’s tests P > 0.05) (Appendix. 2.3). 
 
Significant heterogeneity among studies was observed in the cherry juice studies 
assessing executive function (I2 = 95 %, P < 0.01) and the berry group assessing 
psychomotor speed (I2 = 72 %, P = 0.03). Higher physical activity levels were shown 
to link with better cognitive functioning in younger and older adults [170]; 2 studies 
supplementing blueberry juice concentrate and cherry juice concentrate instead of 
100 % juice, could also cause variations to the juice quality and bioavailability [77, 
132]. There was no heterogeneity in executive function assessment after the 
sensitivity analysis excluding studies applying physical activity adjustments, the 




Figure. 3.2  The effect of (a) berry interventions and (b) cherry juice 
interventions assessing psychomotor speed 
 
3.1.13  Principal findings 
 
Two cherry juice studies including 41 participants receiving cherry juice with mean 
dosage of 340 ml/d for 12 weeks induced a borderline significant improvement in 
psychomotor speed. However, It is important to note that only 2 studies were included 
and one of those had a low Jadad score (< 3) [132], which limits the impact of this 
finding. The long term investigation for whole fruit intervention assessing cognition is 
lacking and worth exploring. The current analyses also do not support the notion that 
the consumption of fruit powder or other fruit juice will confer a cognitive-protective 




3.1.14  Previous evidence of RCTs assessing cognition and mood 
 
Our systematic review collected a range of frozen, freeze-dried, powdered and juiced 
fruit interventions, specifically the berry group (n = 11) reporting positive findings on 
the impact on cognition or mood; the largest portion of studies involved fruit juice (8 
out of 14 studies) with grape juice (n = 3) being the most intensively studied 
supplementations, followed by cherry juice (n  =  2). As demonstrated by the meta-
analysis, 2 cherry juice studies including 41 participants receiving cherry juice with 
mean dosage of 340 ml/d for 12 weeks induced a borderline significant improvement 
in psychomotor speed. However, it is important to note that only 2 studies were 
included and one of those had a low Jadad score [132], which limited the impact of 
this finding. No improvement was observed on executive function and memory.  
 
However, our meta-analyses suggested no differences between the intervention and 
control groups in any cognitive domains following berry or other fruit-based 
supplementations. Overall, the individual interventions showing improvements in our 
systematic review still require further substantiation given that the meta-analysis only 
suggests that cherry juice may have cognition-protective potential. 
 
The systematic review suggested the potential for whole blueberry, blueberry juice 
concentrate, blueberry powder, grape powder, grape juice, cherry juice, orange juice 
and cranberry juice supplements to improve cognitive health. Supplementing grape 
juice also showed potential to improve mood. From the meta-analysis, we found a 
borderline significant improvement in psychomotor speed following chronic 
consumption of cherry juice, which has high content of the flavonoids catechin, 
epicatechin, procyanidins and anthocyanins [171, 172]. The participants of cherry juice 
studies included here were older healthy and have dementia. Lower psychomotor 
speed has been found to be associated with increased risk of all-type dementia 
(hazard ratio [HR] 3.41, p < 0.0001), Alzheimer’s disease-type dementia (HR 3.18, p 
< 0.0001), Parkinson’s disease (HR 2.98, p = 0.04) and depressive symptoms (HR 




Although the meta-analysis indicates a lack of evidence supporting improvements in 
mood by specific fruit interventions, another meta-analysis with 10 observational 
studies involving 227,852 participants suggested an inverse association of fruit (RR 
0.83, 95 % CI, [0.77, 0.91]; P = 0.006) intake with risk of depression [174]. A previous 
systematic review has also assessed the association between cognitive benefits and 
fruit consumption but only included limited evidence from juice interventions, where 
improvements to memory in mildly cognitive-impaired adults after 12 - 16 weeks of 
consumption were illustrated [151]. The reported grape and blueberry juice studies 
[166, 167, 175] were identified in our screening process; however, Krikorian et al. was 
not eligible for inclusion in our review due to the lack of randomisation details and an 
unavailable standard deviation value for the grape juice studies that overall hampered 
the process of entering the data into our meta-analysis [34, 35]. The small sample 
sizes in these studies should also be noted. Support for positive cognitive effects of 
blueberry juice is evident from studies in children but these were not included here 
due to the eligibility criteria [176, 177]. In another review, consumption of blueberries 
or freeze-dried blueberry powder ranging from 30 mg concentrate to 460 g frozen 
whole blueberries for chronic interventions (6 - 48 weeks) and 30 g freeze-dried 
blueberries for acute intervention (2 h) were reported in their review to improve some 
measures of cognitive performance, particularly episodic memory in primarily older 
adults (> 60 years) [114]. There was also a systematic review that reported studies 
supplementing blueberries to children, older adults ( > 60 years old) and adults with 
MCI [178]. The results indicated that cognitive benefits may be found for delayed 
memory, executive function and psychomotor function in older healthy and MCI adults 
and the dosage ranged from 15 - 30 g freeze-dried blueberry powder, 30 ml 
concentrate - 621 ml juice and 300 g whole frozen blueberries with duration ranging 
from 1 - 6 h acutely and 6 - 24 chronically [178]. Same studies that meet the eligibility 
criteria in the current reviewed have also been included here.  
 
High levels of flavonoid metabolites (e.g. anthocyanidin) from blueberries can 
transport through the blood brain barrier into regions such as the hippocampus to 
impact on memory and learning [179]. In the pathogenesis of neurological conditions 
such as Parkinson’s disease, flavonoids have been shown to counteract the damage 
induced by reactive oxygen species (ROS) and neuroinflammation, and to modulate 
synaptic signalling and cerebrovascular blood flow [180]. Therefore, several potential 
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mechanisms could be in action. Previous epidemiological studies assessing 
neurocognitive health provided discordant evidence on the impact of differing levels of 
fruit and their processed forms. One review collated data from cohort studies with a 
follow-up of 6 months or longer but found no inverse association between regular fruit 
consumption and risk of dementia and cognitive decline [181]. One epidemiological 
study reported significantly lower hazard ratio (95 % CI) for probable Alzheimer’s 
disease when comparing subjects who drank fruit juice ≥ 3 times per week with 
subjects who drank < 1 time per week: 0.24 (0.09 - 0.61) vs. 0.84 (0.31 - 2.29) [182]; 
whereas another showed no association between either habitual juice or fruit 
consumption and cognitive changes in middle-aged adults [183]. As mentioned above, 
knowledge about powdered fruit forms for the association with disease risks including 
cognitive decline is currently very limited [143]. 
 
It should be noted that in addition to the lack of consideration of different intervention 
types in previous reviews, generally the cognitive tasks chosen in each intervention 
study were not uniform because of the polyfactorial nature of neurocognitive measures 
[181]. There were also instances where different studies have used the same or similar 
tests to assess different cognitive domains. For example, as a valid and sensitive 
measure of cognitive dysfunction and changes, digit symbol substitution test (DSST) 
has been applied to assess processing speed and executive function in clinical 
neuropsychology [184]. In our meta-analyses, the chosen cognitive tasks were 
isolated from other domain-specific tasks to most likely pool the data as we can, 
however this pooling analysis overlooked the positive results from other domain-
specific tasks in the trials (e.g. TMT-B has been reported in executive function 
assessment too), thus the effect size derived from the meta-analysis in each outcome 
assessment was inevitably underestimated.   
 
Currently, the majority of evidence in this area has included the association between 
intake of fruit combined with vegetable intake and cognitive function. The positive 
findings also mainly arise from studies with older subjects. Degeneration-induced 
cognitive impairment is a common and important phenotype in ageing and is likely to 
be accompanied by increased risk of dementia or Alzheimer’s disease [185], it is 
necessary for future intervention and epidemiological studies to continue to examine 
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the benefits of fruit in their various delivery forms on cognitive health in an older 
population.  
 
Blueberry is the only fruit that was delivered in whole frozen form among chronic (> 1 
week) interventions assessing cognition, which showed a trend for cognition 
improvement [68]. So far, research has mainly focused on fruit juice interventions, 
nevertheless, it should be noted that the daily consumption of fruit juice should not 
exceed 150 ml glass as set out by Public Health England guidelines [186]. Validation 
of metabolites and biomarkers for cognitive impairment should be incorporated into 
future trials to help identify the potential mechanisms underlying any influence 
between fruit-based intake and cognitive health. 
 
To our best knowledge, this is the first systematic review and meta-analysis to 
compare the impact of various forms of specific fruit in isolation from other food 
supplementation on cognition and mood. Firstly, in addition to the comprehensive 
search of the literature in the topic, we also applied the newly developed Hartung-
Knapp-Sidik-Jonkman method for modelling random effects in meta-analysis, in 
addition to a comprehensive search of the literature in the topic. Secondly, the 
interventions included in this review have assessed either general cognitive 
performance or specific cognitive domains using well-established cognitive tasks.  
 
There are limitations to our review. Although our systematic review results showed the 
positive results in interventions supplementing with blueberry or grape, the small 
sample size and inadequate studies (< 2 studies) that used the same cognitive task in 
the searched literature may partially explain the lack of support from our meta-analysis. 
Even though studies supplementing cherry juice have shown a significant effect, they 
were not accompanied by improvements to other cognitive domains. The 
improvements were limited to relatively small sample sizes within 2 studies, so the 
implications of the study effect should be treated with caution. Heterogeneities 
presented in our results, however, were explored by subgroup analyses of different 
intervention subgroups, due to the limited number of studies under each participants 
characteristic and country region, we were unable to further compare among different 
baseline characterised subjects (i.e. physical activity, gender) and regions (i.e. 
western and other countries) to take helpful information for our study design. 
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3.1.15  Implications for the intervention design 
Several points were raised from these reviews to help inform our study design: 
i. Combining evidence from RCTs assessing vascular function in Chapter 
2, cranberry and cherry juice studies have shown significant 
improvement to blood pressure or borderline significant improvement to 
psychomotor speed (P = 0.05). However, we have to emphasize that the 
analyses were limited to either small samples size, unbalanced baseline 
blood pressures, or neglected diet refrainment. Furthermore, 
improvements to other outcomes were not observed, which does not 
support the notion that the consumption of these specific fruit powder or 
other fruit juice will confer a cognitive-protective benefit. 
ii. Future interventions on supplementing berry (e.g. blueberry, 100 mg 
extract powder - 200 g whole blueberry equivalent, 6 - 24 weeks) with a 
sufficient sample size are warranted, as these appeared to have the 
biggest potential to improve cognition in both young and old adults.  
iii. No fresh fruit was identified in the previous interventions, which could be 
due to the difficulty of storage and allocation during the intervention. 
Fresh whole fruit is generally how the fruit is consumed in the general 
population, which highlights a novel and necessary intervention for 
future studies.  
iv. Apart from fruit juice, blueberry and grape powders is supplemented the 
most and could also be an effective method to increase overall fruit 
consumption. Combining evidence from RCTs assessing vascular 
function in Chapter 2, the long-term investigation for whole blueberry 










Chapter 4. Intervention design and 







Considering the review results presented in Chapters 2 & 3 along with other 
epidemiological and meta-analyses evidence [187, 188], the consumption of a range 
of berries have been linked with improved vascular and cognitive health, however, the 
meta-analyses were insufficient and inconsistent to substantiate the consumption of a 
specific type of berry or other fruit as a vascular- or cognitive-protective dietary 
strategy. Nevertheless, the review helped focus the intervention to berries. 
 
This chapter discussed dose-response studies supporting the choice of blueberry, the 
dosage and intervention duration. Intervention design, participant recruitment, study 
protocol, sample size calculation, statistical analysis and methodologies for biological 
sampling, clinical chemistry and measurements are also described. 
 
4.2 Design of a berry-oriented intervention  
 
Blueberry is the only fruit that was delivered in the form of whole fruit among our 
reviewed chronic studies assessing cognition. Some acute post-dose (300 g, 24 hours) 
blueberry interventions assessing blood pressure were also previously reported (95 % 
CI of - 3.87 [- 7.86, 0.12], P = 0.05). As shown in Chapter 2, the meta-analysis including 
both acute and chronic blueberry supplemental studies also showed overall reduction 
in SBP (95 % CI of - 2.78 [- 5.60, 0.03], P = 0.05). The largest number of RCTs 
supplementing fruit powder in this review were using blueberry powder (n = 7) with 
presence of variations in the study design and characteristics of participants. The 
mean dosage of blueberry powder supplementations was 25.7 g (ranging from 22 to 
45 g, equivalent to up to 150 g fresh blueberry depending on the freeze-drying ratio). 
An uncontrolled, single arm, single blind pilot study was performed to investigate the 
time-response effects of 11 g blueberry powder (equivalent to 100 g whole blueberry) 
on FMD from 1 - 4 weeks [189]. The study reported significantly improved FMD at 1 
week and sustained improvement at 2 weeks, suggesting optimal chronical time point 
for blueberry powder intervention to improve vascular function [189]. Another 6 month 
RCT, reviewed in Chapter 2, investigated the dose-response effects of 13 g and 26 g 
blueberry powder (equivalent to 75 and 150 g of whole blueberry respectively) on 
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vascular function [73]. The 150 g of whole blueberry-equivalent powder was shown to 
improve blood lipids profile and vascular function as assessed by FMD and 
augmentation index compared to 75 g whole blueberry equivalent powder [73]. In 
terms of the processing impact on the bioavailability and vascular effects of blueberry 
polyphenols, one RCT has reported similar improvement to FMD post-acute 
consumption (1, 2, 4, 6 h) of baked blueberry-containing product compared to 
unprocessed blueberry, despite significant differences in the plasma metabolites 
levels [190], Another time-response RCT was performed to investigate the effect of 
consuming blueberry juice acutely (1, 2, 5 h) on BP, cognitive function and plasma 
brain-derived neurotrophic factor (BDNF) levels [191]. Improvement to cognitive 
function and trends for attenuating BP increase and BDNF concentrations were shown 
but no time course effects of blueberry juice consumption were suggested [191]. 
However, the sustained dietary blueberry effect (> 24 h) on vascular and/or cognition 
function and human metabolites have not been compared between processed forms 
of blueberry and whole blueberry consumptions. 
 
The National Health Service recommendation for blueberry is 2 adult portion sizes or 
160 g per day [192] and is achievable through diet. From above, 160 g/d of whole 
blueberries was considered for the treatment dosage in the current study. Blueberry 
is very popular among consumers in the United Kingdom [38]. In an exploration of the 
contribution of berry phytochemicals to the human metabolome, a blueberry 
intervention provided a 60 % higher abundance of anthocyanins and 49 % more total 
polyphenols compared to a strawberry intervention [193]. The study applied a 
systematic review approach hence focused on blueberry and strawberry as they are 
the main berries focused on in epidemiological studies and have the most available 
clinical trial data to date [193].   
 
A recent paper emphasized the need for additional research assessing the effect of 
processed fruit on health, as fruit in processed forms provide consumer options while 
reducing costs and food waste in the meantime [194]. Apart from fruit juice, fruit 
powder could also be an effective method to increase overall fruit consumption; it is 
useful to deliver dietary options to the public regarding different fruit groups and 
delivery forms. Blueberry powder is another strategy to increase fruit intake but the 
freeze-drying process for blueberry powder may lead to different levels of bioactives 
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compared to the whole blueberry [195]. Therefore, it is of nutritional interest to test 
powdered berry against whole berry if an RCT with consistent dosage and intervention 
length is conducted. It’s also of nutritional interest to investigate an alternative form of 
the fruit to establish if these forms have similar effects to whole fruit. 
 
The average intervention duration as reviewed in Chapters 2 & 3 ranged from 1 week 
to 6 months. No meta-analysis was performed based on the intervention duration. In 
this proposed RCT, a 1 week duration was chosen for the interventional duration. High 
rates of attrition (49.3 %) and difficulties maintaining participant compliance (reported 
by 37.8 % of participants) were major threats to the viability of long-term interventions 
(up to 12 months) [196]. Therefore, compliance issue for participants adhering to long 
term intervention and the logistical issue of storing fresh blueberries over long term 
were considered also. The current study also aimed to assess metabolic differences 
within blueberry treatments and between responder (RS) and non-responder (NRS) 
groups manifesting opposite responding levels. Therefore, the time taken for 
observing metabolomic changes over an intervention should be considered too. A 
phytochemical dietary study followed by magnetic resonance/mass spectrometry 
(NMR/MS) and multivariate analysis reported distinct discriminations of metabolomic 
profiles between the 1st void morning urinary samples of subjects following 2-d low-
phytochemical diet and urinary sample following 2-d normal diet or following 2-d 
standard phytochemical diet [197]. This study suggested that the plasma elimination 
half-life for major phytochemicals is between 1.1 and 28.1 hours so that 2 days were 
adequate to show distinctive metabolomic changes with a dietary intervention, with 1 
- 2 days of washout period implemented [197, 198]. Another short-term dietary 
intervention study using liquid or gas chromatography coupled with mass spectrometry 
(LC-MS/MS and GC-MS), and NMR spectroscopy metabolomic profiling reported 
distinctive dietary metabolite markers in fasting plasma and 24-hour urinary samples 
from subjects following a 4-days mixed intervention of red wine and grape juice 
extracts [111]. Therefore, to observe metabolomic changes during a dietary 
intervention, a shorter term is sufficient rather than longer conventional interventions 





A cross-over design can reduce the influence of confounding covariates such as intra-
subjects’ variability, each cross-over participant can act as his or her own control; 
furthermore, an optimal cross-over design is statistically efficient that requires fewer 
subjects than a non-cross-over design [199, 200]. Similarly, a 1 week of wash out 
period was chosen after each intervention arm. Apart from the 2 cross-over treatment 
arms, a control arm was required. For RCTs collected from the literature review in 
Chapters 2 & 3, colour-matched placebo powder containing no polyphenols or calorie-
matched polyphenols-free drink were implemented for the fruit powder or frozen 
blueberry as control.  
 
Encapsulated microcrystalline cellulose powder, a plant derived fibre which is calorie-
free and contains no equivalent bioactive to blueberry, was chosen as a placebo arm 
in this study. As a wash-out period needed to be implemented for 3 treatment arms in 
a cross-over design, the overall length of the trial would take 6 weeks and there was 
also a need for completing the trial within the certain time range of the project. Due to 
the procedural nature of the researcher assigning treatments to the participants, only 
participants were concealed to the placebo treatment. Ultimately, a randomised, 
placebo-controlled, counter-balanced-cross-over design was employed. The study 
was approved by Northumbria University’s Faculty of Health and Life Sciences Ethics 
Committee (reference: 10113; approved: 30th October 2018) and was registered under 
ClinicalTrials.gov (ID: NCT04015258). 
 
4.3   Participants 
The current study adhered to Consolidated Standards of Reporting Trials (CONSORT) 
guidance [201]. The reviews combined with meta-analyses in Chapters 2 & 3 were 
used to help inform the blueberry intervention design and the participant groups, where 
that data was available. Previous fruit interventions have included participants with 
different age groups and different health status, although the subgroup analyses were 
not able to explore further and most studies included participants at older age or with 
high health risks, the study results were inconsistent. The current study aimed to 
recruit adults with age range of 18 - 60 years old with normal (18.5 - 24.9 kg/m2) to 
overweight (25.0 - 29.9 kg/m2) BMI so that to include generally healthy participants 
with low-mild health risks developing vascular and/or cognitive function. 
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Forty participants were required based on data from two previous studies targeting 
vascular health and cognition following 300 g and 2 cups (approx. 300 g) fresh-frozen 
blueberry supplementations respectively [68, 137]. An effect size based on the group 
mean difference (d = - 4.70) (e.g. treatment vs. control: 124.40 mmHg vs. 129.10 
mmHg, P < 0.05) assessing SBP, with a SD of 6.8 mmHg following 300 g frozen 
blueberry intervention [137] and d = - 1.83 (treatment vs. control: 4.26 vs. 6.09, P = 
0.042) assessing number of errors of psychomotor/adaptive test, with a SD of 1.74 
following approx. 300 g frozen blueberry intervention [68] respectively indicated that 
total of 35 and 17 subjects were required for detecting an effect difference in the 
blueberry treatments separately at a two-sided 0.05 significance level with statistical 
power of 0.8. The sample size estimation was not performed for all the primary 
endpoints in the current study, therefore, a retrospective post hoc power calculation 
was performed (provided in section 5.4). Considering a dropout rate of 10 %, 40 people 
were required to be drawn in the study to see a treatment effect. From our approach 
to identify response at the 25th (Q1) and the 75th (Q4) percentile of the calculated 
response level of the endpoints (described later in section 4.9.1) we would need 
approximately 10 RS and NRS from the 25th and 75th percentiles respectively in a 
sample cohort of 40 participants.  
From the above, 40 participants were needed to be recruited through an opportunity 
sample within Newcastle upon Tyne and the surrounding areas. The inclusion criteria 
included requirement of no relevant pre-existing medical condition/illness such as 
heart disease, hypertension (≥ 140/90 mmHg) and neuropsychological disorders, and 
no current use of prescription medications (excluding contraception pills); no smoking 
and had body mass index (BMI) of 18.5 -30 kg/m2 (inclusive), which were all assessed 
on the screening visit; no current condition of migraines (> 1 per month) and no visual 
impairment that cannot be corrected with glasses or contact lenses; being proficient in 
English and equivalent to IELTS band 6 or above; did not regularly consume 
blueberry/blueberry-contained products more than twice a week; no current 
participation in other clinical or nutritional interventional studies and had no habitually 
used supplements within the last month (defined as more than 3 consecutive days or 
4 days in total). Participants were not recruited if at least one of the criteria did not 
apply to them. Each participant would receive a £ 20 shopping voucher upon their 
completion of the study for a compensation. 
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4.4  Treatment 
Fresh blueberries (Vaccinium corymbosum. L.) throughout four seasons were 
purchased from a local retailer using the same source; freeze-dried blueberry powder 
was purchased from Lio-Licious freeze-dried fruit range and processed from fresh 
blueberry (Vaccinium corymbosum. L. as provided by the supplier); the 
microcrystalline cellulose was purchased from Blackburn Distributions. The powder to 
fresh blueberry net weight conversion was provided by the supplier. Total polyphenol 
analysis (TPC) was completed for blueberry, blueberry powder and placebo capsules 
using the Folin Ciocalteau reagent method [202] (Table. 4.1). 
The present study supplied either 160 g of fresh whole blueberry (4 handful portion, 2 
of NHS adult portion size) or 20 g of freeze-dried blueberry powder (measured with 
tablespoon provided; equivalent to 160 g of whole fresh blueberry), or placebo capsule 
with plant-derived fibre microcrystalline cellulose (participants have been told that this 
was encapsulated blueberry extract components) to participants on separate 
occasions for 1 week with 1 week of washout period. Each participant was given each 
treatment in random sequence. The random permutation was carried out by the online 
randomisation tool (http://randomization.com/), the blinding of the placebo treatment 
was conducted by the researcher (YW) who co-ordinated intervention. 
All treatments were prepared 1 day prior to the study visit and were given to the 
participants with 7 days portion. Blueberries were asked to be stored in the fridge to 
keep fresh. Blueberry metabolites could be used as marker of compliance adhering to 
the interventions. Compliance was also checked on each study visit using 1-day food 
diary as described below. Energy and macronutrient intake were also calculated 
throughout the trial using 1-day food diary to evaluate any displacement effects of the 
different dietary intervention arms.
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Table. 4.1 Nutrient composition of freeze-dried blueberry powder and placebo 
compared with whole blueberry 
    
Blueberry 
(per 160 g)a 
Blueberry 
Powder (per 20 
g)b 
Placebo 
(per 1 g)c 
Energy (kcal) 
 120.00 69.20 0.00 
Fat (g) 
 0.32 1.30 0.00 
From Saturates (g) 
 0.00 0.08 0.00 
Total Carbohydrates (g) 23.20 13.90 1.00 
From Sugars (g) 
 22.40 7.78 0.00 
Protein (g) 






220.48 288.43 0.00 
a US department of Agriculture National Nutrient Database for Standard Reference 
b Lio-Licious freeze-dried blueberry powder information 
c Blackburn Distribution information 
d Analysed by the researcher (YW) at Northumbria University 
 
4.5  Study protocol 
 
Figure. 4.1 demonstrates the study timeline. The 1st visit was a screening appointment; 
upon arrival the participants were asked to give signed informed consent to participate. 
Once they have completed the consent form, they were measured for blood pressure 
for an eligibility check. This screening session usually lasted approximately 2 hours. 
They were also screened for general physical health (including measurement of 
demographic data (age, height, weight)) and criteria questions to confirm eligibility. All 
participants data were recorded in the pre-defined Case Report Form (CRF). Then the 
participants were trained on computerised cognitive tasks. 
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After the training, they completed a questionnaire based upon consumption of 
blueberry and related products. Once the participants met with the inclusion criteria, 
the participants were asked to completely avoid consumption of polyphenol-rich berry 
(e.g. blueberry, raspberry, and blackcurrant etc.), cherry, raisins and vegetables (e.g. 
eggplant, purple cabbage etc.), and any foods containing them, a list of food that they 
should refrain from taking were given to the participants. In addition to these, 
participants were also asked to stick to their usual diet. Before they left, the participants 
were given a 1-day food diary to record their dietary intake on the day prior the visit 
days (they should bring this diary to every appointment they attend). At the end of this 
screening session, they were provided with urine sample collection kits and 
instructions on their use. They were also asked to bring the completed samples for 
their second urination in the morning of the day on their next visit.  
The 2nd, 4th and 6th visits were the baseline visits for each treatment. These visits took 
place 7 days after the last visit (ideally the same day of the week). Participants 
completed their urine collection on the morning of this visit and brought this sample 
with them to the laboratory (second urination of the morning). Their 1-day food diary 
questionnaire was also returned. The participants arrived at the laboratory having not 
consumed any food or drink other than water for 12 hours prior. Upon arrival at the lab, 
the researcher (YW) checked that they still complied with inclusion/exclusion criteria 
and were in good health and were well rested. Changes to medication and/or illness 
between visits were recorded if applicable. At this session they were required to bring 
the 20 ml spot urine in the morning (second urination of the day) with the given urine 
sample collection kit from the previous visit. Then 10 ml of their venous blood sample 
was taken by the BD Vacutainer™ Flashback Blood System into BD Vacutainer™ 
Heparin Plasma Tubes by a suitably qualified individual (YW). Then their systolic and 
diastolic blood pressure was measured (approx. 15 min). Following which participants 
underwent their computerised cognitive assessment (approx. 30 min). Finally, the non-
invasive measurement of pulse wave velocity assessing arterial stiffness was 
performed (approx. 15 min). This was the completion of participant testing. 
Participants were provided with a 1-day food diary and a urine sample kit upon their 
departure to record their food intake of the day prior to their next visit and were 
reminded to bring their 2nd urination to the next visit day. The participants were 
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instructed to take their treatment for the following 1 week, and adhere to the 
instructions and consume either (according to their treatment randomisation): 
i. 160 g of fresh whole blueberry daily for 7 days; which were weighed prior to 
each study visit and provided to the participants. The blueberry was packed 
in 7 separate food grade sealed bags and participants were told to store the 
blueberries in a refridgerator and take one bag out for consumption daily. It 
was suggested that the blueberries were preferably consumed prior to lunch. 
ii. Or 20 g of blueberry powder ( for the next 7 days, which were measured in 
a sachet prior to each study visit and provided to the participants. The 
blueberry powder was to be measured with a tablespoon provided that had 
a 20 g marker line which was validated with Benchtop Electrical food scales. 
Participants were told to store the blueberry powder in a cool and dry place 
and take one tablespoon of the powder (measured with the marker line) for 
consumption daily. It was suggested to mix and consume the powder with 
water at room temperature, preferably prior to lunch. 
iii. Alternatively, encapsulated placebo (the placebo content was revealed to 
the participants as blueberry extract) to be taken daily for next 7 days, which 
was provided to the participants. The 7 capsules were packed in food grade 
capsule containers and the participants were told to take 1 capsule with 
water for consumption daily, preferably prior to lunch. 
Instructions on when and how to take the supplementations were carefully explained 
to each participant on their departure following each study visit. The procedure on the 
3rd, 5th and the 7th visits was identical to the aforementioned procedure, in addition to 
that the participants were not be given treatments upon their departure so as to enter 
the 1-week washout period. On visit 7, all participants were asked to finish a treatment 
guess questionnaire in order to check their blinding status and compliance; the 
compensated voucher would be given to participants upon their completion on the last 
visit. The CRF and 1-day food diary templates are provided in Appendices. 3.1 - 3.2. 
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4.6 Biological sampling 
 
i. Plasma separation: 10 ml of fasting venous blood was collected from 
participants by the BD Vacutainer™ Flashback Blood System into BD 
Vacutainer™ Heparin Plasma Tubes by the researcher (YW) and 
centrifuged for 10 minutes under 1200 relative centrifugal force (xg) to 
separate the plasma, which were stored in aliquots at -80 °C. 
ii. Urine collection: 20ml of a spot urine sample (2nd urination of the day 
following the morning void) were collected and stored in aliquots at -80 °C 
 
4.7   Primary and secondary endpoints 
 
i. Primary endpoints: pulse wave velocity (PWV), systolic and diastolic blood 
pressure (SBP and DBP), accuracy of Immediate Word Recall and Delayed 
Word Recall Tasks, correct response of Serial 3s Subtraction, correct 
response of Serial 7s Subtraction, reaction time and accuracy of Digit 
Vigilance Task.  
ii. Secondary endpoints: Plasma lipid profile including concentrations of 
plasma total and high-density lipoprotein (HDL-), low-density lipoprotein 
(LDL-) cholesterol and triglycerides, plasma nitrite concentrations. mental 
fatigue, alert, calm and content scores. Untargeted urinary metabolites. 
Measurements for these endpoints are described below. 
 
4.8   Methodology 
 
4.8.1 Anthropometric measurements 
 
Participants’ age, gender, height, and weight were recorded at the screening session. 
Height and weight were measured using digital scale (Seca Scales 703, Seca Ltd. 
Birmingham, UK) and BMI was calculated correspondingly.  
 
4.8.2 Cognitive testing 
 
A battery of computerised cognitive tests that would take approximately 30 minutes to 
complete was applied on each study day. Those tasks were provided by software 
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called the Computerised Mental Performance Assessment System (COMPASS, 
Northumbria University), which has shown stable sensitivity to a range of nutritional 
interventions [203, 204]. Table. 1.2 summarises the domains in cognition trials that 
have demonstrated significant results in interventions. Attention and vigilance, long-
term memory, working memory and mood were the ones with significant reports in fruit 
interventions and were entered into the tasks battery from COMPASS [30, 115, 161, 
166, 167, 205-208]. Table. 4.2 shows the selected cognitive tests and mood measures 
in the study.  
 
4.8.3 Whole body measurements of vascular function  
 
The following markers were measured in line with the assessment of vascular health: 
i. Ambulatory blood pressure (BP): Systolic and diastolic blood pressures 
(SBP and DBP) were measured 3 times by a vital signs monitor (GE 
Carescape) with participants sitting in an upright position for 5 minutes. A 
first reading was taken but discarded. If the average reading was out of 
range, but the third was lower than the second reading, a fourth reading was 
taken. This reading alone was then used as the final measurement. 
Readings were taken > 1-minute intervals.  
ii. Pulse Wave Velocity (PWV): PWV reflects the speed of the blood pressure 
wave to move down the blood vessel, it is a good indicator of arterial 
dispensability and stiffness [20]. It’s a non-invasive whole-body 
measurement and has been applied in nutritional interventions before and 
is now commonly used [14, 209]. It was assessed by pulse wave time (s) 
dividing brachial-radial distance (m), PWV will be presented in the units of 
m/s. PWV of carotid artery and radial artery (crPWV) was assessed using 
SphygmoCor (ScanMed medical) and the cardiac rhythm was monitored 




Table. 4.2 Cognitive and mood tasks completed at baseline and 1-week post-intervention for each treatment arm in the 
order of testing 
 




The 16 Bond-Lader visual analogue scales were used; participants are asked to rate 
how much these descriptors match their current state by placing an ‘x’ on a line with 
the end points labelled ‘not at all’ (left hand end) and ‘extremely’ (right hand end); 
the results were combined to form 3 mood factors: “alert”, “calm” and “content”  
 % along the line from left to right.  Mood 
Word 
presentation 
A series of words is displayed on the screen, one word at a time. In this case, 15 





Participants are instructed to write down the words that were presented. In this 
case, 60 s were given to complete the task  




A fixed number appears on the right of the screen and a series of changing numbers 
appear on the left of the screen at the rate of 150 per minute. Participants are 
required to make a response when the number on the left matches the number on 
the right. In this case the task lasted for 3 min  
Accuracy (%), reaction time for the 
correct responses (ms) and false 




A starting number between 800 and 999 appeared on the screen and participants 
were instructed to count backwards as quickly and as accurately as possible from 
this number in threes, using the linear number keys to make their response. 
Responses were cleared when the ‘enter’ key was pressed. Participants were only 
shown one number on screen and the rest of the numbers were generated by 
subtracting from the previous number in their head. In the case of incorrect 
responses, subsequent responses were scored positively if they were correct in 
relation to the new number.  
Number total responses, correct 




This task is identical to the serial 3s subtraction task except that it involves the serial 
subtraction of 7s. 
Number total responses, correct 





The participant was asked to use the keyboard to click an 'X' at a point on the scale 
which best represents how they feel in response to the questions "How mentally 
fatigued do you feel right now", the 'X' can be repositioned if necessary. 
% along the line from left to right.  Mental fatigue 
Delayed word 
recall 
Participants are instructed to write down the words that were presented to them at 
the beginning of the assessment. In this case, 60 s were given to complete the task  





All target words that were shown during Word presentation plus an equal number of 
decoys are displayed on the screen one at a time. Participants indicate if they 
remember seeing the word earlier or not.  
Accuracy (%) and reaction time for 
the correct responses (ms)  
Episodic memory  
*The task order Serial 3 – Serial 7 – Mental fatigue VAS was repeated 3 times during each testing 
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4.8.4 Clinical chemistry assessment 
 
Plasma was used to measure concentrations of glucose, lipid status (total and HDL- 
LDL-cholesterol, triglycerides) and the nitric oxide (NO) intermediate nitrite (NO2-). 
 
i. Glucose: The Randox Daytona GOD-PAP (Cat. No. GL8038) with 
measuring range of 0.200-35.5 mmol/l was used, a correlation of r=0.999 
against another commercially available method was reported. 
ii. Lipids: Plasma lipid status was measured using Randox Daytona GOD-
PAP with measuring range of 0.22 - 21.7 mmol/l (Cat. No. CH200), and 0.1 
- 13.4 mmol/l (Cat. No. TR210) for total cholesterol and triglyceride 
respectively. Randox Daytona Direct Clearance Method was used (Cat. No. 
CH1383) for measuring HDL-cholesterol with measuring range of 0.189 – 
4.03 mmol/l. A correlation of r=0.999 against another commercially available 
methods was reported. LDL-cholesterol level was further calculated using 
Friedewald equation: LDL-cholesterol (mmol/l) = total cholesterol (mmol/l) – 
HDL-cholesterol (mmol/l) – (triglyceride/5) (mmol/l) [210]. 
iii. Nitrite (NO2-): The total amount of nitrite (NO2-) in deproteinised plasma was 
determined by using chemiluminescence method via the purge system of 
Sievers Instruments (model NOA 280i, Boulder, CO, USA) with repeatability 
of +/- 5 %. Plasma samples used for nitrite analysis was deproteinised by 
using ethanol to prevent foaming. Plasma samples were mixed with ethanol 
in a 2-fold dilution in microcentrifuge tubes and stood for 30 min. The 
microcentrifuge tube was centrifuged at 12500 rpm for 5 min. The 
supernatant then was removed for analysis. Standard solutions containing 
10 nM, 50 nM, 100 nM, 1 µM, 5 µM, 10 µM, 50 µM and 100 µM of sodium 
nitrite (NaNO2) were prepared with nitrate-free deionised water and 
analysed to construct a calibration curve. 
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4.9 Metabolomics  
 
4.9.1 Sample extraction and preparation 
 
Hydrophilic interaction chromatography (HILIC) was used on polar urine samples as if 
offers a broad coverage of compounds [211]. For urine sample preparation, urine (100 
µI) was mixed with same volume of chilled LC-MS grade methanol (- 20°C) containing 
0.125 % formic acid, mixed and allowed to chill in freezer (- 4°C) for 30 min. The 
sample was then centrifuged for 2 min at 4 °C at 10,000 rpm, then carefully transferred 
to a sample vial for HILIC analysis. QCs were prepared by pooling an aliquot of all 
samples together. 
 
4.9.2 Mass spectrometer parameters 
 
Urine samples were analysed on a Dionex 3000 Ultra High Pressure Liquid 
chromatography (UHPLC) system hyphenated to the Q-Extractive high resolution 
mass spectrometer system (ThermoScientific, Bremen, Germany). All solvents and 
ionization agent used were of analytical grade or higher unless stated. The 
chromatographic separation was performed on a Water Acquity Ethylene Bridge 
Hybrid (BEH) Amide analytical column (1 x 150 mm) with particle size of 1.7 micron at 
a flow rate of 100 µL/min, the column temperature was set to 45 oC. The binary buffer 
system was as follows: Buffer A was MilliQ water and Buffer B was ACN, both with 10 
mM ammonium formate adjusted to pH 3.5 using formic acid. The LC profile was as 
follows: T:0 min: 95 % (B), T:2 min 60 % (B) ,T:5 min 40 % (B), T:7.5 min 40  %(B), 
T:7.6 min 95 % (B), T:10 min 90 % (B). The Heated spray ionization source (HESI) 
was set to the following parameters: Sheath gas flow rate of 50, the Aux gas flow rate 
was set to 13 and the sweep gas flow rate was 3. The Spray voltage of set to 3.5 kV 
with a Capillary temperature of 275 oC. The Aux gas heater temperature was adjusted 
to 425 oC. The MS1 mass acquisition range was as follows: 75 - 1000 m/z units at a 
mass resolution of 35,000 at approximately 7.6 scans per second, microscan: 1, lock 
mass: off. The AGC was set to 1e6 and the ion injection time was 100 mS-1. A 3 µL 
injection was applied. The system was primed with a minimum of 10 sequential 
injections of a pooled QC to stabilise the HESI source and to check for 
chromatographic stability before starting the batch analysis. Samples were analysed 
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in random order, with pooled QC samples and blank injections. The data should be 
acquired in both Positive and Negative ionisation mode, however due to Covid-19 
restrictions only positive mode was performed. Peak table generation and alignment 
was performed using compound discoverer 2.1 (ThermoScientific, Bremen, Germany) 
with an alignment window of 0.25 min, mass tolerance: 5 ppm and a signal intensity 
threshold of 200,000 counts with a signal to noise ratio of 5:1.   
 
4.9.3 Data alignment and processing  
 
Post data acquisition processing and alignment was performed using Thermo 
Scientific™ Compound Discovery™ small molecule identification software (Thermo 
Fisher Scientific, Loughborough, UK). The software identifies compounds using 
automatic multiple database and spectral library search tools including mzCloud™, 
Chemspider™, KEGG, and BioCyc, and local database search tools such as the 
mzVault™ spectral library or mass lists. Positive mode data were categorised into 
different treatment groups for analysis. Pooled QC samples and sample blanks were 
also included and grouped accordingly in order to assess and evaluate system stability 
and track potential carry over effects throughout the entire batch analysis.  
 
The resulting peak table was sequentially filtered using QC parsing with 30 % RSD to 
screen out features that showed instability or irreproducibility across the dataset, 
reducing the original feature list. The molecular features were categorised by putative 
molecular name, formula, accurate mass (mw), and retention time (min). The features 
were coded from M0001 to Mxxxx. This coding system remained throughout all 
chapters. Datasets were grouped by treatment, pre- and post- treatment, RS and NRS 
groups separately and uploaded to MetaboAnalyst 5.0 for univariate statistical analysis 
and multivariate chemometric analysis. 
 
Non-parametric relative standard deviation (MAD/median) was used for filtering 
untargeted metabolomics datasets (i.e. spectral binning data, peak lists) with a large 
number of variables to screen out baseline noises [212]. Careful normalisation of MS 
peak intensities enable greater accuracy and precision in quantitative comparisons of 
metabolites abundance levels while also avoiding overfitting that would invalidate 
downstream statistical inference [213]. A log transformation helped to remove 
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heteroscedasticity from the data and correct for a skewed data distribution, autoscaling 
was able to remove the dependence of the rank of the metabolites on the average 
concentration and the magnitude of the fold changes and showed biologically sensible 
results after principal component analysis [214]. Log10 normalisation and autoscaling 
were implemented for intensity normalisation as shown in Figure. 4.2. 
 
Figure 4.2 The effect of normalisation on signal intensities 
 
* Box plots and kernel density plots before and after normalization. The boxplots show at most 50 
features due to space limit. The density plots are based on all samples. Selected methods: Row-




4.10 Data analysis 
 
4.10.1 Characterisation of response in the biological endpoints 
As a measure of variability in the descriptive statistics, the quartiles divided rank-
ordered dataset into 3 points: the lower quartile, median and the upper quartile to form 
4 groups (Q1, Q2, Q3 and Q4). Quartiles have been previously used to stratify 
responses to disease [215, 216]. For example, clinical studies have applied this 
mathematical calculation to characterise the best and worse responses for non-
diabetic essential hypertensives following short-term thiazide treatment [217], physical 
fitness following training exercise [218] or coronary syndrome patients following the 
antiplatelet therapy etc. [219]. However, the quartile dividing variations following the 
supplementation of dietary blueberries and in the investigation of both vascular and 
cognitive health have not been incorporated previously. Basing on the effect direction, 
the Q1 or Q4 could be dividing either positive responders or the negative responders 
(so called non-responders) in this study, consequently the Q2 - Q3 represented the 
average responders.  
 
The identification of RS to the treatments was performed by the calculation of 
response level first: response level = (post intervention score - baseline score)/mean 
group baseline score x 100 %. The calculated response levels were used to 
characterise subjects from highest response to lowest response level. Basing on the 
effect direction, the 25th and the 75th percentiles were applied to split participants with 




Figure. 4.3 The characterisation of responder (RS) using quartiles division 
 
4.10.2 Statistical analysis 
 
The data for each assessed outcome from post intervention were analysed separately 
using linear mixed-effects models (MIXED) in SPSS statistics 26. This analysis is 
appropriate for repeated measured designs (e.g. cross-over design) that include a 
baseline covariate and fixed factors of random effects along with interactions among 
other confounding factors (e.g. treatment, testing day) that can be accounted for each 
subject [220]. 
 
The data for each assessed outcome were checked for homogeneity of variance 
(Levene’s test) prior to the MIXED model. The post intervention measures were 
modelled including respective baseline values as covariate and the terms treatment, 
visit, treatment*visit, baseline as fixed factors. Participant was included as random 
factor. Repetition, treatment*repetition and treatment*visit*repetition interactions were 
further included in cognitive results analyses as there were repetitions for some tasks 
including Serial 3 and 7 subtraction tasks, digit vigilance task and mental fatigue in 
Average responders Non-responder (NRS) group Responder (RS) group 
Q1 
Q4 
Q2 – Q3 
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one cognitive testing. Post hoc analysis used Least Significant Difference test (LSD) 
and adjusted P values for pairwise comparisons among treatments, visits and 
repetitions. One-Way ANOVA was used to analyse the difference of participants’ 
dietary total energy, carbohydrate, fat and protein intakes between treatment groups 
pre- and post-intervention separately. Paired T-Test was used to analyse the 
difference in participants’ dietary total energy, carbohydrate, fat and protein intakes 
within each treatment group, 
 
A Chi-square test was used to assess the assciation of gender factor, BMI range with 
identified response. Other univariate and multivariate analysis were used in 
metabolomic analysis and described below. 
 
4.10.3  Metabolomic analysis 
 
For group-wise differences of features within and between interventions, unsupervised 
and supervised multivariate analysis was performed using MetaboAnalyst 5.0 [221]. 
For multivariate analysis, unsupervised method principal component analysis (PCA) 
was used to capture initial profile patterns and to screen out any outliers without using 
grouping information [109, 222]. The data was summarized into much fewer variables, 
called scores, which are weighted average of the original variables. The 2-D scores 
plot providing an overview of the various separation patterns between the most two 
significant PCs was used.  
 
Then a supervised method, partial least squares-discriminant analysis (PLS-DA) 
model, was constructed to discriminate the profiles between samples taken pre- and 
post-blueberry interventions (within group), and also between treatment groups. 
MetaboAnalyst supports two types of test statistics for measuring class discrimination. 
To validate the model, cross validation (CV) of leave-one out CV (LOOCV) was used, 
presenting with model accuracy R2 and Q2 values as estimates of the predictive ability 
of the model. Typically a Q2 score > 0.4 and an R2 > 0.5 indicates a robust model, 
scores between 0.7 and 1.0 indicates a highly robust model [223]. A negative Q2 could 
be indicative of model overfitting [224]. To assess the significance of class 
discrimination, a permutation test was performed. In each permutation, a PLS-DA 
model was built between the data (X) and the permuted class labels (Y) using the 
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optimal number of components determined by cross validation for the model based on 
the original class assignment [225].  
 
Heatmaps were used to illustrate the association between feature intensity and the 
intervention groups. Random forest (RF), developed by Breiman [226], is a machine 
learning method using a combination of tree-structured predictors (decision trees) and 
was used in the current study as a discriminatory metric. Each tree is constructed via 
a tree classification algorithm and casts a unit vote for the most popular class based 
on a bootstrap sampling (random sampling with replacement) of the data. RF 
measures the importance of a variable and includes Mean Decrease Accuracy (MDA) 
to measure how much it contributes to predictive accuracy. MDA is used to present 
how much accuracy the model loses by excluding each variable. The more the 
accuracy loses, the more important the variable is for the successful classification. RF 
has been shown to outperform other methods for imputing LC-MS untargeted 
metabolomics data [227]. The ion intensity following interventions were expressed in 
fold changes and ranked basing on the log2 transformed fold change values. These 
top features were futher ranked by MDA scores for each intervention group. Univariate 
analyses were also used to detect any significant features for group-wise difference 
within and between interventions. 
 
4.10.4  Biomarker analysis 
 
For responder (RS) and non-responder (NRS) participant groups, receiver operating 
characteristic (ROC) curve analysis was used to identify predictive biomarkers. The 
ROC curve analysis provides a predictive model to assess the diagnostic or predictive 
accuracy of a test with a continuous outcome by graphically displaying the cut-offs of 
the true-positive rate (sensitivity) and false-positive rate (1-specificity), and the area 
under the curve (AUC) for predictive accuracy [228]. Univariate analysis of single 
biomarkers and multivariate analysis of multiple biomarkers selected by the RF 
method was used. Single features that increased intensity in RS relative to NRS and/or 
ranked high in RF method was reported. After features were reported, pathways of 
discriminating features following blueberry interventions and between RS/NRS were 
identified where available in KEGG using KEGG ID generated from Thermo 









Chapter 5. Effect of blueberry 










The ultimate goal of the current study was to investigate the individual response to a 
blueberry intervention over multiple endpoints, in line with this, the interventional effect 
to improving vascular and cognitive responses following different blueberry 
supplementations was also evaluated. A one week duration of intervention was 
chosen based on previous evidence [16] and has also considered logistics for the 
participants; for example in the storage of fresh blueberry and number of study visits. 
This study applied a moderate dosage of whole blueberry and it was more applicable 
for participants in real world scenario consumption. The dosage of blueberry was 
equivalent to double the daily adult portion size as recommended by NHS [229], which 
constitutes one variety of the recommended 5 a day portions of fruit and vegetable 
intake in addition to the participants’ usual dietary regime and it was expected to 
augment efficacy within a shorter term.  
 
Assessment of vascular function and clinical chemistry included systolic and diastolic 
blood pressure (SBP and DBP), pulse wave velocity (PWV), plasma triglyceride, total-, 
HDL -, LDL - cholesterol levels, plasma glucose and nitrite levels. Assessment of 
cognition included domains of working memory, episodic memory, attention, as well 
as mood and mental fatigue. Figure. 5.1 displays the procedure for participants to 
follow through on each testing day. 
 
A linear MIXED model was used for statistical analysis as it included baseline as a 
fixed factor as well as adjusting for the covariate. This cross-over study consisted of 7 
visits including a screening session, the baseline visit followed by the post-intervention 
visits. Due to the randomised treatment sequence, each post-intervention visit (3 in 
total) consisted of blueberry, blueberry powder and placebo group. Therefore, effect 
of visit order was included as a fixed factor in the statistical analysis. Participant was 
included as random factor. Participants completed 3 repetitions for working memory, 
digit vigilance and mental fatigue assessment during one test session so the effect of 
repetitions were also included as cofactor in the statistical analysis evaluating 
intervention effects on these domains.  
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Forty people received the interventions and 37 people finished the trial. Homogeneity 
of variance was checked in order to test the group variances prior to the statistical 
analysis. Depending on the indication of cognitive tests assessing attention and 
psychomotor speed, some data were excluded as outliers which could indicate that 
participants were not fully committed on the tests. The population for analysis (see 
Figure. 5.2) consisted of 37 adults (13 males/24 females). 
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Figure. 5.2  CONSORT flow diagram




Participant characteristics at baseline can be found in Table. 5.1. Participants were 
asked to provide the food diary for the day prior to fasting for each study visit so that 
researcher can check whether they have consumed the blueberry intervention. 
Therefore, the compliance was checked on each study visit using the 1-day food diary. 
Two participants found out about the placebo during the trial and 1-day food diary 
confirmed 92 % of compliance. The data for these participants were retained for 
analysis. 
 
Table. 5.1  Participant demographics  
 
      Variables       Valuea 
Age (years) 25.86 ± 6.81 
BMI (kg/m2) 23.15 ± 3.12 




2 Indian Asian 
3 Chinese Asian         
31 white European 
 
Fruit and vegetables intake 
(portions/day)    
2.13 ± 0.85 
Berry intake  (portions/day)c 0.06 ± 1.61 
 
a: Data are expressed as mean ± SD; BMI: body mass index 
b: Pre - Whole blueberry intervention vs. Pre - Freeze-dried 
blueberry powder intervention vs. Pre - placebo intervention  
c: 1 portion size equals to 80 grams 
 
The food diary was collected to calculate dietary energy intake throughout the trial and 
the mean energy and macronutrient intake values pre- and post-intervention groups 
are shown in Table. 5.2. Homogeneity of variances were tested prior to the analysis 
(P > 0.05). There was no statistical difference in the total energy, carbohydrate, fat 
and protein intakes of participants between and within intervention groups (Table. 5.2). 
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Table. 5.2 Participant dietary intake pre- and post- interventions 
 





Placebo  Significancea Blueberry  
Blueberry 
powder  





























































P = 0.206 
a: Adjusted for between - group comparisons: least significant difference (LSD) P ≤ 0.0167 for all pairwise comparisons;  







Table. 5.3 summarises the frequency of berry intake for participants at baseline. 
Participants demonstrated low daily intake of berry (e.g. blueberry, raspberry, and 
blackcurrant) and cherry prior to receiving the blueberry interventions. 
 
Table. 5.3  Frequency of berry and cherry intake at baseline 
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5.3.1 Who body measurement of vascular function 
 
No effect of treatment was found for SBP , DBP and PWV with covariance adjustment 
for baseline. LSD with adjusted P value was used for post hoc analysis for pairwise 
comparisons among treatments and visits. However, there was a significant 
treatment*visit interaction effect for PWV (F (4, 93.615) = 2.552, P = 0.044). Figure. 
5.3 displays the effect of interventions on selected endpoints including values of SBP 
and PWV. Pre- and post-intervention baseline-adjusted means of PWV and blood 




Figure. 5.3 The effect of blueberry interventions on selected vascular 

























*: The range of the error bars is the 95% confidence interval, the bottom and top of the box 




































































































Table. 5.3  Change in PWV, blood pressure and plasma biomarker levels from pre- to post-intervention by the blueberry intervention 
groups1  
  Blueberry intervention   Blueberry powder intervention   Placebo  intervention  
Effects2   Pre Post △ 
 
Pre Post △ 
 

































BP, mmHg             















0.418 P = 0.068  




























P = 0.536 
 
Plasma biomarkers 
           















0.055 P = 0.836 




























P = 0.402 




























P = 0.318 
Table. 5.4  (Continued) 
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P = 0.485 
 
         Glucose 
 

























P = 0.334 




























P = 0.184 
 
△ Changed scores compared to the baseline: (post-intervention - pre-intervention) 
1
Values are baseline-adjusted means ± SEs unless otherwise indicated;  
2 Only P values for treatment effect was reported; Adjusted for pairwise comparison: least significant difference (LSD) P ≤ 0.0167 for all pairwise comparison 
significance and effects observed. PWV, pulse wave velocity; BP, blood pressure; TAG: triglyceride; LDL- C: Low density lipoprotein cholesterol: HDL: high 





5.3.2 Plasma biomarkers   
 
Table. 5.4 shows pre- and post-intervention baseline-adjusted means for plasma 
biomarkers for each intervention group. No effect of treatments, visiting days or the 
interaction effects of treatment*visit were shown for plasma triglycerides (TAG), total 
cholesterol, HDL - cholesterol, LDL - cholesterol, glucose and nitrite (NO2-) level with 
covariance adjustment for baseline. Both blueberry supplementation and blueberry 
powder supplementations reported improved NO2- level (+ 68.66 % and + 4.34 % 
separately) compared to the baselines whereas the placebo supplementation reported 
a decrease (- 9.10 %). However, the difference between the blueberry treatments and 
the placebo was not statistically significant. Figure. 5.3 displays the effect of the 




Table. 5.5 shows pre- and post-intervention baseline-adjusted means for cognitive 
tasks. LSD with adjusted P value was used for post hoc analysis for pairwise 
comparisons among treatments, visits and repetitions. As shown in Figure. 5.4, 
although no difference of treatments was demonstrated by the interventions, effect of 
interventions on digit vigilance that assessed attention compared are displayed. There 
was a repetition effect on the correct response of the digit vigilance (F (2, 223.223) = 
3.382, P = 0.036). There was significantly lower correct responses on the 3rd repetition 
compared to the 1st repetition (95% CI of - 2.877 [- 5.138, - 0.616], P = 0.013). There 
were also an effect of visit (F (2, 241.677) = 5.155, P = 0.006) and repetition (F (2, 
241.357) = 8.357, P < 0.001) respectively on the reaction time (ms) of the correct 
responses to the test. The 3rd post- intervention visit showed significantly more slowed 
responses to the test compared to the 1st post-intervention visit (95% CI of 6.735 
[2.314, 11.157], P = 0.003). The 2nd post-intervention visit also showed significantly 
more slowed responses to the test compared to the 1st visit (95% CI of 5.421 [1.201, 
9.641], P = 0.012). The 3rd repetition showed significantly more slowed response to 
the test compared to the 1st repetition (95% CI of 8.643 [4.280, 13.006], P < 0.001) 
and the 2nd repetition also showed significantly more slowed responses to the test 




Figure. 5.4  The effect of the blueberry interventions on selected cognitive 























* Attention assessed by the correct responses of example task: digit vigilance; working 
memory assessed by the correct number of example task: seral 7 subtraction; the range of 
the error bars is the 95% confidence interval, the bottom and top of the box are the 25th and 



































Table. 5.5 Change in cognitive scores from pre- to post-intervention by the blueberry intervention groups1 
 
  Blueberry intervention   
Blueberry powder 
intervention 
  Placebo intervention 
Effects2 
  Pre Post △    Pre Post △    Pre Post △  
 
Working memory 
           

















2.115 P = 0.675 

















P  = 0.388, 
Visit* 

















- 0.120 P = 0.698 
















































P = 0.994 

















0.113 P = 0.657 
 
Episodic memory 
           

















- 0.140  
 
P = 0.445 
 


















0.195 P = 0.367 
Table. 5.5 (Continued) 
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- 1.812 P = 0.580 






















   
 
   
 
   















- 1.830  
P  = 0.414, 
Repetition*  





















P  = 0.720,  
Visit*, 
Repetition* 
















1.160 P = 0.912 
 
Mood 


















































4.932 P = 0.278 
 
Fatigue 
            
















- 1.813  
P  = 0.271, 
Visit*  
△ Changed scores compared to the baseline: (post-intervention - pre-intervention) 
1Values are baseline-adjusted means ± SEs unless otherwise indicated; 2 Only P values for treatment effect was reported; adjusted for pairwise comparison: 
least significant difference (LSD) P ≤ 0.0167 for all pairwise comparison significance and effects observed. RT, reaction time; VAS: Visual Analogue Scale. 
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5.3.4 Working memory  
 
No effect of treatments was shown for the serial 3 subtraction and the serial 7 
subtraction tasks. There was a significant visit effect on the correct number of serial 3 
subtraction (F (2, 224.248) = 7.527, P = 0.001). There was significantly higher correct 
number at the 2nd post-intervention visit compared to the 1st post-intervention visit (95% 
CI of 2.427 [0.845, 4.009], P = 0.003) and a significantly higher correct number at the 
3rd post-intervention visit compared to the 1st post-intervention visit (95% CI of 3.154 
[1.485, 4.823], P < 0.001). For serial 3 and serial 7 subtraction tasks, participants tried 
for 3 repetitions for each task during the assessment of working memory. There was 
also a significant treatment*visit*repetition interaction effect for the total number of 
serial 7 subtraction (F (20, 256.024) = 1.614, P = 0.049). On the 1st post-intervention 
visit and the 3rd repetition, total number of serial 7’s task was significantly higher after 
receiving the placebo intervention compared to the blueberry intervention (mean 
difference 8.343, 95% CI [4.050, 12.635], P < 0.001) and the blueberry powder 
intervention (mean difference 8.290, 95% CI [4.269, 12.310], P < 0.001); for the 3rd 
repetition in the placebo intervention, the total number of serial 7 subtraction task was 
significantly higher on the 1st post-intervention visit compared to the 2nd post-
intervention visit (mean difference 8.329, 95% CI [4.034, 12.635], P < 0.001) and the 
3rd post-intervention visit (mean difference 5.812, 95% CI [1.721, 9.903], P = 0.006); 
for the placebo intervention on the 1st post-intervention visit, the total number of serial 
7 subtraction was significantly higher on the 3rd repetition compared to the 1st repetition 
(mean difference 6.831, 95% CI [2.425, 11.236], P = 0.003). Figure. 5.4 displays the 
effect of interventions on selected domains including serial 7 subtraction scores which 
assessed working memory. 
 
5.3.5 Episodic memory 
 
 
No effect of treatment, visiting day or the interaction effects of treatment*visit were 




5.3.6  Mood and mental fatigue 
 
  
Calm, alert and content were not affected by treatments, visits and the treatment*visit 
interactions with baseline covariance adjustment. Mental fatigue was not affected by 
treatments or the treatment*visit*repetition interactions. There was a visit day effect 
(F(2, 239.553) = 4.564, P = 0.011). There was a significantly lowered fatigued score 
on the 3rd post-intervention visit compared to the 2nd post-intervention visit (95% CI of 
-5.589 [-9.509, -1.669], P = 0.005). Figure. 5.4 also displays the effect of interventions 
on fatigue score. 
 
5.4 Post hoc power calculation 
The standard deviations and mean values of the primary endpoints as identified in 
section 4.7 were obtained from Table. 5.4 and Table. 5.5 to perform retrospective post 
hoc power calculations [230]. The observed power for all primary endpoints are 
summarised in Table. 5.6. The hypothesis as described in section 1.5 included 
detecting significant treatment difference compared to the control for at least one 
primary endpoint. As shown in Table. 5.6, the observed powers ranged between 61 % 
- 100 %. The assessments for SBP, Correct Serial 3s and Correct Serial 7s were 
underpowered according to the initial sample size calculation with 80 % power as 
described in section 4.3. 
 
 








PWV 1.000 1.000 
SBP 0.681 0.976 
DBP 0.971 0.833 
Correct Serial 3s 0.762 0.705 
Correct Serial 7s 0.610                                  0.656 
Delayed word recall - Correct 1.000                                                0.998 
Immediate word recall - Correct  0.991 0.848 
Digit vigilance - % Correct  0.934 0.804 
Digit vigilance - Correct RT  0.935 0.684 
a: Computed using α = 0.05 
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5.5 Effects of the blueberry interventions on urinary metabolite profiles 
 
5.5.1 PCA and PLS-DA analysis pre- and post-interventions 
 
 
Following LC-MS analysis and peak picking, 5,523 mass spectral features were 
successfully detected. The resulting peak table was sequentially filtered to include only 
stable and reproducible peaks that resulted in a final 3327 features in positive 
ionisation mode (negative ionisation mode not performed due to COVID-19 
restrictions). Multivariate analysis was applied to this peak table. In order to assess 
whether there were metabolomic differences at baseline prior to receiving 
interventions, pre-intervention data and post-interventions data were both analysed. 
QC samples were checked that clustered together and provided in Appendix. 4.1.  
The PCA was performed first to screen out any outliers and 3 samples were removed 
prior to PLS-DA. The PLS-DA scores plot showed no obvious clustering among 
blueberry treatment samples (N = 38), blueberry powder treatment samples (N = 34) 
and placebo treatment samples (N = 36) pre-intervention (Figure. 5.5a). PLS-DA also 
validated the significance of variable class discrimination in the dataset by a 
permutation test (P = 0.69) and demonstrated no significant difference among the 
interventions at baseline (R2 = 0.02, Q2 = -0.04, accuracy 22 %).  
 
There were 6 outliers removed by PCA for post-interventions data. The PLS-DA 
scores plot displayed noticeable overlap in the clustering among post-intervention 
groups across Component 1 and 2, where Component 2 only accounted for 6.9 % of 
variation and was increased only by 4.4 % compared to the baseline data (Figure. 
5.5b), suggesting only moderate changes to the metabolome post-interventions 
compared to the baseline. The discrimination between variables was assessed by a 
permutation test (P = 1). Although there was some clustering, no significant difference 








































Figure. 5.6  presents a heatmap of ion feature intensities for each post-intervention 
group. 
 
Figure. 5.6 Hierarchical clustering heatmap for the post-intervention groups 
 
 
*The colour corresponds to an intensity level. Individual samples (horizontal axis) and 
features (vertical axis) are separated using hierarchical clustering (Ward’s algorithm), with 
the dendrogram being scaled to represent the distance between each branch (distance 
measure: Pearson’s correlation). The clusters corresponding to post-blueberry, post-




5.5.2 Data mining of important discriminating features 
 
Random forest (RF) was used as a metric for determining discrimination among the 
interventions. RF shows the most important features ranked by their contributions to 
the classification accuracy shown as Mean Decrease Accuracy (MDA) for post-
intervention groups. Features showing 2-fold increases or decreases in intensities 
after the interventions were further ranked by MDA. Ion features shown as 
discriminatory in the placebo intervention were excluded for whole blueberry and 
blueberry powder interventions. Table. 5.7 and 5.8 display the top discriminating 
features selected by RF and MDA after whole blueberry intervention and blueberry 
powder intervention respectively and P values of comparing feature intensities among 
post-intervention groups (between group analysis). Table. 5.7 and 5.8 also present 
univariate analysis for feature intensity changes with P values of each intervention 
comparing with baseline (within group analysis). The PCA and PLS-DA sores plots for 
within group analysis were provided in Appendices. 4.2 - 4.4. 
 
There were approximately 57 % of ion features showing higher intensity after receiving 
whole blueberry intervention compared to blueberry powder (85 %) intervention. As 
shown in Table. 5.7 and 5.8, only features M2075, M2974, M1526, M2961, M2353 
and M1448 showed increases in intensity following both blueberry and blueberry 
powder interventions, feature M1738 showed decreases in intensity following both 
interventions. But these findings were not significant. Feature M1223 increased 
intensity significantly following blueberry powder but not whole blueberry intervention, 





Table 5.7 Discriminating features ranked by random forest following whole 
blueberry intervention  






MDAa P valueb   Log2(FC)c P valuec 
M1223* 233.163 1.788 x 10⁻³ 1.267 x 10 -6   -0.400 0.987 
M1472 257.106 5.775 x 10⁻⁴ 0.723   0.689 0.256 
M3014 152.051 1.476 x 10⁻⁴ 0.040   1.377 0.761 
M3058 185.062 1.160 x 10⁻⁴ 0.324   -1.203 0.466 
M1819 298.151 1.151 x 10⁻⁴ 0.398   -1.197 0.247 
M3056 358.117 1.100 x 10⁻⁴ 0.028   0.664 0.076 
M1448 163.100 -1.026 x 10⁻⁴ 0.821   1.270 0.475 
M1738 844.535 -1.043 x 10⁻⁴ 0.552   -1.407 0.723 
M1839 182.058 -1.427x 10⁻⁴ 0.183   0.745 0.016 
M3279 179.058 -2.935 x 10⁻⁴ 0.044   0.516 0.077 
M2961 578.305 -4.954 x 10⁻⁵ 0.747   3.448 0.630 
M1290 320.124 -5.405 x 10⁻⁵ 0.149   -1.048 0.282 
M3123 129.079 -6.061 x 10⁻⁵ 0.307   -1.227 0.319 
M1950 161.094 -7.245 x 10⁻⁵ 0.603   -1.16 0.663 
M3290 159.090 -1.587 x 10⁻⁶ 0.572   -1.054 0.848 
M2974 289.153 -5.357 x 10⁻⁶ 0.774   3.377 0.580 
M1526 569.303 -5.623 x 10⁻⁶ 0.980   1.359 0.833 
a : Mean decrease accuracy scores for all post-intervention groups                                                                                                                                                                           
b : For univariate analysis of post-intervention groups comparing among groups; The false discovery 
rate(FDR) is 1.000 for all the features except for M1223 (FDR = 2.527 x 10⁻5)                                                                                                                                                                                                                                                                         
c : For univariate analysis of post-intervention groups compared to baseline only; Log2(FC): log 
transformed fold changes; FC: fold changes were the ratio of ion intensity post-intervention compared 
to baseline; the FDR is 1.000 for all the features 






Table. 5.8 Discriminating features ranked by random forest following blueberry 
powder intervention 




Within-group analysis   
MDAa  P valueb   Log2(FC)c  P valuec 
M1223* 233.163 1.788 x 10⁻³ 
1.267 x 10 -
6 
  2.453 1.060 x 10⁻5 
M0645 250.132 8.898 x 10⁻⁴ 0.179   0.635 0.045 
M0320 114.032 4.519 x 10⁻⁴ 0.727   1.029 0.425 
M2358 276.169 3.476 x 10⁻⁴ 0.446   1.808 0.044 
M2075 170.069 3.273 x 10⁻⁴ 0.245   1.404 0.086 
M2021 253.132 2.867 x 10⁻⁴ 0.782   4.05 0.396 
M2242 182.092 1.871 x 10⁻⁴ 0.016   1.577 0.001 
M0968 456.270 6.452 x 10⁻⁵ 0.457   1.123 0.031 
M2388 340.162 -1.055 x 10⁻⁴ 0.635   2.442 0.028 
M3244 286.190 -1.187 x 10⁻⁴ 0.887   1.823 0.291 
M1839 182.058 -1.427x 10⁻⁴ 0.183   0.313 0.121 
M3279 179.058 -2.935 x 10⁻⁴ 0.044   0.762 0.008 
M1135 295.063 -4.860 x 10⁻⁵ 0.009   1.093 0.003 
M2353 231.057 -5.714 x 10⁻⁵ 0.740   2.799 0.192 
M3123 129.079 -6.061 x 10⁻⁵ 0.307   1.477 0.086 
M3290 159.090 -1.587 x 10⁻⁶ 0.572   1.252 0.094 
M2974 289.153 -5.357 x 10⁻⁶ 0.774   1.441 0.137 
 a : Mean decrease accuracy scores for all post-intervention groups                                                                                                                                                                           
b : For univariate analysis of post-intervention groups comparing among groups; The false 
discovery rate(FDR) is 1.000 for all the features except fort M1223 (FDR = 2.527 x 10⁻5)                                                                                                                                                                                                                                                                         
c : For univariate analysis of post-intervention groups compared to baseline only; Log2(FC): log 
transformed fold changes; FC: fold changes were the ratio of ion intensity post-intervention 
compared to baseline; the FDR is 1.000 for all the features except for M1223 (FDR = 0.021) 
*: Significant for univariate analysis of post-intervention groups comparing between groups 
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5.5.3 Putative annotations of important discriminating features  
 
The discriminatory features ranked by MDA and shown in both blueberry and 
blueberry powder interventions were annotated where available basing on respective 
accurate mass using Thermo Fischer Compound Discovery Software. KEGG 
database was incorporated for annotations where available as summarised in Table. 
5.9. It should be noted that all the annotations made here are putative and thus need 
further confirmation. Unfortunately, due to COVID-19 restrictions further fragmentation 
work was not possible.  
 
Five putative annotations were made including adducts of 3-Dehydrocarnitine (M3290), 
O-Adipoyl carnitine (M2974), D-Pipecolic acid (M3123), (R)-3-(4-
Hydroxyphenyl)lactate (M1839) and Hippuric acid (M3279). Univariate analysis of 
one-way ANOVA has shown one significant feature M1223 between post-intervention 






Table. 5.9 Annotation of putative metabolites that discriminate blueberry interventions  
 
Features ID    m/z MDAa Mass error (ppm)   Formula Putative annotation KEGG ID and pathway 
M1223       233.163 1.788 x 10⁻³ -5.250               C12 H19 N5 N/A N/A 




Phenylpropanoic acids; C03964, 
map00130 Ubiquinone and other terpenoid-
quinone; map00350 Tyrosine metabolism; 
map01100 Metabolic pathways; map01110 
Biosynthesis of secondary 
metabolites                 
M3279      179.058 -2.935 x 10⁻⁴  1.080               C9 H9 N O3 Hippuric Acid 
 
Benzoic acid; C01586, map00360 
Phenylalanine metabolism; map01100 
Metabolic pathways        
M3123       129.079 -6.061 x 10⁻⁵ 1.090              C6 H11 N O2 D-Pipecolicacid 
 
D-alpha-amino acids; C00408, map00310   
Lysine degradation; map00960   Tropane, 
piperidine and pyridine alkaloid 
biosynthesis; map01060   Biosynthesis of 
plant secondary metabolites; map01064   
Biosynthesis of alkaloids derived from 
ornithine, lysine and nicotinic acid; 
map01100   Metabolic pathways; 
map01110   Biosynthesis of secondary 
metabolites 
 
M3290      159.090 -1.587 x 10⁻⁶ 1.190             C7 H13 N O3 3-Dehydrocarnitine 
Short-chain keto acids and derivatives; 
C02636   
M2974      289.153 -5.357 x 10⁻⁶ 1.620           C13 H23 N O6 O-Adipoyl carnitine Acyl carnitines 
*: Mean decrease accuracy for variable importance ranked in random forest 
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5.6 Discussion  
5.6.1 Principal findings of the effect of blueberry interventions 
 
To our best knowledge, this is the first cross-over RCT investigating the efficacy of 
improving endothelial function, blood pressure, blood lipids and inflammatory 
biomarkers of vascular function, and cognition after whole blueberry (160 g) or freeze-
dried blueberry powder (20 g) in a 7-day chronic intervention. We found that increasing 
daily blueberry consumption to 160 g/d or equivalent blueberry powder in healthy 
adults for 1 week did not influence blood pressure, endothelial function, plasma lipids, 
glucose, vascular inflammatory biomarkers and cognition. Plasma nitrite levels were 
improved 68.66 % and 4.34 % separately following whole blueberry and blueberry 
powder supplementations compared to the baseline whereas the placebo 
supplementation reported a decrease (- 9.10 %), although not statistically significant. 
There were significant effects of visit order due to randomisation of treatment 
sequence and interaction effects between treatments and visits were also observed in 
the study. For cognition, an interaction effect with task repetition and treatment was 
also observed for some cognitive tasks. The participants displayed significantly slowed 
reaction time in the assessment of attention after 3 repetitions of the assessment, 
suggesting that the interventions did not alleviate fatigue over time during the cognitive 
assessment.  
 
5.6.2 Comparison between whole blueberry and blueberry powder  
 
As discussed in the above section, there was no major effect of the interventions 
supplementing whole blueberry compared to blueberry powder in both vascular and/or 
cognitive function. There is a lack of studies comparing metabolomic differences 
between whole blueberry and blueberry powder consumptions. In the current study, 
there are some similarities in the metabolite profiles between blueberry interventions 
(Fig. 5.5) but differences were also observed. Feature M1223 (m/z 233.163) was 
increased in intensity solely after blueberry powder intervention, and because of that 
it is logical to speculate that it may originate from the freeze-drying processing of 
blueberry to powder, even though freeze-dried blueberry powder should arise from 
100 % whole blueberry.  
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Even though limited metabolomic differences were found between whole blueberry 
and freeze-dried blueberry powder in the current study, there could be differences in 
bio-accessibility between freeze-dried powder and whole blueberry in the study that 
were likely induced from freeze-dried processing for powders. In terms of the 
nutritional value, the blueberry powder supplemented in the current study had lower 
sugar content (22 % less) compared to the whole blueberry and glucose load in the 
fruit matrix has been shown to delay anthocyanins absorption, which could result from 
the competitive action of glucose and anthocyanin on the sodium-dependent glucose 
cotransporter SGLT-1 [80]. The blueberry skin is rich in anthocyanins and usually kept 
during the freeze-drying processing of the blueberry to powder [81]. It has also been 
shown that fibre content is contained during the processing from blueberry to powder 
[82]. The technological processing for blueberry powder in relation to the whole 
blueberry could also cause increased bio-accessibility and absorption of bioactives 
[78].  
 
Indeed, there were more ion features with increased intensity following blueberry 
powder (85 %) intake compared to whole blueberry (57 %), but the differences were 
not statistically significant. In another study comparing between blueberry and 
blueberry juice interventions (2-h post consumptions only) approximately 15 % of 
metabolites were higher in intensity after whole blueberry compared with juiced 
(approximately 3 %) blueberry [55]. In the current study, there could be differences in 
bioactives and nutrient values between freeze-dried blueberry powder and whole 
blueberry, but the metabolomic differences were not significant and neither was any 
treatment effect on improving endpoints, so it has not been possible to demonstrate if 
whole or powdered blueberry is the most effective at health promotion. 
 
5.6.3 Urinary metabolite profiling  
 
Metabolomics was used here to add mechanistic evidence for the role of blueberry. 
Metabolomics is of interest in nutritional studies [105], for instance, in the exploration 
of dietary patterns [231], biomarkers for specific fruit [232] or carbohydrate [233]. Here, 
only very modest changes to the urinary metabolome following blueberry interventions 
were found compared to placebo, the variation described was only 7 % and PLS-DA 
models showed poor discriminating ability (Fig. 5.5). Nevertheless, the use of both 
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univariate and multivariate methods are encouraged to complement the findings in 
biomarker studies [234]. The current study was able to show discriminatory features 
that were increased in intensity following both blueberry interventions relative to 
control. Blueberry metabolites that increased in intensity following the interventions 
could be also used as markers of compliance. 
 
Discriminatory ion features shown in the placebo intervention were excluded from the 
analysis so that the remaining discriminating features reported were likely induced by 
the blueberry interventions. Most features with putative annotations were shown to 
generate from metabolism (endogenous). 3-Dehydrocarnitine (M3290) and O-Adipoyl 
carnitine (M2974) are involved in the metabolism of fatty acids in the mitochondria for 
the generation of metabolic energy [235]. D-Pipecolic acid (M3123) is an endogenous 
metabolite of amino acids and originates from the metabolism of intestinal bacteria but 
could also originate from dietary sources [236]. A number of fatty acyl derivatives 
following acute blueberry consumption have being found previously, confirming a 
possible consequence of endogenous metabolism of acyl derivatives 3-
Dehydrocarnitine and O-Adipoyl carnitine found in the current study [55].  
 
Here, putative metabolites of phenolic acids (R)-3-(4-Hydroxyphenyl)lactic acid 
(M1839) and hippuric acid (M3279) were increased in intensity after both blueberry 
and blueberry  powder interventions and are likely to be of exogenous origin and 
indicators of blueberry intake. (R)-3-(4-Hydroxyphenyl)lactate, or 3-(4-
Hydroxyphenyl)lacetic acid a phenolic acid that is likely derived from phenolic or 
polyphenolic compounds in the diet [237]. Hippuric acid levels can rise with the 
consumption of phenolic compounds including berry polyphenols; the phenols are first 
converted to benzoic acid, and then to hippuric acid and excreted in urine [238]. There 
has been other research that has investigated the metabolomic differences induced 
by dietary blueberry or blueberry polyphenol interventions [73, 239]. Urinary hippuric 
acid has been found following 22 g blueberry powder (200 g blueberry equivalent) 
consumption in an acute 2-h post dose study [73, 239]. Hippuric acid, including its 
derivatives, were responsible for the major urinary and plasma metabolites changes 
after 1 month following 22 g blueberry powder daily consumptions [239]. Urinary 3-(4-
Hydroxyphenyl)lacetic acid has been found increased in intensity following 150 g 
blueberry supplementation after 2 - 4 h and the metabolites have shown to originate 
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from procyanidins (flavonoids contained by blueberry) in culture models [73, 240, 241]. 
Phenylacetic acid derivatives have also been detected following 22 g (200 g blueberry 
equivalent) blueberry powder consumption metabolites [239]. For chronic 
consumptions, hippuric acid has previously been found in both serum and urinary 
metabolites following 150 g blueberry consumption for 6 months and also found in 
plasma metabolites following strawberry drink intake after 45 and 90 days [239, 242]. 
Compared to hippuric acid, hydroxyphenylacetic acid was also found following chronic 
consumption (45, 90 days) but was not increased in intensity compared to the baseline 
[242]. The current study was not acute and only observed the presence of putative 
annotations of hippuric acid and (R)-3-(4-Hydroxyphenyl)lactic acid after chronic 
consumption of both whole and powdered blueberry (1 week), which does suggest 
better retention of these compounds among a wide array of blueberry metabolites after 
sustained anthocyanin metabolism compared to other blueberry phenolic acids. In 
addition to phenolic acids, glucuronide, sulphate and glycoside derivates of 
anthocyanins, a range of major metabolites following phase II metabolism, have been 
reported previously following blueberry intake in both positive and negative ion mode 
but the current study did not find increased intensity of these compounds solely in 
positive mode [51, 55]. 
 
The bioavailability of dietary polyphenols could also interact with several factors 
including the metabolic process mediated by the liver (phase I and II metabolism) [243].  
Variations could be caused by phase II metabolism for blueberry anthocyanins and 
the involved enzymes all could play a role at microbial, age, smoking, sex, and genetic 
levels to induce variability between individuals affecting anthocyanin metabolism [53, 
54]. These metabolic differences between individuals thus may lead to differences in 
the biological effects of the dietary polyphenols on the health risk factors [52]. 
Therefore, the determination of the inter-individual variations in response to dietary 
intervention is important to explore towards a more personalised dietary 
recommendation. The inter-individual variation in response to the current interventions 
is further explored in Chapter 6. 
 
Metabolomics was included in this study to provide mechanistic evidence. However, 
as no overall effect of the treatments were found and limited effects on metabolite 
profiles were observed, it is not possible to go further into detail. However, it should 
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be noted that due to COVID-19 disruptions, the metabolomic profiling in this study was 
not complemented with negative ionisation mode nor further fragmentation analysis to 
confirm metabolite identifications, which is unfortunate as negative ion mode is more 
favourable for excreted metabolites [233] and especially polyphenol metabolites [55]. 
Furthermore, the multivariate analysis model for differences between interventions 
was not robust (R2 = 0.049, Q2 = - 0.07, accuracy 30 %). The lack of significant 
metabolomic changes during the interventions are consistent with the lack of 
interventional effects shown in the trial.  
 
5.6.4 Study limitations and implications 
 
The lack of major effects of the interventions may also explain the limited changes to 
the urinary metabolome and also without confirmatory analysis then mechanisms of 
action could not be reported. The metabolomic analysis was also limited to LC-MS 
positive mode to provide more features for identification and for checking compliance 
of participants following the blueberry interventions. The total polyphenol content, but 
not anthocyanins, in blueberry and freeze-dried blueberry powder was measured and 
reported in this study. Nevertheless, the excreted anthocyanin levels usually are very 
low and metabolised to low molecular weight phenolic acids and several factors 
affecting response to the interventions are discussed in Chapter 6. Potential 
covariances of sex, age, BMI, ethnicity. socioeconomic status, and physical activity 
were not included in the analyses, but there were mostly young participants (25.86 ± 
6.81 years old), white ethnicity (N = 31) and all healthy with non-smoking status during 
the trial. There were significant effects of visit order observed due to randomisation of 
treatment sequence and interaction effects between treatments and visits were also 
observed in the study. A cross-over design includes repeated visits and has the 
limitation of carryover effect of different treatments, which may explain the influence 
of visit order on treatment effects in the study [244]. There was low retrospective power 
(< 80 %) for some of the endpoints, therefore certain endpoints were underpowered 
which could impact on the ability to detect significant treatment effects for some of the 
primary endpoints in the current intervention. 
 
It should be noted that harvest condition and post-harvest processing could lead to 
differences in the phytochemical profile and nutrition value between the whole 
 
 128 
blueberry and freeze-dried blueberry powder [245]. There were also batch to batch 
variations in the phytochemical profile of supplied whole blueberry throughout the 
study timeline and the variations were not assessed in the study [246]. The nutritional 
difference and anthocyanins concentrations for both the two interventions were not 
analysed in the study. The total polyphenol content for the two interventions were 
analysed using Folin-Ciocalteu colorimetric assay, but many chemical compounds 
may act as interfering agents such as ascorbic acid in this method, producing 
inaccurate estimations of the real phenolic compounds concentrations in the matrix 
[247, 248]. The dietary energy intake of participants were analysed pre- and post - 
interventions but no significant difference was found for the dietary intake between 
and within the whole blueberry and blueberry powder intervention arms.  
 
Prevention of cognitive impairment and vascular diseases, including CVD, are key 
priorities for both NHS England and the Government [249, 250]. A recent science-
based report of the U.S. Dietary Guidelines Advisory Committee, also recommended 
dietary intervention for the preventing chronic (non-communicable) diseases including 
vascular diseases and dementia [60, 251]. However, the study here was performed 
on healthy people rather than participants with developed disease risks. Previous 
RCTs also implemented a longer duration of dietary intervention, whereas a more 
realistic intervention duration should be taken into account to assess their impact in a 
faster period and also assure good compliance from participants [252]. Here, all 
assessed endpoints for study participants were in normal range, which could account 
for the absence of the improvement on assessed vascular function and cognitive 
function. The presence of blueberry metabolites (hippuric acid) post-interventions may 
be used to confirm the compliance but the metabolite intensity was not significantly 
higher compared to the baseline and limited to only positive mode from LC-MS 
analysis.  A validation of bioavailability may be necessary. 
 
The length of each treatment arm was relatively short with 1 week compared to an 
average of 8 weeks with long-term interventions of blueberry assessing vascular 
function and 13 weeks assessing cognition and mood, as reviewed in Chapters 2 & 3. 
The current study was informed from the reviews. A moderate dosage from the range 
of whole blueberry dosages was applied and it was more applicable for participants in 
real life consumption. Therefore, the dosage of blueberry was equivalent to doubled 
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daily adult portion size as recommended by NHS [229], which was expected to 
augment efficacy within a shorter term. In addition to this, the logistics including the 
delivery and storage of blueberry during a long-term intervention were also considered. 
 
It also should be noted that berry polyphenols and phytonutrients, not isolated 
anthocyanins, appear to be either more or less effective depending on the synergistic 
effect within the food matrix on improving blood pressures, plasma nitrite, lipid, and 
glucose controls [253]. This may be possible depending on the type of berry or the 
food matrix consumed and both the aforementioned interventions and the current 
study predominantly used fruit supplementations containing rich phenolic compounds 
instead of isolated anthocyanins. Furthermore, these blueberries could be ingested 
either before, after or with meals during the interventions. Therefore, the variations of 
findings between studies may be partially explained by the different food matrix and 














Chapter 6. Inter-individual variation 







6.1   Introduction 
 
Understanding inter-individual variation in response to dietary interventions is 
important for understanding the efficacy for improving health at the individual level. 
Multi-dimensional data including molecular signatures of genes, transcripts, proteins, 
metabolites, and microbes among individuals have been applied in the areas of 
disease detection, prognosis and treatment [254]. To this end, the integration of these 
multi-dimensional data also allows transforming -omic approaches towards nutritional 
science by characterising the phenotypes or the susceptibility to the disease risk under 
controlled dietary conditions [255]. However, challenges lie with the complexities of 
individual responses to diet and their phenotypic variations. However, in order to 
achieve the ultimate goal of integrating an accurate and predictive approach for a 
sustained and effective health maintenance, these challenges need to be conquered.   
 
A high inter-individual variability was observed in the present and most dietary 
interventions [256-258]. However, there is a lack of evidence to identify if individual’s 
response is consistent across biological phenotypes or if the response is inconsistent; 
for example if a certain participant responds well to an intervention in terms of blood 
pressure, do they also respond similarly to other endpoints? A consistent response 
will help to identify a sustainable approach to improve health and prevent disease. 
Therefore, the current study aimed to characterise and identify consistent responder 
(RS) and non-responder (NRS) groups following the blueberry interventions in the 
assessment of vascular function and cognition; two important clinical endpoints for 
health maximisation. We have also attempted to identify putative metabolites at 
baseline that could act as predictors of response to the intervention. A quartile division 
was used as approach for RS and NRS characterisation. In order to demonstrate the 
approach of characterising RS and NRS, the identification of features predicting RS 





6.2   Results 
 
6.2.1 Inter-individual variations in the assessment of endpoints following the 
interventions 
 
A high range of variation was found for both vascular and cognitive endpoints. Table. 
6.1 displays the proportion of participants that showed either improved, worsened, or 
no changes in scores compared to the baseline in the assessed endpoints following 
the blueberry interventions. 
 
Table. 6.1  Proportion of participants showing improved, worsened scores or no 






↑ ━ ↓ ↑ ━ ↓ 
PWV 49 % 6 % 46 % 53 % 0 % 47 % 
SBP 52 % 9 % 39 % 43 % 14 % 40 % 
DBP 56 % 6 % 38 % 49 % 14 % 37 % 
Nitrite (NO2-) 71 % 0 % 29 % 37 % 0 % 63 % 
Glucose 45 % 0 % 55 % 50 % 3 % 47 % 
TAG 34 % 0 % 66 % 59 % 0 % 41 % 
Total cholesterol 36 % 0 % 64 % 42 % 0 % 58 % 
HDL-C 55 % 0 % 45 % 55 % 0 % 45 % 
LDL-C 31 % 3 % 66 % 42 % 0 % 58 % 
Working memory* 57 % 12 % 31 % 48 % 14 % 36 % 
Episodic memory* 48 % 14 % 37 % 45 % 16 % 38 % 
Attention* 47 % 11 % 42 % 50 % 8 % 42 % 
Alert 71 % 0 % 29 % 47 % 0 % 53 % 
Content 54 % 11 % 35 % 33 % 6 % 61  % 
Calm 62 % 3 % 35 % 58 % 3 % 39 % 
Mental fatigue 45 % 3 % 52 % 55 % 4 % 41 % 
*: ↑ Improved score after the intervention; ━ No changes after the intervention; ↓ Worsened 
score after the intervention; TAG: triglycerides; HDL-C: High density lipoprotein cholesterol; 
LDL-C: Low density lipoprotein cholesterol 
*: Multiple tasks were used assess working memory, episodic memory and attention, so 
combined mean value of the proportions of participants in responding to those multiple tasks 





For the assessment of vascular function, all participants showed changes in plasma 
nitrite and lipids levels (triglycerides, total and HDL - C) whereas approximately 3 % - 
14 % of participants did not show changes in the other endpoints. For cognitive 
function, 3 % - 16 % of participants have shown no changes in the majority cognitive 
endpoints except the alert assessment. The response level was further calculated and 
presented with percentage as described in section 4.9.1. Table. 6.2 summarises the 
range of the response level (%) of participants in the assessment of vascular and 
cognitive endpoints following blueberry and blueberry powder interventions. 
 
 Table. 6.2 Range of responses (%) in the endpoints after the blueberry 
interventions 
Outcomes 
Response level (%) 
Blueberry intervention Blueberry powder intervention 
*PWV - 48 % - + 27 % - 51 % - + 31 % 
SBP - 16 % - + 17 % - 20 % - + 11 % 
DBP - 34 % - + 16 % - 28 % - + 12 % 
Nitrite (NO2-) - 141 % - + 525 % - 111 % - + 215 % 
Glucose - 33 % - + 66 % - 32 % - + 25 % 
TAG - 105 % - + 95 % - 94 % - + 132 % 
Total cholesterol - 30 % - + 62 % - 68 % - + 43 % 
HDL-C - 51 % - + 85 % - 90 % - + 52 % 
LDL-C - 34 % - + 79 % - 58 % - + 64 % 
Working memory - 39 % - + 61 % - 21 % - + 51 % 
Episodic memory - 30 % - + 30 % - 12 % - + 21 % 
Attention - 33 % - + 18 % - 34 % - + 14 % 
Alert - 57 % - + 48 % - 70 % - + 59 % 
Content - 41 % - + 42 % - 33 % - + 28 % 
Calm - 39 % - + 60 % - 29 % - + 40 % 
Mental fatigue - 65 % - + 96 % - 114 % - + 80 % 
*PWV, pulse wave velocity; BP, blood pressure; TAG: triglycerides; HDL - C: high 
density lipoprotein cholesterol; LDL - C: low density lipoprotein cholesterol 
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As shown in Table. 6.2, following the dietary blueberry interventions, participants 
presented dynamic variations for plasma vascular biomarker levels including nitrite, 
glucose and lipids with responses ranging from - 141 % to + 525 %. The non-invasive 
assessment for vascular function including PWV and blood pressures presented 
relatively lower variations with response level ranging from - 51 % - + 31 %. A range 
of moderate to high inter-individual variations were also shown for cognition and self-
rated mental fatigue presented the most dynamic changes relative to other cognitive 
endpoints varying from - 114 % + 96 %. To better demonstrate the variations, Figures. 
6.1 - 6.8 depict the inter-individual variations in response to a range of clinical 
endpoints assessing vascular function and cognition.  
 
It can be noticed that most participants showed random responses across vascular 
and cognitive endpoints following the interventions. For example for PWV, participant 
S3 responded the highest following the whole blueberry intervention but was the 
lowest responder for the blueberry powder intervention. For mental fatigue, participant 
S31 responded high following whole blueberry intervention but responded the lowest 
for blueberry powder. However, participant S2 improved responses to most vascular 
and cognitive endpoints, except to plasma nitrite level after both two interventions. 
Participant S2 also showed a high consistency of improved responses to cognitive 
assessments after the blueberry powder intervention, but not to the vascular function. 
Participant S19 and S25 showed a high consistency of improved responses to 
vascular function following both blueberry and blueberry powder interventions, but 





















































































































































































































































































































Figure. 6.4  Inter-individual variation in plasma low-density lipoprotein 































































































































































































































































































































*Episodic memory assessed by the correct number of word recognition task 
 
 141 




























































































































































































































6.2.2 Characterisation of responder (RS) and non-responder (NRS) groups 
 
The response level for each assessed endpoint was calculated from post - 
interventions compared to baseline and presented as a percentage (%). For each 
endpoint, particpants were ranked basing on their response level from highest to 
lowest. Then, participants that ranked at the upper quartile (Q1) or the lower quartile 
(Q4) were identified, considering the effect direction of each assessed endpoint. There 
were 43 endpoints assessing cognition, 9 endpoints assessing vascular function and 
52 endpoints in total. Finally, based on the rank of the number of the endpoints that 
participants responded to from the largest to the smallest, the Q1 of participants were 
identified as the RS group. Respectively, based on the rank of the number of endpoints 
that participants non-responded to from the largest to the smallest, the Q1 of 
participants were identified as NRS group. Figure. 6.9 shows the number of endpoints 
for identifying RS and NRS. 
 
















Cognitive task endpoints 




Q2 – Q3 Q4 Q1 
*Q1: the upper quartile basing on the rank of response level: Q2 - Q3: the second to third 








Blueberry intervention Blueberry powder intervention 





















S1 16 3 13                   
S2 16 4 12               2 12 
S3       18   18         3   
S4 15   15   3   16 4 12       
S5 14   14             19   18 
S6     11 14 6     4         
S7 16   13             16   16 
S8                         
S9                         
S11               3         
S13               3         
S14             23   20       
S15             23   21       
S16   3                     
S18   4   15   13 16   14       
S19         3               
S20   3               17 5 12 
S21               3         
S22 16 5                     
S23 13   12             15   13 
S24       18 6         25 3 22 
S25           14   4   16   15 
Table. 6.3  (Continued) 
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S26         3   16   14       
S27               4         
S28         3         24 4 20 
S29         4     4         
S30               3   17   15 
S31 15   14             15 4   
S32   3                 5   
S33                         
S34   4       13         4   
S35   3   15   14             
S36       17   14 15   14       
S37       19 4 15 23   21       
S38 15   14       16   15       
S39       17   15         5   
S40       21 4 17 22   20       
 
*Total number of endpoints: 52; number of vascular function endpoints: 9; number of cognitive endpoints: 43 
RS in the total endpoints after whole blueberry intervention:  S1, S2, S4, S5,S7, S22, S23, S31, S38 
NRS in the total endpoints after whole blueberry intervention: S3, S6, S18, S24, S35, S36, S37, S39, S40 
RS in the vascular endpoints after whole blueberry intervention: S1, S2, S16, S18, S20, S22, S32, S34, S35 
NRS in the vascular endpoints after whole blueberry intervention: S4, S6, S19, S24, S26, S28, S29, S37, S40 
RS in the cognitive endpoints after whole blueberry intervention: S1, S2, S4, S5, S6, S7, S23, S31, S38 
NRS in the cognitive endpoints after whole blueberry intervention: S3, S18, S25, S34, S35, S36, S37, S39, S40 
RS in the total endpoints after blueberry powder intervention: S4, S14, S15, S18, S26, S36, S37, S38, S40 
NRS in the total endpoints after blueberry powder intervention: S5, S7, S20, S23, S24, S25, S28, S30, S31 
RS in the vascular endpoints after blueberry powder intervention: S4, S6, S11, S13, S21, S25, S27, S29, S30 
NRS in the vascular endpoints after blueberry powder intervention: S2, S3, S20, S24, S28, S31, S32, S34, S39 
RS in the cognitive endpoints after blueberry powder intervention: S4, S14, S15, S18, S26, S36, S37, S38, S40 





Table. 6.3  presents the participants that were characterised into either RS or NRS 
groups for the separate vascular or cognitive endpoints following the interventions 
based on the number of endpoints they responded or non-responded to. Following 
whole blueberry intervention, 2 participants (S1, S2) were identified as RS and another 
2 participants (S37, S40) were identified as NRS across both vascular and cognitive 
endpoints. Following blueberry powder intervention, 1 participant (S4) was identified 
as RS and 4 participants (S2, S20, S24, S28) were identified as NRS across both 
vascular and cognitive endpoints. For the assessment of total 52 endpoints, there were 
2 out of 9 participants (S4, S38) identified as RS following both whole blueberry and 
blueberry powder interventions. The remaining identified RS and NRS demonstrated 
random responses to either the total endpoints, or the separate vascular and cognitive 
endpoints.  
 
6.2.3 Effects of gender, BMI, and study visit order on response 
 
There was RS/NRS with different gender and with either normal (18.5 - 24.9 kg/m2) or 
overweight (25.0 - 29.9 kg/m2) BMI. Study visit effect (treatment sequence) was shown 
in intervention effect for some of the endpoints. Therefore, to assess the effect of 
gender, BMI and visit order on the response group, chi-square test was applied. The 
age group recruited in the current study is mostly young (97 % of pariticipants being 
less than 42 years old) so the association of age and response to clinical endpoints 
was not assessed. No relation between gender and response, BMI and response, or 
visit order and response was shown (Table. 6.4). 
 
Table. 6.4 The asscoaition of gender, BMI, and study visit order with response 









Gender X2 =1.000 P = 0.620 X2 =1.286 P =0.576 
BMI X2 =0.000 P =1.000 X2 =0.000 P =1.000 
Visit X2 =0.000 P =1.000 X2 =1.067 P =0.587 
Vascular 
Function 
Gender X2 =0.234 P = 1.000 X2 =1.000 P =0.620 
BMI X2 =0.234 P = 1.000 X2 =0.000 P =1.000 
Visit X2 =0.533 P =0.766 X2 =0.900 P =0.638 
Table 6.4 (continued) 
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Cognition 
Gender X2 =1.000 P =0.620 X2 =3.600 P =0.206 
BMI X2 =0.234 P =1.000 X2 =0.000 P =1.000 
Visit X2 =1.111 P =0.574 X2 =1.067 P =0.587 
*: Degree of freedom =1; sample size (N) =18;  2-sided alpha level of 0.05 significance 
 
6.2.4 Receiver operating characteristic (ROC) curve analysis for RS and NRS 
groups to blueberry powder 
 
There were more ion features increased in intensity following blueberry powder 
intervention (85 %) compared to whole blueberry intervention (57 %) as shown in 
Chapter 5. Therefore, only the blueberry powder group was chosen for the ROC 
analysis in order to identify predictive biomarkers for response. Responder (RS) and 
non-responder (NRS) in response to blueberry powder intervention underwent 
biomarker analysis in MetaboAnalyst 5.0. Baseline data only was used to identify 
predictive features as any predictor of response should be found pre-intervention. 
Figure. 6.10a shows the ROC curve for a random forest classification model created 
using a subset of 100 features selected by the random forest ranking. The area under 
the curve (AUC) value was 0.701 and 95 % confidence interval (CI) was 0.247 - 0.889. 
Meanwhile, the predictive accuracy for the variables was 61.3 % (Figure. 6.10b). The 
predicted class probability for each RS and NRS sample based on AUC is shown in 
Figure. 6.11. The predication results demonstrated that in the 9 RS samples, 5 were 
predicted correctly, and in the 9 NRS samples, 6 were predicted correctly. The 
features were further ranked by their contribution to discriminate between RS and NRS 
as shown in Figure. 6.11. There were 79 % of total features higher in intensity for NRS 
relative to RS. Feature intensity in RS group was also indicated whether was higher 
or lower relative to NRS group in Figure. 6.12. 
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Figure. 6.10 The ROC curve (a) and the predictive accuracy (b) discriminating 































*a. the corresponding sensitivity and specificity indicate the true positive rate and 1-false positive rate 
respectively for the prediction and AUC represents the degree of discriminability of the RS and NRS; b: 
the predictive accuracy changes with the number of features for permutation in the RF model 
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*The image shows the prediction probabilities of RS and NRS classes using Monte-Carlo 
cross validation (MCCV) analysis for each sample using the best classifier (based on AUC); 4 























*The selected frequency of the top features was based on random forest (RF) built-in method; 
importance of features were presented with selected frequency (%) in the predictive model from 
0.3 to 0.8 with the right axis indicating the relative concentrations of the corresponding metabolite 
in each group. 
 
As shown in Figure. 6.12, features were ranked based on a RF model in descending 
order of importance. However, actual intensities for those ranked features were higher 
in NRS group and thus cannot be used to predict response. There are some features 
with higher intensity in RS but all ranked low in the RF model and had low AUC values. 
Therefore, Table. 6.5 summarises the important features identified from the ranking 
and also a number of features that showed higher intensity in RS relative to NRS. The 
performance details of ROC curve analysis are also summarised for the selected 
features including area under individual ROC curve, sensitivity and specificity, T-
statistics and Log2 fold change (FC). 
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Table. 6.5 ROC analysis details for individual features 







P value Log2(FC)c 
M2115 340.059 0.951, 95  % CI (0.815 -1) - 0.248 100 % 90 % 0.002 5.307 
M1193 184.085 0.926, 95 % CI (0.741 -1) - 0.116 90 % 90 % 0.002 2.454 
M1383 435.247 0.926, 95 % CI (0.753 - 1) 0.130 90 % 90 % 0.001 2.228 
M2340 152.059 0.926, 95 % CI (0.728 - 1) - 0.145 100 % 80 % 0.004 1.703 
M2514 296.077 0.914, 95 % CI (0.722 -1) 0.289 90 % 90 % 0.002 3.675 
M1170 144.042 0.914, 95 % CI (0.747 -1) 0.205 90 % 90 % 0.002 1.552 
M2313 320.075 0.901, 95 % CI (0.679 - 1) - 0.409 100 % 80 % 0.005 1.811 
M1953 511.278 0.901, 95 % CI (0.716 - 1) - 0.523 90 % 80 % 0.001 4.150 
M2512 302.124 0.889, 95 % CI (0.697 - 1) 0.241 90 % 90 % 0.014 1.684 
M0877 317.148 0.889, 95 % CI (0.667 - 1) - 0.185 100 % 80 % 0.002 1.499 
M2764 280.143 0.889, 95 % CI (0.704 - 1) 0.178 90 % 90 % 0.009 1.709 
M2784 151.029 0.889, 95 % CI (0.670 - 1) 0.080 100 % 80 % 0.018 1.271 
M1884 405.200 0.840, 95 % CI (0.598 - 1) 0.280 90 % 90 % 0.037 1.097 
M2075 170.069 0.728, 95 % CI (0.457 - 0.914) - 0.291 70 % 80 % 0.113 -0.919 
M0323 244.997 0.605, 95 % CI (0.304 - 0.864) - 0.376 80 % 60 % 0.650 -0.952 
M1950 161.094 0.556, 95 % CI (0.222 - 0.815) - 0.496 80 % 60 % 0.889 -1.009 
M2579 1310.866 0.543, 95 %CI (0.247 - 0.827) - 0.420 90 % 40 % 0.367 -2.261 
a : AUC: area under the curve with 95 % of confidence interval;  
b: Cut-off value indicates the criterion value of feature intensity that predicts RS;  




The cut off value here refers to a threshold for individuals being identified as either 
NRS or RS when the intensity level is lower than the cut of value. The corresponding 
sensitivity and specificity indicate the true positive rate and 1-false positive rate 
respectively for the prediction and AUC represents the degree of discriminability of  
the RS and NRS [259]. The higher these values are the better the prediction is. As 
shown in Table. 6.5, on the basis of cut-off values ranging from - 0.523 to 0.289 for 
predicting RS versus NRS using important features (AUC > 0.800) based on the RF 
method and the model exhibited sensitivities ranging from 90 % to 100 % and 
specificities ranging from 80 % to 90 %. However, the actual intensities for all these 
features were higher in NRS in relative to RS (Log2 fold changes 1.097 - 5.307), 
therefore these highest ranked features by RF model could not be used to predict RS. 
 
For individual features that presented higher intensity in RS compare to NRS, there 
were smaller AUCs ranging from 0.543 to 0.728, and moderate sensitivities ranging 
from 70 % to 90 % and smaller specificities ranging from 40 % to 80 %. M2075 and 
M3203 presented slightly higher AUCs but the intensity differences between RS and 
NRS were not significant. Therefore these features did not present the ability to predict 












































































*: P < 0.05; **: P < 0.01; ***: P < 0.001 
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6.2.5 Putative annotations of important features predicting RS and NRS 
 
Putative annotations for above features with KEGG compound identifiers (with C letter 
prefix) and putative KEGG biological pathways where available (Table. 6.6). Four 
putative annotations were made for features that had relatively higher intensity in RS 
including N-Carbamoylputrescine (M2075), 3,5-dimethoxy-2-methylphenol (M0323) 
Dihydrothymine (M1950), and Ganglioside GA1 (M2579). However, the features could 
not be used to predict RS because of low ROC analysis scores. 
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Table. 6.6 Annotated features from ROC analyses 
 
Features ID    m/z AUC, 95 % CI* Mass error (ppm)             Formula   Putative annotation KEGG ID and pathway 
M2115    340.059 0.951, 95 % CI (0.815 -1)      - 3.120                     C12 H16 N6 S3 N/A N/A 
M1193    184.085 0.926, 95 % CI (0.741 -1)       1.080                      C8 H12 N2 O3 N/A N/A 
M1383    435.247 0.926, 95 % CI (0.753 - 1)      - 2.110                     C21 H33 N5 O5 N/A N/A 
M2340    152.059 0.926, 95 % CI (0.728 - 1)       0.320                      C7 H8 N2 O2 N/A N/A 
M2514    296.077     0.914, 95 % CI (0.722 -1)      - 0.100                     C9 H17 N2 O7 P N/A N/A 
M1170    144.042 0.914, 95 % CI (0.747 -1)      1.490                       C6 H8 O4 2,3-Dimethylmaleate 
C00922,  map00760   
Nicotinate and nicotinamide 
metabolism; map01120   
Microbial metabolism in 
diverse environments 
M2313    320.075 0.901, 95 % CI (0.679 - 1)      1.680                       C12 H16 O10 N/A N/A 
M1953    511.278 0.901, 95 % CI (0.716 - 1)     - 2.170                      C27 H37 N5 O5 N/A N/A 
M2512    302.124 0.889, 95 % CI (0.697 - 1)      4.900                       C13 H25 N2 P3 N/A N/A 
M0877    317.148 0.889, 95 % CI (0.667 - 1)      0.750                       C14 H23 N O7 N/A N/A 
M2764    280.143 0.889, 95 % CI (0.704 - 1)      1.030                       C14 H20 N2 O4 N/A N/A 
M2784    151.029 0.889, 95 % CI (0.670 - 1)      N/A                                     N/A N/A N/A 
M1884    405.200 0.840, 95 % CI (0.598 - 1)      3.540                       C22 H33 N O2 P2 N/A N/A 




Arginine and proline 
metabolism; map01100, 
Metabolic pathways 




M1950    161.094  0.556, 95 % CI (0.222 - 0.815)     N/A                                    N/A Dihydrothymine C00906 
M2579   1310.866 0.543, 95 % CI (0.247 - 0.827)    - 0.550                       C69 H120 N10 O10 P2 Ganglioside GA1 C06136 
*: AUC: area under the curve, 95 % confidence interval 
 
 157 
6.3  Discussion  
 
6.3.1 Principal findings 
 
To our best knowledge, this is the first known study characterising inter-individual 
variations based on clinical endpoints assessing both vascular and cognitive health 
comparing the supplementation of dietary blueberry and blueberry powder. In the 
current study, 31 % - 71 % of participants presented improved responses and 29 % - 
66 % of participants presented worsened responses for the vascular and cognitive 
endpoints. A higher proportion (71 %) of participants presented improved responses 
to plasma nitrite concentration and self-rated alertness and these high proportions 
were only observed following the whole blueberry intervention. There were also more 
participants (3 % - 16 %) showing no changes in cognitive endpoints that assessed 
aspects of working memory, episodic memory, attention, and mood compared to 
vascular endpoints. In regards to the inter-individual differences in response levels, 
plasma nitrite and triglyceride concentrations and mental fatigue were observed to 
have the most dynamic changes. For example, plasma nitrite showed responses 
ranging from 525 % increase to 141 % decrease following the blueberry interventions. 
A dynamic response level from - 114 % to + 96 % for mental fatigue was observed 
compared to other cognitive endpoints following the interventions. There was no 
association found between participants characteristics (gender and BMI) or the study 
visit and the response. 
 
No consistent responders (RS) across multiple endpoints were identified in the current 
study. When characterising the inter-individual differences shown in the assessed 
endpoints, only a small number of RS (2 out of 9) demonstrated consistent responses 
to the assessment of the total number of endpoints following both of the blueberry 
interventions, but the response was not shown across both vascular and cognitive 
functions. This finding could be expected as the assessed endpoints are in different 
biological systems [260]. Among 52 assessed endpoints, the consistency of improved 
responses was not high for most of the identified RS and no consistent responses 
were shown for vascular and cognitive endpoints. Only 3 participants (S14, S15 and 
S37) showed the most consistent response as they all were identified as RS in the 
assessment of 44 % of endpoints. However, their responses to cognitive and vascular 
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functions were not consistent. The comparison of response across more similar or 
closely associated endpoints may be necessary to observe a consistent response for 
individuals. Furthermore, most of the ion features presented higher intensity in NRS 
(79 %) relative to RS and there was no metabolic predictor for RS identified in the 
study. Therefore, the identified responses across clinical endpoints in the study were 
random. 
 
6.3.2  Inter-individual variations in the response of clinical endpoints 
 
For the endpoints assessing vascular function, non-invasive assessment of vascular 
function including PWV, BP and lipid profiles have been reported previously with SD 
ranging from 1.2 - 7.7 but reached up to 23.6 for plasma nitrite concentrates following 
either blueberry powder or juice interventions [16]. Similar to these findings, in the 
current study, the plasma nitrite response demonstrated the highest inter-individual 
variation (- 141 % - + 525 %) following blueberry interventions compared to other 
vascular assessments. The highest trend of intervention effect shown on nitrite level 
may also explain this observation. Plasma nitrite (NO2-) is converted from nitrate (NO3-) 
and body nitrate (NO3-) stores can be boosted via diet (e.g. from leafy vegetables and 
beetroot) quickly and approximately 25 % of NO3- can be absorbed and concentrated 
in the saliva to be converted to NO2- [261]. Therefore, apart from the potential effects 
following blueberry interventions, the dynamic conversions for nitrite in the circulating 
plasma can account for the fluctuations shown for the nitrite response levels. Pulse 
wave velocity (PWV) and blood pressure reductions have been shown to associate 
with NO3- - NO2- - NO pathway, and because of that it is logical to speculate similar 
response variations in PWV, SBP, and DBP [262]. However, the current study 
observed relatively moderate response variations for PWV (- 51 % to + 31 %) and 
small variations for SBP (- 20 % - + 17 %) and DBP (- 34 % - + 16 %) compared to 
nitrite. In order to further explore the consistency of response between participants for 
PWV, BP and plasma nitrite level, the current study compared participants for their 
response but no consistent response was identified. For instance, following the whole 
blueberry intervention, participant S25 showed improved response across PWV, SBP, 
and plasma nitrite endpoints but not DBP and participant S2 showed improved 
response across PWV, SBP, DBP but not plasma nitrite. No other participants were 
identified with a consistent response across vascular endpoints including PWV, SBP, 
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DBP, plasma nitrite, glucose and lipids. Therefore, no consistency was observed for 
the response across the vascular endpoints.  
 
For the endpoints assessing cognition and mood, there were also larger proportions 
of participants presenting with no changes in the cognitive endpoints relative to other 
endpoints. The susceptibility of participants in response to different assessments may 
lead to different extent of response but it’s worth noting that the cognitive tasks for the 
current study were selected on the evidence of previous sensitivity to nutritional 
interventions [204, 263]. The complex regulatory mechanisms of cerebral blood flow 
and cognition may explain the lack of intra-individual changes on cognitive 
performances following the interventions [156]. It’s interesting to notice that following 
the Mediterranean diet, the inter-individual difference in response to alert score was 
also higher (+ 6.93 of response change) compared to content (+ 5.35 of response 
change) and calm (- 0.28 of response change) based on the visualised rating scale 
[95]. The current study observed a similar trend for alertness (- 70 % - + 59 %) 
compared to content (- 41% - + 41%) and calm (- 39 % - + 60 %). The inter-individual 
variations were not limited to mood assessment though. The inter-individual 
differences in cerebral blood flow dynamics, neural correlates, heritability, physical, 
social environment, and personality all constitute complex associations between 
individual response and specific cognitive domain phenotype. The review in Chapter 
2 demonstrated a larger variation across studies assessing memory (SD of 2.2) 
relative to executive function (SD of 0.08 - 0.16) following either blueberry powder or 
blueberry concentrate intervention [77, 93, 94]. However, in the current study, working 
memory, episodic memory and attention all demonstrated moderate to high variations 
(- 39 % - + 61 %) and only participant S36 showed improved response across working 
memory, episodic memory and attention but not mood assessments after the 
blueberry powder intervention. No other participants had a consistent response across 
cognitive endpoints so that the response in cognitive abilities also seemed random 
across domains.  
 
Unfortunately, there are limited studies characterising response in vascular and 
cognitive endpoints at the individual level. Most studies reported average response for 
group effects only and the variation for response were reported utilising mostly SD and 
coefficient of variation [88, 89]. No other study was found that has compared the 
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individual response across clinical endpoints. The current study assessed response 
variations at the individual level for both the vascular and cognitive endpoints following 
the blueberry interventions. A high range of inter-individual variations was observed 
but no consistent response of individuals was identified across the assessed 
endpoints. It is worth noting that a trend of improved plasma NO2- level was observed 
following the blueberry intervention (Chapter 5) and more people responded with high 
levels in the endpoint of NO2-. Therefore, if significant treatment effects were observed 
with longer duration and/or larger dosage, the responses might show more 
consistency across endpoints. It is also logical to presume that the response is random 
if no consistency was found even a significant treatment effect was shown following 
the same type of intervention. Therefore, the inter-individual variation may be due to 
the fact of either the absence of treatment effect or the random effect and similar 
studies to the current one may be necessary for further exploration. 
 
6.3.3 Predictors of response 
 
The inter-individual variations in response to diet have been widely studied 
complementing the investigation of metabolomic differences induced by nutritional 
interventions. The first step in characterising the response is important. 
Characterisation of individuals that could benefit the most from a dietary intervention 
will help to target the phenotype in favour of the intervention. Currently, most studies 
characterised response (RS/NRS) including the development of a model or score 
based on the health outcomes assessment or the combination of metabolomics, 
genomics, gut metagenomics, body composition, and/or glycaemic responses for 
predicting response variations [89, 264-266]. Due to the development of ‘-omic’ 
technologies, most dietary interventions have been phenotyping participants for their 
genotypes, plasma, urine metabotypes, and gut microbiome or at least one of these 
factors [89, 264, 265]. A number of interventions also utilised quartiles or tertiles to 
characterise high or low response (RS/NRS) [267-269] or used a threshold number of 
improved level (e.g. ≥ 5 % compared to baseline) to report high response in the 
assessment of clinical endpoints [270]. 
 
The INRA POSITIVe COST action has addressed inter-individual variations in 
bioavailability and physiological responses to consumption of plant food bioactives in 
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relation to cardiometabolic endpoints across Europe [101]. One randomised controlled 
trial investigated the metabotype in order to explain the inter-individual variability in 
the assessment of cardiovascular biomarkers following pomegranate polyphenol 
extracts [257, 271]. The microbial-derived urolithin metabotype UM-B was shown to 
solely associate with individual improvement in the response of blood lipid profile 
including total cholesterol (- 15.5 ± 3.7 %) and LDL - cholesterol (- 14.9 ± 2.1 %) [271]. 
Although the individual response was not described, the metabotype could be used to 
predict RS that could benefit from pomegranate supplementation.  
 
Another study investigated the lipid metabolome in response to dietary interventions 
enriched in unsaturated fatty acids and a metabotype consisting of triacylglycerol, 
phosphatidylcholine lipid and apolipoprotein B fractions was identified to discriminate 
among the 3 participants [272]. Their study utilised a targeted investigation to identify 
lipid metabolic phenotype in an acute postprandial manner but with a very small 
sample size (n = 3), nevertheless if a large number of participants were included then 
the measurement of metabotype could be reproducible.  
 
In a similar approach, Garcia-Perez et al. developed a prospective dietary metabotype 
score (DMS) to directly map individual urinary metabolites to differentiate metabotypes 
[273]. A ranking was used with DMS to further classify individual responses into either 
a healthy or unhealthy diet based on WHO guidelines [273]. Their DMS score 
consisted of nutrient responsive metabolites including hippurate, 3-methylhistidine, 
carnitine that derived from intake of specific foods. When the metabotypes following 
the highly controlled healthy or unhealthy diet were profiled, other individual’s 
metabotypes in the DMS score could be used to predict the diet they were adhering 
to. A significant association between urinary metabotypes and glycaemic and lipid 
profile was shown but the variation was not quantified in their study. Compared to their 
work, a DMS score could not be applied in the current study as only one unknown 
feature was found that significantly increased in intensity (m/z 233.163) following 
blueberry interventions and no metabotype predicting RS was found that would enable 
the development of a similar ranking scheme. Both their study and the current 
characterised urinary metabolites in order to identify RS that could present different 
metabolomic profiles but the current study could not identify neither one or a group of 
predictive metabolites that could distinguish different responses at the clinical 
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endpoints. The current study did not measure blueberry polyphenol metabolites and 
this may have been beneficial to improve metabotyping of response as demonstrated 
by Rodriguez-Mateos et al. that 21 plasma metabolites of blueberry anthocyanins 
were observed to correlate with improved endothelial function assessed by flow-
mediated dilation (FMD) chronically [189].  
 
Nevertheless, currently the in-depth characterisation of inter-individual variation in 
response to vascular and/or cognitive endpoint following blueberry-based 
interventions is still scarce. Rodriguez-Mateos et al. combined different human trials 
and animal models to provide evidence that blueberry anthocyanins metabolites in 10 
healthy humans (e.g. gallic acids) were linked to cellular gene expression variation   
(FOXO3 towards an cardiovascular protective profile) [189]. The investigators found 
74 % - 99 % of the variability in gene expression changes were explained by blueberry 
(poly)phenol metabolites including 3-O-ß-D-glucuronide and homovanillic acid using 
multivariate linear regression. The current study used a different approach of 
untargeted profiling and ROC analysis was utilised to explore the accountability of 
urinary untargeted metabolites for the inter-individual variability in response to 
vascular and cognitive endpoints. However, 79 % of features showed increased 
intensities in non-responder (NRS) group and thus cannot be used to predict response. 
Several features (i.e. m/z 170.069, 244.997, 161.094) demonstrated higher intensities 
in RS relative to NRS but the differences in the intensities were not significant and the 
area under the curves (0.56 - 0.72) and specificities (40 % - 60 %) did not achieve a 
high enough level to make them predictive for RS.  
 
6.3.4 Potential factors influencing inter-individual variation 
 
The influence of visit order (treatment sequence) on individual response was explored 
and no association was found. The inter-individual variation in the baseline level has 
been considered as fixed factor and covariate in the analysis of intervention effects on 
assessed endpoints and the baseline levels of each endpoint could also influence the 
individual response following the intervention. Even though the response level 
calculated in this chapter was presented as percentage change from baseline, 
participants with relatively higher cognitive level at the baseline were unlikely to 
achieve higher cognitive response further following a dietary intervention due to 
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‘ceiling effects’ [274]. Similarly, participants with relatively lower levels of vascular 
dysfunction risks, such as a low BP, maybe unlikely to achieve a reduction further 
[275]. Therefore, a larger sample group covering participants with both low and high 
health risks at the baseline may be necessary to investigate the association between 
baseline health risks with the response of vascular and cognitive endpoints. 
 
A large range of factors including SNPs, bioavailability and gut microbiota are known 
to influence the biological response [101]. Inter-individual variations induced by 
genetic mutations including ABCG5, NPC1L1, ABCA1, APOE that modulate response 
to a range of diet and food bioactive (i.e. flavonoids, plant-sterols, and Mediterranean 
diet) have been shown [257, 258, 276]. For instance, after ingestion in the 
gastrointestinal tract, enzyme catechol-O-methyltransferases (COMT, AA or GG 
genotype) at the genetic level is involved in anthocyanins metabolism and could play 
a role to induce variability in response to the intervention [277]. A range of 
polymorphism variations have been shown to associate with clinical phenotypes 
directly. For example, the COMT genetic variation (rs4646312) was shown to involve 
in the biological pathway of presynaptic depolarization and calcium channel opening 
across neuronal synapsis [278]. The SNP was reported with increased risks 
developing schizophrenia [279]. Gene ITPR1 (rs6798160) was shown to be 
associated with reduced levels of blood pressure via the NO pathway and 
maintenance of platelet homeostasis [280]. The genetic polymorphism variations such 
as GRIA1 (rs12153160), FADS1 (rs174546), APOE (rs429358), PTPN11 (rs11066301, 
rs11066320) that could be used to partially explain for the variations affecting 
responses to dietary intervention and physiological homoeostasis via other biological 
pathways of i.e. synapses protein-protein interactions, lipid metabolism regulations, 
molecule signal transductions, and vascular cell surface interactions [281].  
 
The variation in the bioavailability of blueberry polyphenols between individuals can 
lead to inter-individual variations in response to vascular function and cognition [190, 
282]. Generally, urinary and plasma anthocyanins metabolite levels are found low and 
the variation in urinary levels was between 0.009 ± 0.002 and 0.79 ± 0.90 % of the 
dose consumed, as measured in previous studies [45, 283]. However, some 
associations were found for polyphenol bioavailability with the clinical endpoints. For 
vascular function, Jin et al. have shown no improvement in vascular reactivity targeting 
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healthy participants supplementing with anthocyanin-rich blackcurrant juice and 
hypothesized that was due to the low concentrations (20 %) in juice and thus low 
bioavailability [284]. Rodriguez-Mateos et al. observed an improvement in endothelial 
function following acute blueberry juice intake related to the peak abundance of 
plasma metabolites vanillic acid, benzoic acid, hippuric acid, hydroxyhippuric acid and 
homovanillic acid, that may partially predict the improvement in FMD [285]. Compared 
to their work, no improvement in the endpoints was shown in the current study, but 
metabolomic profiling exhibited 85 % and 57 % of features with increased intensities 
following whole blueberry and blueberry powder interventions separately but only 21 % 
features increased intensity in RS. The inter-individual variations in response to the 
interventions could not be explained by excreted hippuric acid and (R)-3-(4-
Hydroxyphenyl)lactate identified from the current interventions as these were not 
validated for distinguishing between RS and NRS in the current study.  
 
For the association between polyphenol bioavailability and cognitive function, Ammar 
et al. recently reviewed acute and chronic effects of polyphenol-rich supplementations 
on cognitive function and brain health in young and middle-aged adults [286]. An acute 
and/or chronic intervention including a range of 70 - 747 mg polyphenols with 
bioavailability rates of ≥ 30 % may be necessary to improve brain and cognitive 
function assessing working memory and mental fatigue [286]. Compared to their 
findings, the current study supplemented 220 - 288 mg blueberry polyphenols but no 
improvement was shown for working memory and mental fatigue with response level 
ranging from - 58 % - + 74 % and - 50 % - + 74 % respectively, which may suggest 
less than 30 % of average bioavailability rate among participants in the current study. 
Singh et al. also suggested the difference between polyphenols or their metabolites 
that can cross blood-brain barrier (BBB) toward neuroprotective action [287]. 
Specifically, lipophilic and methylated flavonoids (e.g. naringenin and hesperetin) can 
readily cross the BBB compared to their phenolic counterparts [287]. Here, the putative 
annotation of metabolites discriminating between RS and NRS did not observe 
blueberry polyphenols and/or their derivatives and there may also be a low 
bioavailability of phenolic compounds crossing BBB in the peripheral blood circulation. 
 
Gut microbial metabolites could explain inter-individual variation in the response to 
dietary intervention also [257]. Manach et al. have summarised potential factors 
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including gut microbiota that are responsible for inter-individual variability in the 
bioavailability and the physiobiological responsiveness to the consumption of plant 
food bioactive enriching in polyphenols, carotenoids, and glucosinolates in relation to 
cardiometabolic health [257]. After ingestion, enzymes including β-glucosidases at the 
small intestine or the gut microbial level could induce variability between individuals 
affecting anthocyanin metabolisms [53, 54]. For direct association of gut microbial 
products with clinical endpoints, one dietary intervention found that the gut microbial 
metabolite 3-(4-hydroxyphenyl)propionic acid explained 8 % of the reduction in fasting 
plasma total cholesterol levels among healthy adults following an intervention with 
Aronia berry extract for 12 weeks [288]. Another study found lower levels of gut 
microbial metabolites short chain fatty acids (SCFAs) and butyrate in Parkinson 
disease (PD) to be significantly associated with poorer cognition and low BMI via 
energy homeostasis modulations or gut-brain pathways involving immune, endocrine, 
neural and humoral routes [289, 290]. 
 
Apart from above factors, age, BMI, sex, physical activity, smoking, Helicobacter pylori 
infection, blood lipids, medication intake have also been suggested to be responsible 
for inter-individual differences in the response to dietary intervention [101]. The current 
study did not find associations of sex, BMI with response, still, the relative importance 
for each factor to overall inter-individual differences is unknown. Those factors adding 
to the diversity and activity of gut microbiota and the metabolising phase I, II enzymes 
along with genetic variations (i.e. SNPs) all could affect the bioavailability in dietary 
polyphenols and thus play important roles in individual response of clinical phenotypes 
[257]. 
 
6.3.5 Limitations and implications 
 
The mapping for RS predictive features was built using urinary metabolites alone. 
Nevertheless, metabolites have been circulating in plasma prior to being excreted in 
the urine and those metabolites could represent the homoeostatic signatures of 
metabolism [273]. Only positive ion mode was analysed using LC - MS and the 
platform has certain limitations too that it has high sensitivity but requires metabolites 
to be efficiently ionized to be detected and tends to be more susceptible to variability 
[291]. In the current study, quartile division basing on the response level calculated at 
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the endpoints was utilised to quantify the number of responder (RS) and non-
responder (NRS) following the dietary blueberry interventions. Unfortunately, there 
was no consistent response identified, thus the characterisation of response was not 
differentiated at the metabolomic level between RS and NRS. This could be partially 
explained by a relatively small sample size for RS and NRS groups (9 each) and the 
inter-individual variation at the baseline. Therefore, the predictive features should be 
explored and validated in a larger population so that a larger number of response and 
a wider range of individuals can be classified as RS and NRS. However, it is worth 
noting that previous therapeutic studies have applied a similar quartiles calculation to 
characterise different responses for non-diabetic essential hypertensives following 
short-term thiazide treatment [217], or for physical fitness following training exercise 
[218] or for coronary syndrome patients following an antiplatelet therapy [219]. 
Furthermore, a genetic mapping for nutrient and physiological responsive variants 
may help to characterise RS and NRS in an intervention based on the genotypic 
feedback. A recent trial (Food4Me) has screened nutrient-responsive genes for 
participants to characterise participants for personalised dietary plans [292].  
 
The study here did not assess other factors, e.g. ethnicity, that may induce variations 
in the bioavailability of (poly)phenol metabolites from dietary interventions [293]. The 
ethnicity data was collected but there was not enough non-white participants to allow 
an assessment of its effects on the inter-individual variation. The study consisted of 
young adults only (97 % of participants being less than 42 years old) and the 
association of BMI, gender or the study visit order with response was not significant. 
The compliance of participants was assessed using a 1-day food diary that confirmed 
92 % of compliance, the presence of blueberry metabolites (e.g. hippuric acid) could 
have been used to confirm the compliance but the metabolite intensity was not 
significantly higher compared to the baseline. Gut microbial metabolites of blueberry 
(poly)phenols could induce variations in response following the dietary interventions 
[257]. Human gut microbes have also been explored that was combined with plasma 
and urinary metabolome in the studies of inter-individual variations in response to 
dietary polyphenols [293-295]. The non-invasive method of collecting faecal 
specimens for gut microbial analysis have been widely used [273]. To complement the 
investigation in the future, gut microbial metabolites could be used for studying inter-
individual differences in response to absorption, distribution, metabolism and excretion 
 
 167 
(ADME) of blueberry or blueberry polyphenol interventions in combination with other 
‘-omics’ methods. 
 
In conclusion, the novelty of the current study is the assessment of the consistency of 
individual response across endpoints and demonstrated that no consistency in 
response of vascular and cognitive endpoints was found. To our best knowledge, this 
is the first known study showing inconsistency of individual response across and within 
vascular and cognitive endpoints. The current study could not identify urinary 
metabolites for predicting RS in the understanding of the inter-individual variations 
manifested through vascular and cognitive endpoints. However, there remains many 
gaps in the knowledge. More approaches characterising responses in human 
interventions studies, data coupling with genotypic and lifestyle behaviour feedback 































The aim of the thesis was to characterise inter-individual variations in response to 
vascular and cognitive endpoints following the consumption of blueberries. Within 
each chapter, a range of relevant issues have been discussed, therefore, the following 
sections mainly focuses on the principal findings from the current thesis in the context 
of existing studies, limitations and potential implications for future research work.  
 
7.2 Principal findings 
 
7.2.1 Effect of blueberry interventions on vascular function 
 
The findings on vascular function are in disagreement with most non-acute blueberry 
interventions investigating outcomes including blood pressure (BP) and lipids, arterial 
stiffness and nitric oxide (NO) [69, 70, 72, 73]. Even though BP is commonly evaluated 
as an indicator of vascular function, studies exploring the ingestion of berries or their 
polyphenol bioactive compounds are not unequivocal on BP [16]. There have been 
interventions supplementing freeze-dried blueberry powder (22 - 45 g, 4 - 8 weeks), 
blueberry juice (480 ml, 8 weeks) that have reported either no effects [71-73] or 
improved effects on SBP, DBP [69, 70, 74] 
 
A trend for increased NO2- levels was observed following the blueberry and blueberry 
powder interventions in the current study. The NO synthesis system has been shown 
to benefit both peripheral and cerebral peripheral blood flow (CBF) [191].  
Anthocyanins, a rich polyphenol compound found in blueberry has been associated 
with blood pressure modulation by 3 predominant mechanisms including the 
regulation of endothelial nitric oxide NO synthases (eNOS) expression and activity to 
increase endothelial derived NO (a vasodilator for improving BP), the prevention of 
NO oxidative damage and radical-induced NO conversion such as the reaction caused 
by NADPH oxidative, or the inhibition of the angiotensin-converting enzyme (ACE) 
activity, endothelin-1, and thromboxane via inhibition of the cyclooxygenase (COX) 
pathway to eliminate synthesis of vasoconstricting molecules [296, 297]. Clinical trials 
with dietary polyphenols have also shown benefits on vascular function, with one of 
the proposed mechanisms via the NO3- - NO2- - NO pathway [298]. Despite these, the 
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current study found no significant effect of the interventions on SBP, DBP, and plasma 
nitrite (NO2-). During NO synthesis, the production of NO by iNOS (an NOS isoform) 
has been shown to be maintained for a longer duration and found in much higher 
concentrations in the cell than from the other isoforms of NOS [299]. So any regulatory 
effects on NO systems due to blueberry flavonoids could be beneficial over a longer 
term supplementation in addition to the acute (1 - 6 h) postprandial mechanisms [299]. 
Therefore, a longer intervention duration may be needed for a beneficial observation 
on nitrite levels and manifestation to blood pressure. 
 
However, one chronic blueberry intervention did not show an improvement in 
endothelial function and NO levels after receiving a blueberry drink (25 g freeze-dried 
powder) for 6 weeks [71]. Similar to the current study, blood samples were taken after 
fasting (approximately 12 h) following the blueberry ingestion, when Anthocyanins 
were possibly cleared from the circulation. Currently there is limited data of acute 
freeze-dried blueberry powder interventions investigating vascular function, the 
blueberry powder interventions reviewed in Chapter 2 were all longer-term 
interventions (22 - 50 g, 6 - 8 weeks) and have shown inconclusive results including 
the effect on NO levels [69-73]. Only one 6 h study supplied blueberry powder 
(equivalent to 240 - 560 g blueberry) and demonstrated an improvement in endothelial 
function in healthy humans within 1 - 6 hours after consumption [300]. Compared to 
blueberry powder interventions, there are several acute whole blueberry interventions 
(300 g, 24 h) that also showed positive results on improving peripheral vascular 
function but were from the same author [17, 18, 137]. Nevertheless, the vascular 
protective effects of whole fresh blueberry and blueberry powder supplementations 
have not been compared in a study before, despite the study duration.  
 
The health status of participants could also impact the study findings. Previous 
blueberry interventions (22 - 45 g blueberry powder, 150 - 300 g whole blueberry 
equivalent) assessing adults with high vascular (dys)function risks such as MetS and 
hypertension ranging from 6 weeks - 6 months have reported an improvement in at 
least one of the outcomes (i.e. PWV, BP, lipids, NO levels) compared to either the 
control or the baseline [16]. On the contrary, blueberry interventions targeting 
generally healthy people have reported limited changes to outcomes. An exercise 
intervention combined with blueberry treatment (150 g) among healthy people for 4 
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weeks, demonstrated inconclusive evidence regarding the effect of blueberry 
treatment on vascular (dys)function risk factors, where the HDL-cholesterol level was 
increased in the blueberry group but the TAG level was reduced in the control group 
compared to the baseline [301]. It should also be noted that McAnulty et al. assessed 
a healthy group and observed improved arterial function assessed by augmentation 
index (Aix), although no improvement was shown for PWV [70]. There was also 
significant reductions to DBP following the blueberry supplementation compared to 
baseline, however an improvement was exhibited in a subset of hypertensive 
participants (N = 9), the blood pressure of overall cohort was not affected [70]. 
However, there was one study reporting positive findings on vascular health in healthy 
adults following blueberry consumption. The intervention supplementing 22 g of 
blueberry powder daily that contained 300 mg of Anthocyanins for 1 month to low-risk 
healthy adults demonstrated significantly improved both FMD and 24-h SBP, the 
benefits to the vascular system were shown in healthy adults following both acute and 
chronic blueberry consumptions [189]. However, this was also the first study known to 
show both improved SBP and endothelial function in young healthy adults after chronic 
blueberry interventions (1 month). Thus, in humans, populations with elevated 
baseline inflammatory, hypertensive, hyperlipidaemia, and endothelial (dys)function 
risk factors may be necessary to observe a risk-reduction of blueberry consumption. 
 
7.2.2 Effect of blueberry interventions on cognition 
 
For cognition and mood assessment, long term interventions (100 mg extract powder 
- 200 g whole blueberry equivalent, 6 - 24 weeks) have shown inconclusive results on 
cognitive performance as reviewed in Chapter 3 [29, 68, 77]. The potential effect of 
polyphenols and their impact on cognitive performances via alleviation of 
neuroinflammation, oxidative stress, neuroplasticity in animal models of 
neurodegeneration and aging have also been discussed in other systematic literature 
reviews [36, 299]. Despite this, the results on cognitive changes in current study are 
in disagreement with most acute studies assessing cognition and/or mood that mainly 
included elderly participants. 
 
In addition to vascular effects, the timings of cognitive effects observed also appear 
related closely to the absorption and metabolism rates of the supplemented fruit and 
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its phenolic compounds [299, 302]. This may also explain why more acute studies 
following blueberry supplementations reported positive influence on cognition and 
mood compared to long-term studies. The timings of plasma polyphenol metabolites 
reaching peak intensities at 1 - 2 h and 6 h following blueberry consumption have been 
observed to correspond with 2 peak timings of cognitive effects [300]. This 
corresponding association between peak timings (1- 6 h) of other fruit flavonoids 
including quercetin, myricetin, and kaempferol and their metabolites have also been 
observed for the positive cognitive findings on memory, executive function and mood 
[299].  
 
There were more acute blueberry interventions assessing cognition and/or mood. 
Currently there is correlation suggested between working memory and executive 
function but no correlations of the improvements for cognitive domains following fruit 
interventions were found [152]. There were more acute (25 - 30 g freeze-dried powder, 
2 - 8 h) interventions reported positive cognitive findings on at least one of the aspects 
of episodic memory, executive function and mood compared to the chronic 
interventions. There have been no acute studies supplementing whole blueberry 
though. Blueberry flavonoids have shown acute vasodilatory effects by increasing both 
peripheral and cerebral blood flow (CBF) postprandial [191]. Greater CBF velocity 
usually corresponds with a lower rate of cognitive decline and lower risk of dementia 
in healthy ageing [299]. Glucose control, neuronal enhancement by inhibiting 
monoamine oxidase (MAO) for monoaminergic neurotransmission during cognitive 
performances and improved visual function have also been shown to associate 
extensively with blueberry or flavonoids supplementations acutely [299]. In the current 
study, all drawn blood samples and cognitive assessments were completed following 
overnight fasting (> 12 h), it’s possible that the circulating metabolites, including 
polyphenol metabolites, remained in the CBF circulation and exerted any effect 
acutely and were eliminated from the body on the testing days. However, this was not 
confirmed as bioavailability was not measured in the current study.  
 
It is also worth noting that most blueberry interventions have targeted older 
participants and reported positive findings on cognition or mood in participants with 
cognitive impairment or older participants with age-related cognitive decline. Improved 
executive function, working memory, functional mobility and episodic memory have 
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been reported in older participants (60 - 92 years) following either 100 mg extract - 24 
g blueberry powder, 30 ml blueberry concentrate or 200 g frozen blueberry for daily 
consumptions during 6 weeks to 24 weeks [29, 68, 77, 93]. Only one study 
supplementing 25 g freeze-dried blueberry powder (equivalent to 148 g whole 
blueberry) daily to older people (68 - 92 years) with mild cognitive impairment has 
found no improvement in working memory and mood [94].  For healthy participants, 
cognitive improvements have been observed in an acute study (2 - 8 h) in younger 
adults (< 60 years) following blueberry interventions (25 - 30 g freeze-dried powder, 2 
- 8 h) [303, 304]. The acute postprandial effect of blueberry may contribute to the 
difference as discussed in the previous section. 
 
From the above, interventions targeting high-risk populations consistently 
demonstrated positive findings on the improvement to vascular health and/or cognitive 
health. The current study intended to include older individuals but only younger 
populations were recruited. Results from the current study are consistent with many 
blueberry interventions targeting low-risk populations. In conclusion, low-risk 
populations (< 60 years old and healthy) receiving either blueberry powder or whole 
blueberry (100 mg extract - 560 g whole blueberry equivalent) or concentrate (30 ml) 
supplementations both acutely (1 - 24 h) and chronically (6 - 24 weeks) have shown 
less effects compared to high-risk populations towards vascular- and cognitive-
protective benefit following blueberry consumptions independent of the various 
dosage and duration implemented.  
 
7.2.3  Difference in metabolite profile between whole blueberry and blueberry 
powder interventions  
 
The metabolomic difference and inconsistency of response between whole blueberry 
(57 % of features increased intensity) and blueberry powder (85 % of features 
increased intensity) was also found here despite there being no interventional effects 
on clinical endpoints from both of the interventions. Although freeze-dried blueberry 
powder usually arises from 100 % whole blueberry, the technological processing of 
blueberry powder from the whole blueberry could also change the bio-accessibility and 
absorption of bioactives [78]. However, as both the metabolomic differences were not 
significant and either was any improvement in clinical outcomes, the current thesis 
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could not conclude if whole fresh or powdered blueberry is the most effective at 
improving vascular and/or cognitive health. 
 
The present study observed individual differences in response to the whole blueberry 
and blueberry powder interventions. The high inter-individual variation may account 
for the non-significant changes in the results, despite the potential benefit of dietary 
blueberries for improving vascular and cognitive functions. In this study, the clinical 
endpoint of participants at baseline were in the normal, healthy physiologic range, 
therefore, the effects of whole blueberry or blueberry equivalent powder should be 
evaluated further on subjects with high health-risk levels.  
 
The inter-individual variation following the blueberry interventions was further explored 
by untargeted metabolomics. Putative metabolites of phenolic acids were only 
detected post- blueberry consumption and blueberry powder consumption, which 
helped differentiate the untargeted metabolite profiles post- placebo consumption. 
Furthermore, putative metabolites hippuric acid and hydroxyphenolacetic acid, as 
found in our study showed differences in intensity between the two blueberry 
interventions, suggesting possible biokinetic differences post- whole blueberry and 
blueberry powder intakes.  One acute dose-response study examined whether the 
bioavailability of freeze-dried blueberry powder (poly)phenols is intake - dependant in 
9 healthy volunteers, where plasma hippuric acid was among the most abundant 
metabolites in different dosages consumed, followed by metabolites including 3- and 
4- hydroxyphenylacetic acids [41]. In a blackcurrant juice post- dose study, the 
hydroxyphenylacetic acid derivatives were detected in a minor group of participants, 
whereas hippuric acid derivatives were detected in all participants, suggesting 
metabolically inter-individual differences in the circulating levels of polyphenol 
metabolites [305]. Among hippuric acid derivatives, hippuric and 4-hydroxyhippuric 
acid reached max amount post-intake at 2 hours, where 3-hydroxyhippuric acid 
reached max amount post intake during 8 - 16 hours, suggesting different metabolic 
pathways for different berry polyphenols [305]. 
 
Biokinetic differences are usually assessed after a single dose and were not measured 
in our study, no studies comparing biokinetics of metabolites between whole blueberry 
and freeze-dried blueberry powder have been compared, as far as we know. It is 
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possible that there could be differences between whole blueberry or freeze-dried 
blueberry powder polyphenols biokinetics in terms of Cmax in the current study. 
Individuals could metabolically respond differently with different phenolic metabolite 
pathways due to complex kinetic mechanisms. Therefore, inter-individual differences 
in metabolomic pathways could account in part for the inconsistent responses found 
across the endpoints following the blueberry interventions.  
 
7.2.4 Consistency and prediction of response across endpoints 
 
Dietary interventions have been shown to reduce cardiovascular disease (CVD) risks 
by 60 % [306] and reduce Alzheimer’s disease (AD) risks by 35 % - 54 % [307]. 
However, individuals usually do not benefit from the full potential of the protective 
effects of a healthy diet because the phenomenon of inter-individual variability in the 
response [101]. It has also been calculated previously that approximately 40 % of 
participants could benefit from an intervention [308]. The current thesis observed up 
to 71 % of participants benefiting in their vascular function (+ 105 % - + 525 % of 
improved response level) and up to 71 % of participants benefiting their cognition (+ 
61 % - + 114 % of improved response level) following the consumption of whole 
blueberry (Chapter 6).  
 
Apart from the common benefit from polyphenol-rich fruit interventions on vascular 
and cognitive health, the two endpoints may not be directly linked but some 
associations were highlighted. For example, age‐related impairment in cardiovascular 
function may disrupt neuronal micro-environmental homeostasis and lead to impaired 
downregulation of cerebral blood flow (CBF) [309]. Vascular dysfunction is also an 
important contributor to Alzheimer's disease (AD) and treatments targeting vascular 
health may contribute to preserving cognitive function [310]. Therefore, the 
consistency of high response to both endpoints were of interest.  
 
Despite the moderate to dynamic inter-individual variations observed, several 
participants, for example participants S22 showed high responses to vascular function 
following whole blueberry intervention, S38 showed high response to cognition 
following both whole blueberry and blueberry powder interventions but the responses 
were not consistent across endpoints. No consistent response across endpoints 
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following both two interventions was identified. The assessment of response across 
endpoints is important because knowing if one individual will continue responding at 
high levels to another endpoint can help to maximise individual health benefits and 
give personalised nutrition guidelines.   
 
The current thesis also could not identify a predictive biomarker predicting RS group 
following blueberry interventions. Studies predicting individual response in the clinical 
endpoints following blueberry interventions are still scarce but the response variations 
have been explored previously in therapeutic trials that have undertaken quartile 
division to characterise high and low responses [217-219], similar to the present study. 
Currently, interventional studies that predicted responses to a range of clinical 
endpoints can be divided into either a prospective [89, 264, 265, 272, 273] or 
retrospective [267, 271, 311] design. For the first type of studies, the responder/non-
responders (RS/NRS) are usually identified with known conditions and a range of 
biomarkers and response was further characterised post-intervention. These types of 
studies are usually able to report strong predictors that are associated with RS either 
downstream or upstream in a biological pathway such as the investigation of predictive 
biomarkers for CVD [312] and type 2 diabetes [313]. 
 
The current study falls under the latter category that required the characterisation of 
RS/NRS prior to applying biomarker analysis to search for predictors for response. 
The characterisation of RS and NRS has previously included development of a model 
or score based on the health outcomes assessment or the combination of 
metabolomics, genomics, gut metagenomics, body composition, and/or glycaemic 
responses for predicting response variations [89, 264-266]. To identify candidate 
prognostic metabolites, various statistical approaches have been used. Receiver 
operating characteristic (ROC) curve analysis is usually used to identify signature 
biomarkers [265, 314], linear mixed model and logistic regression models have also 
been applied to obtain associations between the response and the predictive 
biomarkers [265, 273].  
 
However, to our knowledge, there have been no previous studies investigating the use 
of predictive markers for screening potential responders to maximize the benefits of 
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blueberry interventions improving vascular and cognitive function. In addition, we 
tested whether there are predictive metabolite(s) validated by ROC analysis. However, 
the ROC curve for the top 100 metabolites basing on random forest model did not 
confirm any single feature to be predictive for RS, highlighting that more work including 
larger sample size and further fragmentation identification need to be done to identify 
predictive metabolites. The association between the response and the biomarkers 
could not be explored further due to the lack of predictive biomarkers.  
 
7.3 Limitations and implications for future work 
 
To our best knowledge, this is the first study that has compared effects on vascular 
and cognitive health coupled with untargeted metabolite profiling between whole 
blueberry and freeze-dried blueberry powder interventions in the same study. A 
number of other covariates should be considered apart from what were discussed in 
Chapters 5 & 6 that the use of a standardised blueberry interventions, populations and 
standardised control formulations should be considered when comparing with other 
similar studies. Those covariates include prescribed medications [315], participants’ 
sleep and exercise patterns [316, 317] apart from the variations in the anthocyanin 
content of whole blueberries as these may affect cognitive performances and vascular 
function. Those covariates should be better controlled in an RCT. The sample size 
calculation also should be carried out for each primary endpoint to decrease the risk 
of insufficient statistical power to detect a significant treatment effect [230]. However, 
the efficacy of improving vascular and cognitive health cannot be adequately 
established on the basis of a single endpoint, the number of endpoints analysed in the 
current thesis increased (n = 52). Therefore, the type II error rate of falsely concluding 
the intervention is ineffective is also increased [318]. 
Attention should be drawn to the fact that the intake of dietary blueberry 
supplementation could induce glucose loads and synergise with the postprandial 
effect of blueberry polyphenols. Dietary polyphenols, and vitamins act on cognition via 
pathways such as intracellular neuronal and glial signalling, energy metabolism, 
regulation of cerebral blood flow, and protection against neurotoxins and 
neuroinflammation [153-155]. Glucose loads could induce cognitive changes via 
sympathetic activation, glucocorticoid secretion, and pancreatic β-cell function, rather 
than simply boosting neuronal activity [319]. Nevertheless, the carbohydrate intake 
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was analysed and no significant changes were found between and within the 
intervention groups.  
 
There are other limitations in our study. Plasma and urinary metabolites of flavonoids 
and phenolic acids from blueberries can be found in vitro and in vivo [56]. However, 
blueberry polyphenols, and especially anthocyanins, are well-known for their low 
bioavailability in human plasma following ingestion [320]. The levels of polyphenol 
metabolites may also saturate after absorption and distribution as time increases [321]. 
Furthermore, circulating plasma polyphenol concentrations are much lower than 
urinary concentrations, whereas the plasma is essential to deliver the polyphenols and 
their metabolites to the targets exerting their physiological effect [320]. Although the 
biokinetics post-interventions in the current study are unknown, the dosage the 
subjects consumed in our study may not be able to maintain polyphenols levels within 
the body after absorption and overnight fasting (> 12 h) prior to the study visit. It also 
should be noted that the batch to batch variations in the nutrition value and polyphenol 
content, especially anthocyanins for whole blueberry, were not assessed in the current 
study [246]. There were also differences in the nutritional value and polyphenol content 
between freeze-dried blueberry powder and whole blueberry, arising from different 
cultivars, harvest and post-harvest processing [245]. Even though the total polyphenol 
content were assessed for the whole blueberry and blueberry powder, the Folin-
Ciocalteu method has limitations that may lead to inaccurate estimation of the phenolic 
compounds in the fruit [247, 248]. 
 
The LCMS profiling in negative ion mode and further fragmentation work were also 
absent in the current work, which could help to obtain a wider range of urinary 
metabolites. Furthermore, currently very few studies have combined genomics, 
epigenetics metabolomics, and gut microbiome and anthropometric characteristics 
together to assess individual response in the assessment of clinical endpoints 
following dietary interventions. The current study recruited mainly females (71 %) and 
there was no association suggested between gender and response. The above factors 
all could influence the absorption, distribution, metabolism and excretion (ADME) 
processes known to influence metabolic phenotypes [101]. However, a range of 
studies under the scheme of COST Action POSITIVe revealed a lack of knowledge 
about the carriers, enzymes, isoforms, and gut bacteria involved in ADME, making it 
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difficult to identify a key biomarker of ADME variability [101]. In addition, the genetic 
variations are not independent of the gut microbiome, although there is study 
indicating that the contribution of genetics to the microbiome is small (1.9 - 8.1 %) 
[322], this interaction in the influence on inter-individual variation in response must 
also be considered [266]. It is important to investigate how much each factor contribute 
to the inter-individual variations in response (i.e. via linear mixed method or 
multivariate analysis) following a dietary intervention in future work. 
 
It is also important to take social, cultural and personal dietary habit into account when 
tailoring dietary advice to the individual. Although the most challenging part for 
precision nutrition is to characterise individual response to diet from a population, the 
adherence from individuals to follow the dietary intervention is important. Therefore, 
factors including religion, ethnicity, socioeconomic status and lifestyle should be 
considered when designing interventions assessing individual responses that 
individuals can follow through [266]. The field of precision nutrition is still in its infancy, 
the current study did not identify a consistent response and predictive biomarker for 
response but demonstrated one approach for charactering individual response to 
blueberry consumptions in the assessment of vascular and cognitive health, the two 
important health endpoints. The challenges in the field still need to be conquered but 
the knowledge arising from studies similar to this could contribute to individuals and 




To conclude, the systematic reviews and meta-analyses of RCTs spanning at least 1 
week for the assessment of berry, citrus and cherry dietary interventions for improving 
vascular and cognitive health have suggested the potential for berry fruits overall to 
significantly improve SBP and DBP, and thus to benefit vascular function. However, 
the current study supplementing either 160 g whole fresh or 20 g freeze-dried 
powdered blueberry daily to healthy adults for 1 week found no significant effect in 
improving vascular and/or cognitive health. No significant difference of the efficacy of 
improving vascular and cognitive health was found neither between the whole 
blueberry and blueberry powder interventions. Moderate to high inter-individual 
variation for each endpoint was found and the response across endpoints following 
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the blueberry interventions was inconsistent between and within participants. No 
predictive biomarker for discriminating responders to the endpoints following the 
blueberry interventions was identified. Nevertheless, the findings from the current 
thesis suggests that a novel approach characterising response across endpoints 
following a dietary intervention beyond the ‘one size fits all’ dietary strategy is 
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et al. 2017 
(UK) 
1 1 1 1 1 5 
  
Riso et al. 
2013 (Italy) 





1 1 0 1 1 4 
  
Ruel, et al. 
2013 
(Canada) 















1 1 0 0 0 2 
  
Basu, A. et 
al. 2014 
(UK) 
1 0 1 0 0 2 
  
Basu, et al. 
2010  (US) 
1 1 0 0 0 2 
  
Basu, et al. 
2010 (US) 
1 1 0 0 1 3 
  
Basu, et al. 
2011  (US) 












1 0 1 0 0 2 
  
Del Bo, et 
al. 2014 
(Italy) 
1 0 1 1 0 3 
  
Dow, et al. 
2013 (US) 


































1 1 0 1 0 3 
  
Kent, et al. 
2017 
(Australia) 
1 1 0 1 1 4 
  
Khan, et al. 
2014 (UK) 









Lynn, et al. 
2012 (UK) 
1 0 1 1 0 3 
  
Lynn, et al. 
2014 (UK) 
1 0 0 1 0 2 
  
McAnulty, 
et al. 2014 
(US) 
1 0 1 0 0 2 
  
Murkovic, 
et al. 2004b 
Australia 





1 1 0 1 1 4 
  
Park, et al. 
2009 
(Japan) 
1 1 1 0 0 3 
  
Rodriguez. 
et al. 2016 
(UK) 





1 1 0 1 1 4 
  
Stull, et al. 
2015 (US) 





Appendix. 1.2 Example forest plot of berry interventions including (a) cranberry juice, (b) 
grape juice and (c) grape powder assessing FMD and (d) blueberry powder, (e) grape juice 
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to 5)  
Ahles et al. 2020 
(Netherlands) 
1 1 0 1 0 3 
















Lamport, et al. 











Bowtell et al. 
2017 (UK)  
1    1  1  0  1  4  
Boespflug et al. 











Calapai, et al. 











Chai, S. C. et al. 















Crews et al. 











Kent, et al. 2017 
(Australia)  
1  1  0  1  1  4  
Krikorian, et al. 













Krikorian, et al, 





































Schrager, et al. 
2015 (US)  
1  1  1  0  0  3  
Whyte, A. R. et 





1  1  1  5  
 
Appendix. 2.2 Forest plot of (a) Berry studies and (b) Cherry juice studies 
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CASE REPORT FORM 
 
Metabolic mechanisms underlying the responsiveness to blueberry 




Subject ID:                        ______ 
 
Randomisation Number:    ______ 
 
COMPASS Number:          ______ 
 
Subject ID:______  
. 






















Age at Enrolment: 
 
 
____  years 
 












  White 
  Black 
  Asian (Indian, Bangladeshi, Pakistani) 
  Chinese 









Subject ID:______  
. 
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Please check all following inclusion criteria: if one criterion is answered with “No”, the subject is 
not eligible for this study! 
                                           Yes No 
1.  Are you between the ages of 18 and 60 years (inclusive)?       
2. 
Willing to abstain throughout the trial from the intake of nutritional 
supplementation? 
      
3. Willing to abstain throughout the trial from the intake of blueberries or any 
blueberries containing and anthocyanin-rich products (other than those 
provided to you)? 
      
4. 
Have consumed blueberries before but don’t regularly consume blueberry or 
blueberry-contained products more than twice a week? 






Please check all following exclusion criteria: if one criterion is answered with “Yes”, the subject is 
not eligible for this study! 
                        “Do any of these apply to you?”    Yes No 
1.  Food allergies (only exclude if allergic to berries)       
2.  Have vascular disease, hypertension, or other cardiac abnormalities       
3.  Have previously suffered any head injuries, history of seizures or other 
neurological disorders  
      
4.  Have any metabolic disorders, malabsorption syndromes or gastrointestinal 
complications 
      
5.  Irregular bowel function (less than 1 bowel movement per day)   
6.  
Have regularly used nutritional supplements or medications within the 
previous 3 months (defined as more than 3 consecutive days or 4 days in 
total) 
  
7.  Learning difficulties and or dyslexia       
8.  
Visual impairment that cannot be corrected with glasses or contacts, 
including colour blindness 
      
Subject ID:______  
. 
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9.  Currently suffer from migraines (>1 per month)       
10.  
Smoking or the use of any nicotine replacement products e.g. vaping, gum, 
patches 
      
11.  Pregnancy, seeking to become pregnant, or current lactation   






 Yes     No 
13.  Not proficient in English equivalent to IELTS band 6 or above       
14.  Have any known active infections   










Is the Subject vegetarian?    
                                
  
  Yes 
  No 
 
Is the Subject vegan?                               
 
  Yes 
  No 
How many portions of fruit and vegetable does the subject eat in average per day? 
 
____  portion(s) per day 
 
(Portion = one piece of fruit, a handful of vegetables or a glass of fresh fruit juice (each additional glass of juice does not 
count as extra )) 
Subject ID:______  
. 







Physical examination after sitting in an upright position for 5 minutes. A first reading is taken but discarded. If the average 
reading is out of range, but the third is lower than the second reading, a fourth reading can be taken. This reading 
alone will then be used as the final measurement. Readings should be taken > 1 minute intervals. If BP is >139-89, 
subject must be referred to GP. 
1st reading 
Blood Pressure: 
                                          
 
Heart Rate:        
                                                         
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 
               ______ BPM 
2nd reading 
Blood Pressure: 





Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 






Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 






Heart Rate:         
 
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 





Heart Rate:         
 
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 
               ______ BPM 
 
If BP is ≥ 145/100   exclusion; suggest to inform GP for treatment 
Subject ID:______  
. 
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Exclusion Criteria continued: Physiological Examination  
 Yes     No 
1.  
Have high blood pressure (systolic over 145mm Hg or diastolic over 100 
mm Hg) 
      
2.  Have a Body Mass Index (BMI) outside of the range 18.5-30.0 kg/m







Is the subject eligible to be included in the study, fulfilling all inclusion criteria and none of the 
exclusion criteria?          Yes            No 
 
 
Height and Weight If BMI is out of the range 18.5 –30.0  exclusion 
                                                                                                                                                         
Body weight: ____ . __  kg 
 
Body height: ______  cm 
 




I confirm that the information contained in the CRF is correct: 
 
 




_________________________     Date: ____-____-____ (dd-mm-yy) 
Researcher’s signature 
Prior to discharge of the subject 
Subject ID:______  
. 
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Hand out 1-day food diary, food frequency questionnaire and urine collection packs (check 
urine kit is labelled correctly with Subject ID!) and give them the treatment if they are entering into 
the treatment phase next week! and ensure the participant understands they:  
- Must collect urine samples prior to testing visits (within 24 hours of study session) (see 
urine instruction sheet for full instructions)  
- Must record their dietary intake of the day prior next visit in 1-day food diary and bring it to 
testing visits. 
- Must fast for 12 hours prior to testing visits 2-6. 
- Should refrain from alcohol for 24 hours prior to their next study visit. 
- Should not consume medication (except oral contraceptives) for 24 hours prior to the next 
visit (avoid oral antihistamines for 48 hrs; avoid non-prescription medications (e.g. 
paracetamol, ibuprofen etc.) and local (spray) antihistamines for 24 hrs). 
- Should avoid all  anthocyanin-rich berries (i.e. blueberries, raspberries, blackcurrant) and 
cherries or any foods containing them from this point until the study completion 
- Will be required to give a urine sample (2nd urination of that day) when they arrive for their 
next testing visit) 
 
Subject ID:______  
. 
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Physical examination after sitting in an upright position for 5 minutes. A first reading is taken but discarded. If the average 
reading is out of range, but the third is lower than the second reading, a fourth reading can be taken. This reading 
alone will then be used as the final measurement. Readings should be taken > 1 minute intervals. If BP is >139-89, 
subject must be referred to GP. 
1st reading 
Blood Pressure: 
                                          
 
Heart Rate:        
                                                         
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 
               ______ BPM 
2nd reading 
Blood Pressure: 





Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 






Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 






Heart Rate:         
 
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 





Heart Rate:         
 
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 
               ______ BPM 
 
If BP is ≥ 145/100   exclusion; suggest to inform GP for treatment 
Subject ID:______  
. 
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Visit 3 BP measurement continued 
 
 
Physical examination after sitting in an upright position for 5 minutes. A first reading is taken but discarded. If the average 
reading is out of range, but the third is lower than the second reading, a fourth reading can be taken. This reading 
alone will then be used as the final measurement. Readings should be taken > 1 minute intervals. If BP is >139-89, 
subject must be referred to GP. 
1st reading 
Blood Pressure: 
                                          
 
Heart Rate:        
                                                         
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 
               ______ BPM 
2nd reading 
Blood Pressure: 





Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 






Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 






Heart Rate:         
 
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 





Heart Rate:         
 
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 
               ______ BPM 
 
If BP is ≥ 145/100   exclusion; suggest to inform GP for treatment 
Subject ID:______  
. 
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Visit 4 BP measurement continued 
 
 
Physical examination after sitting in an upright position for 5 minutes. A first reading is taken but discarded. If the average 
reading is out of range, but the third is lower than the second reading, a fourth reading can be taken. This reading 
alone will then be used as the final measurement. Readings should be taken > 1 minute intervals. If BP is >139-89, 
subject must be referred to GP. 
1st reading 
Blood Pressure: 
                                          
 
Heart Rate:        
                                                         
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 
               ______ BPM 
2nd reading 
Blood Pressure: 





Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 






Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 






Heart Rate:         
 
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 





Heart Rate:         
 
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 
               ______ BPM 
 
If BP is ≥ 145/100   exclusion; suggest to inform GP for treatment 
Subject ID:______  
. 
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 Visit 5 BP measurement continued 
 
 
Physical examination after sitting in an upright position for 5 minutes. A first reading is taken but discarded. If the average 
reading is out of range, but the third is lower than the second reading, a fourth reading can be taken. This reading 
alone will then be used as the final measurement. Readings should be taken > 1 minute intervals. If BP is >139-89, 
subject must be referred to GP. 
1st reading 
Blood Pressure: 
                                          
 
Heart Rate:        
                                                         
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 
               ______ BPM 
2nd reading 
Blood Pressure: 





Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 






Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 






Heart Rate:         
 
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 





Heart Rate:         
 
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 
               ______ BPM 
 
If BP is ≥ 145/100   exclusion; suggest to inform GP for treatment 
Subject ID:______  
. 
 Case Report Form                                                                                                     Page 202 of 15 
 
 Visit 6 BP measurement continued 
 
 
Physical examination after sitting in an upright position for 5 minutes. A first reading is taken but discarded. If the average 
reading is out of range, but the third is lower than the second reading, a fourth reading can be taken. This reading 
alone will then be used as the final measurement. Readings should be taken > 1 minute intervals. If BP is >139-89, 
subject must be referred to GP. 
1st reading 
Blood Pressure: 
                                          
 
Heart Rate:        
                                                         
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 
               ______ BPM 
2nd reading 
Blood Pressure: 





Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 






Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 






Heart Rate:         
 
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 





Heart Rate:         
 
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 
               ______ BPM 
 
If BP is ≥ 145/100   exclusion; suggest to inform GP for treatment 
Subject ID:______  
. 
 Case Report Form                                                                                                     Page 203 of 15 
 Visit 7 BP measurement continued 
 
 
Physical examination after sitting in an upright position for 5 minutes. A first reading is taken but discarded. If the average 
reading is out of range, but the third is lower than the second reading, a fourth reading can be taken. This reading 
alone will then be used as the final measurement. Readings should be taken > 1 minute intervals. If BP is >139-89, 
subject must be referred to GP. 
1st reading 
Blood Pressure: 
                                          
 
Heart Rate:        
                                                         
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 
               ______ BPM 
2nd reading 
Blood Pressure: 





Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 






Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 






Heart Rate:         
 
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 





Heart Rate:         
 
 
Systolic  ______ mm Hg 
  
Diastolic ______ mm Hg 
 
               ______ BPM 
 
If BP is ≥ 145/100   exclusion; suggest to inform GP for treatment 
Subject ID:______  
. 











Task Deviation from procedure 
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
 




Adverse Event Page 1 of 1 
 
  




Serious Adverse Event Start Date/ Stop Date 
 
Severity Relation-

















2= IP interrupted 
3= Dose reduced 









1= Recovered / resolved 
2=Recovering / 
resolving 
3= Recovered / resolved 
with sequale 




















































































































*Please fill in the complementary pages for serious adverse events and send it immediately to the sponsor. 
 
Record No ____  Comment: _____________________________________________________________________________________ 
 
Record No ____  Comment: _____________________________________________________________________________________
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Date of Completion/early withdrawal:  ____-____-____  (dd-mm-yy) 
 
Did the subject complete the study as planned?     Yes        No           
If No, please give primary reason for premature termination / discontinuation 
  Adverse event(s) (also specify on the Adverse Event form) 
 Major protocol violation, including non-compliance 
 Subject withdrew consent 
 Lost to follow-up 
 Administrative reasons 
 Pregnancy 
 Investigator opinion 
 Sponsor request 
 Other please specify 
 Death (please complete Serious Adverse Events form and record Adverse 
events leading to death on the Adverse Vents form) 
Date of Death ____-____-____  (dd-mm-yy) 
Principal Cause of death:___________________________ 




Was the randomisation code broken?  Yes        No   
 




Reason for breaking the  code:___________________________________________________ 
 
Name of person who opened the envelope: ________________________________________ 
 
  
I have reviewed and found all data pertaining to this subject to be complete and accurate: 
 
Principal Investigator’s Signature       _______________________ 
 
















Appendix. 3.2  1-day food diary 
Faculty of Health & Life Sciences 
1 DAY FOOD DIARY 
TITLE OF PROJECT:   Metabolic mechanisms underlying the responsiveness to 
blueberry interventions aimed at improving cognition and peripheral blood flow 
 
Principal Investigator: Yueyue Wang       Email: yueyue.wang@northumbria.ac.uk                                                                                                                                   
 
How to complete your 1 day food diary 
I would like each participant to keep the diary for one day before each study visit – it should 
be typical of your dietary habits.  It is important that every item of food/drink that is 
consumed is recorded and therefore it is a good idea to keep the diary with you at mealtimes 
and in-between meals.  It will be easier and more accurate, if you fill in the diary as you go 
along rather than leaving it until the evening.  Please indicate the time that the food/drink 
was consumed including the provided supplementation and note the quantity taken.  A good 
description is required.  Honesty is an essential part of the investigation so it is important 
that all foods and drinks are recorded! 
An example of how to complete the diary is shown on the next page. A list of anthocyanin-
rich foods you should avoid taking during the participation in this study is given in the 
Appendix.. 
The food diary templates that follow are for you to fill in accordingly.  These can be accessed 
electronically or simply completed by hand written format.  This will hopefully ensure the 






Date: 7/11/11                   ID Number:  
Before Breakfast 
Time:  7.15 am Description of food/drink:  
1 mug coffee with semi skimmed milk and 1 
tea spoon of white sugar. 
Breakfast 
Time: 8.30am Description of food/drink: 
Small glass of fresh orange juice (Tesco Value) 
2 medium slices of wholemeal bread (Hovis) 
toasted, thickly spread with Utterly Butterfly, 






Description of food/drink: 
1 Mars bar 
 
1 packet of Hula Hoops (Original - Ready 
Salted) 
Midday Meal 
Time: 1.00pm Description of food/drink: 
1 medium apple 
1 baked potato with cheese, beans and side 
salad. 
1 pint coca cola 
Mid-Afternoon Snack 
Time:3.00pm Description of food/drink: 
1 cup of tea with semi skimmed milk and 2 
teaspoons of white sugar. 





DATE:  ID Number: 
Before Breakfast 















Time: 6.00pm Description of food/drink: 
Large bowl of pasta with pesto (green) 
Topped with a handful of grated cheddar cheese 
Pint of tap water 
2 small strawberry Petis filous 






Description of food/drink: 
2 double vodka, lime cordial and lemonade 
1/2 bottle of rose wine (gallo) 
 
McDonalds Happy Meal, chicken nuggets with 
fizzy fanta. 
Final Checklist – Any forgotten items? 


















Description of food/drink: 
 
 
Supper Snacks and During Night 
Time: Description of food/drink: 
 
 
Final Checklist – Any Forgotten Items? 
 
Kindly please note that following listed “purple foods” should be avoid during your participation 
in this study 
Berries 
1. Blueberries  
2. Blackberries 
3. Blackcurrant 













2. Aubergine  
3. Red cabbages 
4. Red onions 
Juices 
All smoothie/juices blended from above foods 
Alcohol 
1. Red wine 
Other foods 
1. Pastry, cake or biscuits containing cherries and berries 
2. Cherries/berries containing muesli and fruit flakes 
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